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ABSTRACT 
Phosphorylation dependent structural function of DNA-PKcs in DNA 
repair and hematopoiesis 
Jennifer Crowe 
 
Genomic stability is essential for maintaining cellular function and preventing oncogenic 
transformation. DNA double strand breaks (DSBs) are the most severe form of DNA damage. Classical 
non-homologous end joining (cNHEJ) is one of two major DSB repair pathways in mammalian cells. During 
lymphocyte development, NHEJ is required for the repair of programmed double strand breaks (DSBs) 
occurring during V(D)J recombination and Class Switch Recombination (CSR). Defects in cNHEJ cause 
severe combined immunodeficiency (SCID) in patients and animal models. Misrepair of physiological DSBs 
generated during normal lymphocyte development results in clonal translocations, which is characteristic 
of human lymphoid malignancy: it is the most common cancer type in children and the third leading cancer 
type in adults. Lymphoid malignancies are characterized by clonal translocations involving the antigen 
receptor loci, which often arise from the misrepair of programmed double strand breaks (DSBs). 
Furthermore, cNHEJ also plays a critical role in aging and therapeutic responses to genotoxic cancer 
therapy.  
My thesis study focuses on the function and regulation of DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs). DNA-PKcs is a vertebrate specific NHEJ factor and one of most abundant proteins in 
human cells. Together with the DNA binding Ku70 and Ku80 heterodimer, DNA-PKcs forms the DNA 
dependent protein kinase (DNA-PK) holoenzyme. In addition to its important role in cNHEJ, DNA-PK also 
orchestrates the mammalian DNA damage response (DDR) together with the related ATM and ATR kinases 
by phosphorylating hundreds of partially overlapping substrates. My thesis goes deeper than the kinase 
and signaling function of DNA-PKcs during cNHEJ. We investigated the structural function of DNA-PKcs in 
cNHEJ (chapter 2) and A-EJ (chapter 3), using a mouse model with point mutations that lead to the 
expression of kinase dead (KD) DNA-PKcs. Second, we explored potential roles of DNA-PKcs outside of 
cNHEJ and A-EJ with a mouse model of DNA-PKcs lacking specific phosphorylation sites (chapter 4). 
Altogether, our results identified an unexpected structural function of DNA-PKcs in cNHEJ and the DNA 
damage response and expanded the purview of the function of DNA-PKcs into new areas, including 
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1: Hematopoiesis and early lymphocyte development 
Lymphocytes, together with other blood cell types, are derived through a hierarchical model from 
common and self-renewing hematopoietic stem cells (HSC). Hematopoiesis in mice and humans originates 
from a population of HSCs, which gives rise to multi-potent progenitors (MPPs). MPPs in turn give rise to 
common myeloid progenitors (CMPs) and common lymphoid progenitors (CLPs). While the CMPs further 
differentiate to megakaryocytes that ultimately give rise to erythrocytes, granulocytes, and monocytes 
(which in turn differentiate into macrophages). CLPs ultimately give rise to B, T lymphocytes and Natural 
Killer (NK) cells (Akashi et al., 2000).  
 
1.1: Hematopoiesis and erythropoiesis 
In general, myeloid cells, especially mature granulocytes, have a very short half-life in the 
peripheral blood (~36h in laboratory mouse strains) and are often used as a convenient indicator for nascent 
hematopoiesis. Yolk sac blood islands containing primitive erythrocytes are detectable in the mouse 
conceptus at embryonic day 7.5 (E7.5) (Russell ES, 1966). The erythrocyte is the most common cell type 
in adult blood and is essential for survival. While the origin of the adult megakaryocyte precursor has been 
one of the most debated areas in the past few years (Woolthuis and Park, 2016), the erythrocyte progenitor 
resides in bone marrow and maintains complex and essential interactions with niche environments, 
including responding to cytokines (i.e. TPO, SCF, and later EPO). The development from the pro-
erythroblast to the reticulocyte requires 4-5 rapid cell divisions and a progressive reduction in cell size. 
Accumulation of large and often immature erythrocytes (macrocytic) is a sign of de novo erythropoiesis. At 
the terminal differentiation stage, erythrocytes shed their nucleus, endoplasmic reticulum, and 
mitochondria, and, consequently are no longer able to proliferate. The new cells enter the circulation as 
reticulocytes that are still engaged in protein translation – maintaining a large number of ribosomes 
(O'Connell et al., 2015). 
  
1.2: Early lymphocyte development 
Once committed to lymphoid progenitors, the successful development of B and T lymphocytes 
requires the ordered assembly of the Immunoglobulin (Ig) and TCR gene products from germline variable 
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(V), diversity (D), or joining (J) gene segments- a process referred to as V(D)J recombination (Bassing et 
al., 2002a, b; Dudley et al., 2005). In human and mouse genomes, there are seven antigen receptor loci, 
which encode four T cell receptor genes (TCR ,,,) and three B cell receptors (also referred as 
Immunoglobulin, IG) genes (IgH, λ, κ). The two lineages of T cells are distinguished by the surface 
expression of either  or  TCRs (Krangel et al., 1998). TCR,  and  variable region exons are 
assembled in slowly cycling CD4-/CD8- (double negative, DN) thymocytes and productive TCR 
rearrangement is required for the differentiation from DN progenitor cells to CD4+CD8+ double positive (DP) 
precursor cells, at which stage the TCR assembly occurs (Krangel et al., 2004). Successful TCR 
rearrangement and surface expression of the TCR/ allow differentiation to CD4+CD8- or CD4-CD8+ single 
positive (SP) T cells and exiting of the thymus. The stage and lineage specific rearrangement of TCR loci 
is achieved by the activation of specific enhancer elements located at each receptor loci (Krangel et al., 
2004). In a similar fashion, the BCR gene products are assembled in developing B cells in the fetal lever 
and later adult bone marrow. IgH genes are assembled first via an ordered process in which D to JH joins 
are followed by VH to DJH joins (Dudley et al., 2005).  Productive VH(D)JH rearrangements in B220+/CD43+ 
pro-B cells signal differentiation to the B220+/CD43- pre-B cell stage where IgL genes (Igκ and Igλ are 
assembled. Expression of an IgL chain allows pre-B cells to develop into IgM+ B220+CD43- immature B 
lymphocytes, which migrate to the periphery.  
 
1.3: V(D)J Recombination 
V(D)J recombination is initiated by the recombination activating gene (RAG1/2), which recognizes 
conserved recombination signal sequences (RSSs), to introduce DSBs between participating V, D, or J 
gene segments and their flanking RSSs. RAG cleavage generates two types of DNA ends: blunt 
phosphorylated signaling ends (SEs) and covalently-sealed hairpin coding ends (CEs). SEs are precisely 
joined to form signaling joins (SJs). CEs are processed before ligation, resulting in imprecise coding joins 
(CJs). CE processing involves hairpin opening as well as the possible removal or addition of nucleotides. 
Except for the nucleotide addition mediated by the Tdt polymerase, end-processing and end-ligation of SJs 
and CJs are exclusively mediated by the cNHEJ pathway. The requirement for hairpin opening in CEs, but 
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not SEs, make V(D)J recombination an ideal system to isolate the end-processing and end-ligation steps 
during NHEJ. 
 
1.4: Class switch recombination  
Upon contact with antigen, naïve B lymphocytes undergo further gene modifications – CSR and 
somatic hyper-mutation (SHM) to achieve different effector functions (isotypes) and higher affinities, 
respectively. During CSR, DSBs occur at switch (S) regions located at the 5’ end of each set of the IgH 
constant region (CH) exons to be joined. While CSR is initiated by T cells in vivo, it can be induced in vitro 
with proper cytokine combinations (e.g. IL4 and anti-CD40 treatment). The Activation-Induced cytidine 
Deaminase (AID) initiates CSR by deaminating cytosine nucleotides to uracil nucleotides, creating 
mismatches in S regions that are subsequently converted to DSBs. In contrast to the exclusive requirement 
for cNHEJ during V(D)J Recombination, a significant portion (25-50%) of DNA repair during CSR can be 
mediated by the alternative end-joining (A-EJ) pathway, which preferentially uses microhomology (MH) at 
the junction (see below) (Boboila et al., 2010; Yan et al., 2007a), making CSR one of the best characterized 
systems to study the mechanism of A-EJ. 
 
2: The DNA damage response and associated signaling proteins 
The DNA damage response exists to respond to the many lesions cells receive daily, programmed 
or not. Lack of repair can cause mutations that, if not repaired, can accumulate and impair the healthy 
lifespan of the cell, which can cause problems like cancerous growth. DNA lesions come in many forms, 
from single stranded knicks to double stranded breaks (DSBs). To respond to this great variety of lesions, 
many proteins orchestrate a dynamic response to DNA stress called collectively the DNA damage response 
(DDR). 
 
2.1: The DNA Damage response 
 The DDR can be divided into 3 main phases: DNA lesion detection, DNA damage signaling, and 
lesion repair. PI3 Kinase related protein kinases (PI3KK), including ATM, ATR and DNA-PKcs, regulate 
these phases of the DDR. ATM and DNA-PKcs are activated in response to DSBs and ATR is activated in 
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response to RPA-coated ssDNA. ATM, in particular, is consisdered the master regulator of the DDR to 
DSBs (Jackson and Bartek, 2009). The Mre11/NBS1/Rad51 (MRN) complex senses DNA damage and 
recruits ATM to sites of DSBs (You et al., 2005). ATM then facilitates a signaling cascade that activates 
various downstream proteins to induce cell cycle arrest, repair protein recruitment, and repair protein 
activation. Proper repair results in the resumption of the normal cell cycle, while improper repair can lead 
to apoptosis or cellular sensence. The role and synergy of these PI3KK proteins (ATM, ATR, and DNA-PK) 
are further discussed below.  
 
2.2: PI3 kinase related protein kinases 
Within the PI3KK family, ATM, ATR and DNA-PKcs predominantly reside in the nucleus, are 
inactive under basal conditions and are rapidly activated upon DNA damage. While ATM and DNA-PK 
primarily respond to DSBs, ATR is activated by various types of DNA damage, including irradiation, DNA 
adducts, crosslinks and DNA polymerase poisons that can lead to the generation of RPA-coated single 
stranded DNA (Marechal and Zou, 2015; Zou and Elledge, 2003). It is worth noting that isolated nicks, 
which occur during normal transcription or nucleotide repair, do not efficiently activate the DNA damage 
response in mice. Activated ATM, ATR and DNA-PK phosphorylates overlapping substrates to promote 
efficient DNA repair and activate downstream cell cycle checkpoints or apoptosis signals in the event of 
unrepaired breaks. Together, they play important roles in genomic stability maintenance and human 
diseases, including aging, cancer and immunodeficiency.  
Over 800 substrates for ATM, ATR and DNA-PK have been identified from large-scale proteomic 
screens. Among them, nearly 100 have been characterized, including many substrates conserved in all 
eukaryotes (e.g. CHK1, CHK2) and several important tumor suppressor genes (e.g. p53, BRCA1, BRCA2). 
In an overly simplified manner, the well characterized substrates of the DNA damage response can be 
divided into two large classes – the ones involved in DNA repair and the ones that regulate checkpoint 
function.  The first class includes H2AX, which is rapidly phosphorylated upon DNA damage, resulting in 
the recruitment of other effector proteins to promote the recruitment of repair factors. The latter class 
includes p53. P53 is phosphorylated at the conserved S15 site (corresponding to Ser18 of murine p53), 
among others, upon DNA damage, resulting in the inhibition of MDM2-mediated p53 degradation and 
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stabilization of p53 (Saito et al., 2002). In response to DNA damage, p53 activates the G1/S checkpoint, 
causing cell cycle arrest and apoptosis (Bargonetti and Manfredi, 2002).  
 
2.3: ATM kinase  
ATM is a serine/threonine protein kinase that acts as a master regulator of the DNA damage 
response. Homozygous inactivation of ATM causes Ataxia-Telangiectasia (A-T) syndrome, a neurological 
disorder often accompanied by immunodeficiency and a predisposition to lymphoid malignancies (Lavin, 
2008). Most A-T patients harbor truncating mutations with no detectable ATM protein expression (Gilad et 
al., 1996). While not absolutely required for lymphocyte development, ATM kinase and its substrates are 
essential for “efficient and precise” DSB repair during both V(D)J recombination and Class Switch 
Recombination (CSR, see above) (Bredemeyer et al., 2006; Callen et al., 2007; Huang et al., 2007). Thus, 
loss of ATM causes reduced lymphocyte numbers (Borghesani et al., 2000), spontaneous chromosomal 
breaks and translocations at the TCR and Ig loci (Callen et al., 2007; Liyanage et al., 2000) and reduced 
serum IgA, IgE and IgG2 levels (Franco et al., 2006) in patients and mouse models. ATM also 
phosphorylates and activates cell cycle checkpoint proteins, including p53, Chk1 and Chk2 (Kastan et al., 
2000). While not absolutely required for lymphocyte development, loss of checkpoint function allows cell 
proliferation in the face of DNA damage, prompting chromosomal instability and ultimately transformation 
(Callen et al., 2007). Accordingly, loss of ATM and its substrates (e.g. NBS1, MRE11) predispose human 
patients and mouse models to lymphoid malignancies with translocations. Given the overlapping function 
between ATM and DNA-PK in DSB induced DNA damage responses, mouse models with double knockout 
of ATM and DNA-PKcs (or KU) die during early embryonic development (Gurley and Kemp, 2001; Sekiguchi 
et al., 2001). ATM and DNA-PKcs double deficient cells have completely abrogates end-ligation (Callen et 
al., 2009; Gapud et al., 2011; Zha et al., 2011). Although ATM and DNA-PKcs share many overlapping 
substrates, the Kap1 protein is predominantly phosphorylated by ATM and is often used as a marker for 





3: Mammalian DNA double stand break pathways 
 DSB occur consistently in mammalian cells, caused either by exposure to genotoxic agents (ie 
irradiation, oxidative stress, etc) or through programmed events that occur during lymphocyte and germ cell 
development. Two major pathways of DSB DNA repair exist in mammalian cells to resolve DSBs and 
maintain genomic integrity. The first pathway, homologous recombination (HR) is one of two major DSB 
DNA repair exist in mammalian cells to resolve DSBs and maintain genomic integrity. HR requires a DNA 
template, and therefore occurs exclusively in the S and G2- phases of the cell cycle. It also requires 5’ to 
Figure 1-1: Diagram of cNHEJ.  
(A) Upon double strand break induction (DSB, step 1), Ku70 and Ku80 form a KU dimer on the DNA ends. 
KU facilitates the recruitment of DNA-PKcs and Artemis (step 2), which perform end processing on complex 
ends (step 3). Next, the ligation complex composed of XRCC4, ligase 4 and likely XLF ligate the ends (step 




3’ end resection to expose 3’ single-stranded DNA overhangs required for homology search for a 
homologous template. The second pathway, Classical non-homologous end joining (cNHEJ), is discussed 
further below. 
 
3.1: Classical-NHEJ (cNHEJ)  
 NHEJ and homologous recombination are the two major DSB repair pathways in mammalian cells. 
NHEJ joins broken ends directly without templates (Bassing and Alt, 2004) and is the prominent DNA repair 
pathway in G1/G0 cell cycle phases when homologous templates are not predominent. NHEJ is specifically 
required for DNA repair in developing lymphocytes in the context of V(D)J recombination and CSR (see 
below). There are eight known cNHEJ factors. Among them, five are referred to as the core-NHEJ factors 
because they are evolutionarily conserved. These include Ligase4 (Lig4), XRCC4, Ku70, Ku80, and likely 
XLF. In response to a DSB, Ku70 and Ku80 form a KU heterodimer on the DNA ends, which recruits other 
cNHEJ factors. The other core-NHEJ factors, XRCC4, Lig4, and likely XLF are responsible for ligating DSBs 
(Fig. 1-1A). Paxx, a novel NHEJ factor was recently identified (Craxton et al., 2015; Ochi et al., 2015; Xing 
et al., 2015) and characterized as having potentially redundant function with XLF (Kumar et al., 2016; Tadi 
et al., 2016), with a key role in stabilizing KU at DNA ends (Liu et al., 2017). 
Cells lacking DNA-PKcs or Artemis can ligate blunt DNA ends together, suggesting DNA-PKcs and 
Artemis might not be essential for cNHEJ. DNA-PKcs and Artemis are not conserved in lower eukaryotes 
(e.g. yeast) and can only be found in vertebrates.  DNA-dependent protein kinase catalytic subunit (DNA-
PKcs) is recruited by Ku70/80 to form the DNA-PK holoenzyme. DNA-PKcs interacts with, and 
phosphorylates, Artemis, to open the hairpin sealed CEs and also fulfill other end processing functions 
during general DSB repair (Fig. 1-1A) (Lieber, 2010). Yet, direct end-ligation (e.g. SEs-> SJs) occurs 
efficiently in the absence of DNA-PKcs or Artemis (Fig. 1-1B) (Gao et al., 1998a; Rooney et al., 2002; 
Taccioli et al., 1998a). Accordingly, Artemis and DNA-PKcs deficient mice are born of normal size without 
other obvious phenotypes, but core NHEJ deficient mice (except XLF) lead to severe neuronal apoptosis 
and even embryonic lethality in the case of XRCC4/Lig4 null (Barnes et al., 1998; Frank et al., 1998; Gao 
et al., 1998c; Gu et al., 1997; Li et al., 1998; Nussenzweig et al., 1996; Zhu et al., 1996). The embryonic 
lethality in XRCC4 and Lig4 deficient mice is rescued by Ku deficiency (Karanjawala et al., 2002), 
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suggesting that the lack of Ku might allow other repair pathway(s), possibly the Ku-independent A-EJ 




3.2: Alternative-End Joining (A-EJ) 
A-EJ is generally defined as DNA repair that happens in the absence of cNHEJ. It has two major 
forms, one that depends on Microhomologies and one that create blunts joints (Fig. 1-2). In the context of 
CSR or a situation of “backup” CSR, A-EJ and Microhomology-mediated end-joining (MMEJ) are often used 
interchangeably to describe the repair of non-homologous breaks that occur in the absence of cNHEJ 
Figure 1-2: Diagram of possible A-EJ pathways.  
(A) Possible MH mediated pathway of A-EJ. (B) Possible direct end joining pathway of A-EJ. Adapted from 
(Boboila et al., 2012). 
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factors. A-EJ occurs through a poorly characterized mechanism that preferentially uses regions of MH, as 
during CSR to some isotypes (Boboila et al., 2010; Yan et al., 2007a). Notably while NHEJ “might” involve 
minimal end-processing in the form of hairpin opening or short deletion/addition of nucleotide (n<10nt), A-
EJ “requires” substantial end-resection (10-25nt or more) to expose the flanking MH. While the mechanism 
and specific proteins involved in A-EJ remain unclear, several repair proteins have been shown to facilitate 
A-EJ repair. These include Parp1, DNA ligase 1 and 3, as well as DNA resection nucleases like CTIP and 
Mre11 (Iliakis et al., 2015). Recently, the DNA polymerase θ has also been shown to be responsible for the 
insertions found during A-EJ (Kent et al., 2015). 
 
4: NHEJ and A-EJ in lymphocyte development and lymphomagenesis 
As discussed above, lymphocyte development requires both V(D)J recombination and CSR. V(D)J 
recombination induces deliberate DSBs between participating V, D, or J gene segments and their flanking 
conserved recombination signal sequences (RSSs; discussed further in Section 3.2), and repair is mediated 
by cNHEJ.  CSR induces DSBs occur within switch (S) regions at the 5’ end of each set of the IgH constant 
region (CH) exons to be joined (discussed further in Section 3.3). These DSBs are largely mediated by 
cNHEJ, with a significant contribution from the A-EJ pathway. The role of cNHEJ and A-EJ in V(D)J 
recombination and CSR are discussed further below.  
 
4.1: The Role of the cNHEJ pathway in V(D)J recombination   
During V(D)J recombination, the core-NHEJ factors are required for end-ligation involving both SEs 
and CEs, while DNA-PKcs and Artemis are dispensable for SJ formation but required for opening hairpin 
sealed CEs before CJ formation (Gao et al., 1998a; Rooney et al., 2002; Taccioli et al., 1998a). 
Consequently, defects in all cNHEJ factors cause defects in lymphocyte development due to impaired V(D)J 
recombination. While Artemis and DNA-PKcs deficient mice have little other phenotypes, Ku70 and Ku80 
deficient mice have growth retardation and increased neuronal apoptosis (Gu et al., 1997; Li et al., 1998; 
Nussenzweig et al., 1996; Zhu et al., 1996), and XRCC4 or Lig4 deficiency results in late embryonic lethality 




4.2: The role of cNHEJ and A-EJ during Class Switch Recombination 
In XRCC4 or Lig4 deficient lines, CSR is reduced to 25-50% of WT levels in all isotypes with the 
remaining CSR exclusively mediated by A-EJ that preferentially uses MH at the junction (100% of MH). In 
Ku-deficient cells, CSR is reduced to 25-50% of WT levels, with a skew to MH mediated end joining (Boboila 
et al., 2010). There is only a moderate reduction in IgG1 CSR efficiency (80% of WT levels) in DNA-PKcs 
null cells, with no defects in CSR to other isotypes (Franco et al., 2008b; Manis et al., 2002) and almost no 
defects in CSR in Artemis-deficient cells. In further support of a non-essential role in CNHEJ, DNA-PKcs or 
Artemis null embryonic stem (ES) cells are more resistant to IR than completely NHEJ deficient lines (Frank 
et al., 1998; Gao et al., 2000; Gao et al., 1998c; Karanjawala et al., 2002). Together, these data suggest 
that DNA-PKcs and Artemis are only required for a subset of CNHEJ, especially those requiring end-
processing, and not for direct end-ligation.  
About 40% of Sµ-Sγ1 junctions from WT cells are direct, but <5% Sµ-Sγ1 junctions from XRCC4-/- 
or Lig4-/- cells are direct (Boboila et al., 2010; Yan et al., 2007b). Notably Ku-deficient or Ku plus Lig4-
deficient B cells are also biased toward MH-mediated CSR joins; but, in contrast to XRCC4 or Lig4-deficient 
B cells, generate substantial numbers (10-20%) of direct CSR joins (Boboila et al., 2010). This finding 
implies that there may be at least two different kinds of A-EJ pathways: the Ku-dependent, pure MH-
mediated and the Ku-independent, MH-mediated and direct joining. Other than the specific NHEJ factor 
that is absent, the degree of MHs is also influenced by the availability of MH in the flanking sequences. 
Switch regions favor A-EJ (MMEJ subset) because of their repetitive nature. Consistent with the limited role 
of DNA-PKcs and Artemis in direct end-ligation, DNA-PKcs or Artemis null B cells had at most moderate 
defects in CSR that is detectable only by very sensitive IgH FISH analysis (Franco et al., 2008a; Rooney 
et al., 2005). 
 
4.3: The role of cNHEJ and A-EJ in tumor suppression 
In a p53-deficient background, all known CNHEJ deficient mice (except XLF), develop aggressive 
pro-B cell lymphomas with IgH-Myc translocation and co-amplifications (Rooney et al., 2004). Junction 
analyses of the Lig4-/-p53-/- pro-B cell lymphomas revealed long MH in all junctions, suggesting that A-EJ 
contributes to oncogenic translocations (Zhu et al., 2002). Indeed, many of the oncogenic translocations 
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between Ig and proto-oncogenes in human B cell lymphomas display evidence of A-EJ. In addition to pro-
B cell lymphomas, XRCC4-/-p53-/- and Lig4-/-p53-/- deficient mice, but not DNA-PKcs-/-p53-/- mice, also 
develop medulloblastomas with N-myc amplifications (Gostissa et al., 2009).  
 
5: DNA-dependent protein kinase catalytic subunit (DNA-PKcs) 
 DNA-PKcs is a large, ~460kDa serine/threonine kinase. The activation of DNA-PKcs kinase activity 
depends on the Ku70/Ku80 heterodimer, which binds DNA double strand breaks (DSB) with high affinity. 
Together, KU70, Ku80 (KU86 in humans) and DNA-PKcs form the DNA-dependent protein kinase (DNA-
PK). DNA-PK has been implicated in the DNA damage response, DNA repair, as well as in telomere 
maintenance and even transcriptional regulation.  Here, we focus on the role of DNA-PKcs in DNA repair, 
especially in the context of normal lymphocyte development and lymphomagenesis.    
 
5.1: Discovery and characterization of DNA-PKcs 
 DNA-PKcs was first characterized in the 1985, when it was reported that human HeLa cells express 
a protein kinase that is activated by DNA (Walker et al., 1985). Further work from two different groups found 
that the protein fraction containing elevated DNA-protein kinase activity also contained the Ku proteins 
(Ku70 and Ku80) and an ATP-binding peptide then called p350 due to its large size (350kDa)(Carter et al., 
1990; Carter et al., 1988; Lees-Miller et al., 1990). The motif and substrates of the newly identified p350 
protein were shown to include the Sp1 transcription factor, p53, and RNA polymerase II (Jackson et al., 
1990; Lees-Miller et al., 1990; Lees-Miller et al., 1992) at TQ/SQ motifs (with the T or S as the actual 
phosphorylation target) (Lees-Miller and Anderson, 1989; O'Neill et al., 2000). It was also shown that Ku 
binds DNA and recruits DNA to dsDNA ends (Gottlieb and Jackson, 1993), and that dsDNA and Ku (and 
ATP) are required for robust activation of DNA-PKcs (Suwa et al., 1994; West et al., 1998). Specifically, Ku 
forms a dimer on DNA ends, with Ku70 binding proximally to the dsDNA end, and Ku80 binding 
distally(Walker et al., 2001). DNA-Pkcs binds to the C-terminal domain of Ku80, which results in a shift of 
Ku away from the DNA ends (Gell and Jackson, 1999; Yoo and Dynan, 1999).  
 
5.2: The structural study of DNA-PKcs and its kinase domain.  
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DNA-PK belongs to the PI3kinase related protein kinase (PI3KK) family, which also includes Ataxia-
Telangiectasia Mutated (ATM), ATR and mTOR. As their name implies, the catalytic domain of PI3KKs is 
highly homologous to that of the phosphatidylinositol 3- and 4- lipid kinases (e.g. P110). Nevertheless, 
PI3KKs cannot phosphorylate lipids (e.g. phosphatidylinositol), instead they phosphorylate 
Serine/Threonines with a preference for SQ/TQ motifs. Specifically, the bilobal kinase domain of DNA-PKcs 
(human aa3676 to 4100) comprises the well-conserved catalytic loop (aa 3919 to 3927), P-loop (aa 3729 
to 3735), and activation loop (aa 3940 to 3963). In particular, the catalytic base D3922 of human DNA-PKcs 
is responsible for substrate activation (Sibanda et al., 2017) and is mutated to Alanine (D3922A) in the 
DNA-PKcs kinase dead mouse model described in chapter 2 and 3. The kinase domain of all PI3KKs is 
wedged between the ~500-amino acid-long FAT (FRAP, ATM, TRRAP) domain and the ~35 residue FRAP-
ATM-TRRAP-C-terminal (FATC) domain (Fig. 1-3) (Hartley et al., 1995; Jette and Lees-Miller, 2015). The 
sequence between the kinase domain and FATC are named as the PIKK-regulatory domain (PRD). 
Although the primary sequence of PRD is not conserved between different PI3KK family members, the 
PRDs interact with specific protein partners implicated in the activation of PI3KKs and presumably transmit 
the activation cue down to the FATC domain, which is adjacent to the activation loop in recently determined 
crystal structural of DNA-PKcs and the related ATR and mTOR (Sibanda et al., 2017; Wang et al., 2017; 
Yang et al., 2013). Specifically for DNA-PKcs, the interaction between KU, PRD, and the upstream FAT 
domain triggers conformational changes that allow the substrate and ATP access to the catalytic loop 
Figure 1-3: Simplified Diagram of DNA-PKcs.  
DNA-PKcs has a number of domains characteristic of the PI3KK family of kinases. Domains include the 
FAT and FATC clusters in the N terminal region. The PI3KK domain is also located in the C terminal end, 
and contains the DNA-PKcs kinase domain. Site D3922 is targeted in Chapter 2 to create a kinase dead 
mouse model. DNA-PKcs has two major clusters of phosphorylation, PQR and ABCDE. The PQR is thought 
to be largely auto-phosphorylation-dependent, while the ABCDE cluster is thought to be ATM-mediated. 




(Sharif et al., 2017; Sibanda et al., 2017). These structural studies provides direct evidence for major 
conformation changes of DNA-PKcs upon activation and suggest that DNA-PKcs protein itself, and not just 
the kinase activity, might have a role in DNA repair and cNHEJ – a focus of our study.   
 
5.3: DNA-PKcs deficiency in mouse and other vetebrates.  
 Two mouse model with targetted “deletions” of DNA-PKcs were generated(Gao et al., 1998b; 
Taccioli et al., 1998b). Even before targetted deletion of DNA-PKcs were generated a in mouse model, 
various spontaneous inactivation mutations involving DNA-PKcs were noted in hamster cells, horse and 
mouse (Blunt et al., 1995; Gao et al., 1998b; Shin et al., 1997). Despite the diverse nature of specific 
mutations, all DNA-PKcs null (or nearly null – very little protein expression) model display T- B- severe 
combined immunodeficiency (SCID) characterized by a complete lack of mature B and T lymphocytes. 
Characterization of these DNA-PKcs null cells and mouse models identified a critical role of DNA-PKcs in 
lymphocyte V(D)J recombination, especially in the step of hairpin opening (see below). Of particular interest 
to this study are the genes related to V(D)J recombination, such as RAG, Artemis, ad DNA-PKcs. DNA-
PKcs SCID cases show variable disease severity, protein levels, and activity of DNA-PKcs. For instance, 
SCID mice have some residual kinase activity, causing a leaky SCID phenotype and allowing some CJ and 
SJ formation (Blunt et al., 1995). Equine SCID animals were found to have completely defective CJ and SJ 
formation, but also had a mutation that ablated the kinase activity of DNA-PKcs (Shin et al., 1997). A canine 
mutation resulted in a truncation mutation of DNA-PKcs with an intermediate level of CJ and SJ formation, 
relative to equine and murine SCID (Ding et al., 2002; Meek et al., 2001).   
Characterization of the DNA-PKcs null mouse models also show that DNA-PKcs is not required for 
embryonic development. DNA-PKcs null mice are of normal size and can have a largely normal life 
expectancy in a complete pathogen-free housing environment. Notably SCID mice with little yet detectable 
residual DNA-PKcs protein have leaky lymphocyte development that can be manifestied to life threatening 
auto-immuno disease or lymphomas in certain strain backgrounds (Gurley et al., 1998; Nacht et al., 1996) 
DNA-PKcs null mice do not have lymphocytes, but form SJs normally, suggesting DNA-PKcs is only 
required for end processing (Gao et al., 1998b). This relatively moderate phenotype is in stark contrast to 
other mouse models deficient in cNHEJ (Ku, Lig4, or XRCC4- deficient). Ku defiicent mice (Ku70 or Ku80) 
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are viable as well, but have growth defects (small stature), completely blocked cNHEJ (ie neither CJ nor SJ 
formation), and neuronal apoptosis (Gu et al., 1997; Gu et al., 2000; Nussenzweig et al., 1996; Zhu et al., 
1996). Ligase 4 and XRCC4 deficient mice are embryonic lethal, with severe neuronal apoptosis and with 
completely blocked cNHEJ (i.e. neither CJ nor SJ formation) as well (Frank et al., 1998; Gao et al., 1998c).  
Given the normal size and development of DNA-PKcs null mice, it was unexpected that the 
complete loss of DNA-PKcs as well as KU (any component of the DNA-PK homoenzyme) is lethal in various 
human cells (Li et al., 2002; Ruis et al., 2008). Notably, the  level of DNA-PK (DNA-PKcs and KU) proteins 
are ~50 fold higher in human cells than in mouse cells. The level of other cNHEJ factors (e.g. XRCC4-Lig4) 
is not altered significantly between human and mouse, suggesting a recent acquisiiton of a cNHEJ 
independent function of DNA-PK. Nevertheless, two SCID patients with DNA-PKcs mutation were 
discovered in 2009 and 2013 respeciviely. In contrast to the lack of DNA-PKcs protein expression in murine 
or equine SCID models, those patients express significant levels of DNA-PKcs protein. One patient has 
isolated SCID carrying a homozygous missense mutation (L3062R) confering intact kinase activity and yet 
inadequate Artemis activation and reduced end ligation (van der Burg et al., 2009). The other patient display 
SCID with severe microcephaly and died at 36 months of age. This patient carries compound heterozygous 
mutations – one reduced DNA-PKcs protein stability and the other partially abolished DNA-PKcs kinase 
activity (Woodbine et al., 2013). The reason for the severe microcephaly was unexpected and intially 
attributed to potentially other genes, given the patient was born from a consanguineous marriage and no 
neuronal phenotype is found in DNA-PKcs null mouse models.   
 
5.4: DNA-PKcs phosphorylation  
 DNA-PKcs can be phosphorylated by two different means: auto-phosphorylation and ATM-
mediated phosphorylation. Phosphorylation happens largely over two major clusters, the PQR and the 
ABCDE cluster (Fig. 1-1) (Davis et al., 2014; Meek et al., 2008). Autophosphorylation has been reported 
within both clusters, but the T2609 cluster (within the ABCDE cluster) is primarily phosphorylated by ATM 
or ATR (Davis et al., 2014; Jette and Lees-Miller, 2015; Meek et al., 2008; Uematsu et al., 2007). Further, 
previous studies have revealed distinct roles for the types of DNA-PKcs phosphorylations in cNHEJ. PQR 
auto-phosphorylation site S2056 has a role in end processing (Chen et al., 2005; Meek et al., 2007), while 
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the ABCDE T2609 cluster has a role in DNA-PKcs dissociation from DNA (Cui et al., 2005; Merkle et al., 
2002). Despite these advances in the understanding individual phosphorylation sites, how phosphorylation 
affects the regulation and function of DNA-PKcs is still unclear. 
 
5.5: Functional interaction bewteen ATM, DNA-PKcs and Artemis. 
 Ataxia telangiectasia mutated (ATM) and DNA-PKcs both belong to the PI3 kinase related protein 
kinase (PI3KK) family, which regulates cell cycle progression after DNA damage, and share many 
substrates during the DNA damage response (Gapud and Sleckman, 2011). The importance of their 
overlapping function is highlighted by their synergistic embryonic lethality and synergistic DNA repair 
defects during V(D)J recombination and CSR in DNA-PKcs and ATM double deficient mice and cells (Callen 
et al., 2009; Gapud et al., 2011; Sekiguchi et al., 2001; Zha et al., 2011). The ABCDE cluster on DNA-PKcs 
is also thought to be considered ATM-phosphorylated. Moreover, DNA-PKcs can be directly 
phosphorylated by ATM at the Threonine (T) 2609 cluster, within ABCDE, and potentially other sites (Chen 
et al., 2005; Chen et al., 2007; Douglas et al., 2002). Mice with alanine substitutions at three residues in 
the T2609 cluster died shortly after birth from bone marrow failure, highlighting the importance of ATM-
mediated DNA-PKcs phosphorylation (Zhang et al., 2011). Artemis is also a shared substrate of DNA-PKcs 
and ATM. In chapter 2, we will discuss the role of ATM-mediated phosphorylation of DNA-PKcs in regulating 
NHEJ end processing and end ligation events.  
 
6:  Concluding remarks 
 My thesis further investigates the role of DNA-PKcs in cNHEJ, A-EJ, and beyond. While previous 
studies have primarily focused on the kinase and the signaling function of DNA-PKcs towards downstream 
events, DNA-PKcs is also “auto”-phosphorylated and can be phosphorylated by other kinases. My thesis 
studies investigate how phosphorylation regulates the function of DNA-PKcs, by charactering mouse 
models with point mutations that leads to the expression of kinase dead (KD) DNA-PKcs (chapter 2 and 3) 
or DNA-PKcs lacking a specific set of phosphorylation sites (chapter 4). Our results not only identified 
specific phosphorylation dependent structural functions of DNA-PKcs in cNHEJ and the DNA damage 
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response, but also expanded the function of DNA-PKcs to new areas including hematopoiesis, alternative 
end-joining and potentially nucleoli stress.  
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1: Background and Significance 
Classical-non-homologous end joining (C-NHEJ) is a major DNA double stand break (DSB) repair 
pathway in mammalian cells. During lymphocyte development, C-NHEJ is exclusively required for the 
assembly of the antigen receptor gene products during V(D)J Recombination and is partially required for 
class switch recombination (CSR) in mature B cell lymphocytes  (Boboila et al., 2010; Yan et al., 2007). 
Defects in the C-NHEJ pathway underlie a subset of severe combined immunodeficiency (SCID) and early 
aggressive lymphoid malignancies in human patients and animal models (Franco et al., 2006). DNA-PKcs 
is the catalytic subunit of the DNA-dependent protein kinase (DNA-PK) and a vertebrate-specific C-NHEJ 
factor. While the complete absence of C-NHEJ is associated with embryonic lethality as well as SCID, DNA-
PKcs null mice are born of normal size with isolated SCID. This is consistent with a strict requirement for 
DNA-PKcs in end-processing of a subset of DNA ends prior to ligation (e.g. opening of hairpin coding ends 
during V(D)J Recombination), but not in direct ligation of blunt DNA ends.  
As a serine/threonine kinase, DNA-PKcs belongs to the PI3 kinase-related protein kinase (PI3KK) 
family that also includes ATM. DNA-PKcs and ATM phosphorylate a partially overlapping pool of substrates, 
including DNA-PKcs itself, to orchestrate the DNA damage response (Chen et al., 2007; Lee et al., 2013; 
Zhang et al., 2011). Over 40 phosphorylation sites have been identified on DNA-PKcs, among them the 
T2609 cluster is primarily phosphorylated by ATM, while the T2056 cluster is thought to be preferentially 
phosphorylated by DNA-PKcs itself (Meek et al., 2008). However, the functional role of DNA-PKcs auto- vs 
trans-phosphorylation is not well understood. 
In this chapter, we report the generation and characterization of a mouse model with a homozygous 
knockin kinase-dead (KD) mutation (D3922A) of DNA-PKcs. Interestingly, homozygous DNA-PKcsKD/KD 
mice die during embryonic development with p53-dependent post-mitotic neuronal apoptosis similar to mice 
with complete defects in C-NHEJ. Indeed, DNA-PKcsKD/KD cells, but not DNA-PKcs null cells, accumulate 
blunt signal ends during chromosomal V(D)J recombination, indicative of end ligation defects. Further, 
deletion of Ku70, which is required for the recruitment of DNA-PKcs to the DNA ends, rescues the 
embryonic lethality and growth retardation in DNA-PKcsKD/KD mice. Together, these and other findings 





2.1: Homozygous expression of Kinase Dead DNA-PKcs is embryonic lethal 
To interrogate the impact of DNA-PKcs auto- vs. trans-phosphorylation on the function of the DNA-
PKcs protein itself, we generated a mouse model that expresses a catalytically inactive DNA-PKcs protein 
by mutating the conserved aspartic acid (D) 3922 in the putative catalytic loop of murine DNA-PKcs into 
alanine (A, D3922A) (Fig. 2-1A-B). This allele is thereafter referred to as “KD” for kinase dead DNA-PKcs 
(Fig. 2-1C-D). A previous study showed that the D to A mutation of the corresponding residue in the related 
ATM kinase, ATR kinase (Kabeche et al., 2018), and lipid PI3 kinases eliminates the kinase activity without 
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affecting protein stability. The expression of the DNA-PKcs KD protein was verified in DNA-PKcsKD/KD 
embryonic stem (ES) cells and murine embryonic fibroblasts (MEFs) by Western blot (Fig. 2-1E). A modified 
DNA-PK kinase assay using a p53-poly peptide as substrate confirmed the loss of DNA-PKcs specific (KU 
and DNA dependent) kinase activities in DNA-PKcsKD/KD cell lysate (Fig. 2-1F).  
In contrast to the normal development of DNA-PKcs-/- mice (Gao et al., 1998a; Taccioli et al., 1998), 
DNA-PKcsKD/KD embryos were visibly smaller at embryonic day 14.5 (E14.5) (Fig. 2-2A) and cannot be 
found beyond E16.5 (Fig. 2-2B-C). Histological analyses of E14.5 brain revealed severe neuronal apoptosis 
in DNA-PKcsKD/KD embryos, at levels comparable to end-ligation deficient XRCC4-/- embryos (Fig. 2-2D-E) 
(Gao et al., 2000). Consistent with normal development, neuronal apoptosis was not found in DNA-PKcs+/KD 
littermates (Fig. 2-2D-E), suggesting the DNA-PK KD protein does not have a classical dominant negative 
function. Notably, the apoptotic inclusions characterized by condensed nuclei are most prominent in the 
“post”-mitotic intermediate zone of the DNA-PKcsKD/KD embryonic brain and are relatively rare in the (Orii et 
al., 2006) (Fig. 2-2D). A similar pattern has been noted for XRCC4- or Ligase4- deficient murine embryos 
and is indicative of defects in the G0/G1 phase of the cell cycle, when NHEJ is more prominent (Barnes et 
al., 1998; Frank et al., 1998; Frank et al., 2000; Gao et al., 2000; Gao et al., 1998b). Notably, DNA-PKcsKD/- 
mice, but not DNA-PK+/KD mice, are also embryonic lethal (Fig. 2-2C), suggesting the DNA-PK KD protein 
is toxic only whenever it is expressed without the WT-DNA-PKcs protein. 
Figure 2-1: Generation of the DNA-PKcs KD allele. 
(A) The schematic diagram of the putative catalytic loop in DNA-PKcs and ATM kinase. We note the official 
NCBI gene name for murine DNA-PKcs is Prkdc.  (B) The genomic sequence of the WT and mutated DNA-
PKcs (KD) alleles. Underlined nucleotides were mutated. The GGA to GGC change is a conserved change 
that introduces a new restriction site for mutation identification. (C) The schematic diagram represents the 
murine Prkdc (DNA-PKcs) locus (top), targeting vector (2nd row), targeted allele (DNA-PKcsKDN, 3rd row), 
and the neo-deleted mutant allele (DNA-PKcs KD, bottom). The 5’ probe is marked as a black line. The 
exons and loxP sites are shown as solid boxes and open triangles, respectively. The exon containing the 
KD mutation is marked as an open box. Restriction site designation: S=SpeI, RV=EcoRV, H=HindIII.  The 
map is not drawn to scale.  (D) Southern Blot analyses of SpeI-digested DNA from representative DNA-
PKcs+/+(WT) and DNA-PKcs+/KDN ES cells. KDN refers to the target allele with NeoR cassette. (E) The 
graph represents the relative DNA-PKcs kinase activity (activity per mg of nuclear lysate, set DNA-PKcs+/+ 
as 100%) measured in WT, DNA-PKcs-/- and DNA-PKcsKD/KD MEFs using a commercially available DNA-
dependent protein kinase kit (Promega, CA) with modifications (nuclear extract instead of whole cell lysate 
was used; ~50 fold more cells were used per assay; the cell lysate were treated with ATM kinase inhibitor 
Ku53399 (15µM) before activation). Independent proof for the loss of DNA-PKcs kinase activity can be 
found in (Fig. 2-1F), where phosphorylation of H2AX is completely abolished in DNA-PKcsKD/KD cells with 
only ATM kinase inhibitor. (F) Western blot for total DNA-PKcs expression in MEFs, ES cells and v-abl 





2.2: DNA-PKcsKD/KD cells show severe genomic instability 
Next we performed telomere fluorescent in situ hybridization (T-FISH), which uncovered a more 
than 50% increase of cells carrying cryptogenic abnormalities in DNA-PKcsKD/KD ES cells (Fig. 2-3A-B) and 
primary MEFs (Fig. 2-3C-D). T-FISH can recognize two kinds of chromosomal abnormalities:  chromosome 
breaks that involve both sister-chromatids and chromatid breaks that involve only one of the two sister 
chromatids. While chromatid breaks likely occur after DNA replication in S or G2 phase of cell cycle, 
chromosomal breaks often result from the replication of a G1 phase DSB. Notably, both DNA-PKcsKD/KD 
 
Figure 2-2: Homozygous kinase dead (KD) mutation of DNA-PKcs leads to late embryonic lethality 
with extensive neuronal apoptosis.  
(A) Representative picture of E15.5 WT and DNA-PKcsKD/KD embryos. (B) Genotypes obtained by inter-
crossing DNA-PKcs+/KD mice.  * indicates post-mortem embryos.  (C) The number of live birth mice 
obtained from intercrossing between DNA-PKcs+/− and DNA-PKcs+/KD mice. The p-value was calculated 
with the chi-square test. (D) Representative H&E staining of the brain from E14.5 embryos. CP, cortical 
plate; IZ, intermediate zone; VZ, ventricular zone. (E) The frequency of apoptotic inclusions per 40x field 
in E14.5 brains from different genotypes.  
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MEF and ES cells preferentially accumulate chromosome breaks (Fig. 2-4A and D), similar to previously 
characterized NHEJ deficient XRCC4 or XLF deficient cells (Li et al., 2008; Zha et al., 2007). Further, while 
DNA-PKcs-/- ES cells are only moderately sensitive to IR, DNA-PKcsKD/KD ES cells are hypersensitive to IR, 
similar to XRCC4-/- ES cells (Fig. 2-4A). Moreover DNA-PKcsKD/KD MEFs also display severe proliferation 
defects (Fig. 2-4B) and hypersensitivity to etoposide, a topoisomerase II inhibitor that generates DSBs (Fig. 
2-4C), but are not sensitive to PARP inhibition (Fig. 2-4D), which preferentially kills homologous 
recombination (HR) deficient cells (Bryant et al., 2005). Furthermore, HR functionality, as measured by an 
integrated DR-GFP reporter (Pierce et al., 2001), is also similar between DNA-PKcsKD/KD and DNA-PKcs+/+ 
ES cells (Fig. 2-4E). Together these findings indicate that expression of catalytically inactive DNA-PKcs 
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protein increases genomic instability by inhibiting NHEJ, but not HR. The severe genomic instability and 
embryonic lethality of DNA-PKcsKD/KD mice in comparison to the DNA-PKcs-/- controls further suggest that 
DNA-PKcs protein has a role in NHEJ beyond end-processing. 
 
2.3: p53 deficiency rescues embryonic lethality, but not lymphocyte development, in DNA-PKcsKD/KD 
mice 
First, the embryonic lethality of DNA-PKcsKD/KD mice was rescued by both homozygous (p53-/-) or 
heterozygous (p53+/-) p53 deficiency (Fig. 2-5A), similar to XRCC4-/- or Lig4-/- mice (Frank et al., 2000; Gao 
et al., 2000). However, the cellularity and the size of the thymus and spleen of DNA-PKcsKD/KDp53+/- mice 
are reduced ~100 fold in comparison to p53+/- littermates (Fig. 2-5B, Tables 2-1 and 2-2). Flow cytometry 
analyses revealed that lymphocyte development in DNA-PKcsKD/KDp53+/-(-/-) mice is blocked at the progenitor 
stage, indicated by the lack of naïve (B220+IgM+)  and precursor (B220+CD43-IgM-) B in the bone marrow 
and the lack of mature (CD4+CD8- or CD4-CD8+ single-positive) and precursor (CD4+CD8+ double positive) 
T cells in the thymus (Fig. 2-5C). Together with the markedly reduced ratio between precursor B cells 
(B220+CD43+IgM-) to progenitor B cells (B220+CD43-IgM-), these observations are consistent with 
defects in V(D)J recombination. Progenitor B cells derived from p53-proficient DNA-PKcsKD/KD fetal livers 
Figure 2-3: Severe genomic instability in DNA-PKcsKD/KD embryonic stem cells and fibroblasts. 
(A) The frequency of chromosomal (black box) or chromatid (open) breaks per metaphase in ES cells of 
different genotypes. Examples of normal metaphase, or chromosomal and chromatid breaks. The 
chromosomal fusion was counted as two chromosomal breaks. (B) Summary of cytogenetic abnormalities 
in WT, DNA-PKcs -/- and DNA-PKcsKD/KD ES cells and MEFs. Abbreviations: Ab- Abnormal, MP- metaphase, 
Csm.- Chromosome, Ctd.- Chromatid, Brk- Break. The data summarizes the results from two or more 
independent experiments using at least two independently derived cell lines of each genotype. All images 
were processed with Metafer (Metasystem Inc). Chromosome breaks were defined by loss of telomere 
signal from both sister-chromatids or fusion of both chromatids (Fig. 2-3A). Chromatid breaks were defined 
by loss of telomere signal from one of the two sister-chromatids or a clearly broken DAPI signal in the middle 
of one chromatid (Fig. 2-3A).  We note that chromosomal gaps could not be reliably identified with the T-
FISH assay; therefore, it is possible that the actual frequency of chromatid or chromosome breaks might be 
even higher than estimated.  (C) Frequency of metaphases with cytogenetic abnormalities in T-FISH 
analyses of primary P3 DNA-PKcs+/+, DNA-PKcs-/- and DNA-PKcsKD/KD MEF cells. At least three 
independently derived lines were assayed for each genotype (D) The frequency of chromatid (open box) 




also failed to differentiate to IgM+B220+ naïve B cells in vitro (Fig. 2-5D-E), indicating that the V(D)J 
recombination defects in DNA-PKcsKD/KD lymphocytes are p53-independent and cell-autonomous.  
 
Figure 2-4: Severe DNA repair defects in DNA-PKcsKD/KD embryonic stem cells and fibroblasts. 
(A) The IR sensitivity of WT, DNA-PKcs-/-, DNA-PKcsKD/KD ES cells. One of the three independent assays 
was shown. (B) Proliferation of P2 MEFs of different genotypes. (B) Proliferation of second-passage 
MEFs with different genotypes. One of two independent repeats is shown. The y-axis is the relative cell 
number measured by the fluorescence-nucleotide dye (CyQuant Cell Proliferation Assay, Invitrogen, CA).  
(C) Etoposide sensitivity of immortalized DNA-PKcs+/+ and DNA-PKcsKD/KD MEFs. (D) Olaparib sensitivity 
of immortalized DNA-PKcs+/+, DNA-PKcs-/-, DNA-PKcsKD/KD and control BRCA-deficient (S1598F/S1598F) 
(Shakya et al., 2011) MEFs. 3x103 cells/well MEFs were plated in 96-well plate in triplicates. Olaparib (in 
DMSO) was added the next day. The cell numbers were determined by nucleotide staining 7 days later 
(Invitrogen, CA). (E) DR-GFP assay is performed as previously described (Pierce et al., 2001). Briefly 
the DR-GFP reporter is targeted into PimI locus in DNA-PKcs+/+ or DNA-PKcsKD/KD ES cells. Two 
independent targeted clones from each genotype were transfected with IsceI expression vector and the 
percentage of GFP positive cells were determined flow cytometry 72 hours after transfection. The data 
represents the average and standard deviation of three independent repeats of two independently 










Figure 2-5: p53 deficiency rescues the embryonic lethality but not the lymphocyte development 
defects in DNA-PKcsKD/KD mice. 
(A) Genotypes obtained by inter-crossing DNA-PKcs+/KDp53+/- mice.  (B) Picture of p53+/-DNA-PKcsKD/KD 
and DNA-PKcs+/+ littermates. (C) Representative flow cytometric analyses of bone marrow, spleen and 
thymus from WT, DNA-PKcs+/KD DNA-PKcsKD/KDp53 +/- and, DNA-PKcs-/- and p53+/- mice. (D) 
Representative flow cytometric analysis and summary (E) of IgM+% out of total B220+ B cells after 10 
days of fetal liver culture as described before. Each dot represents an individual E14.5 embryo of the 











Figure 2-6: End ligation defect in DNA-PKcsKD/KD lymphocytes. 
(A) Schematic of pMX-INV retroviral recombination substrates designed to assay inversional V(D)J 
recombination (Zha et al., 2011a). Diagrams indicate un-rearranged substrate (UR), coding/signal end 
(CE/SE) intermediates and coding/signal joints (CJ/SJ).  The RSS (triangle), GFP probe (solid lines) and 
C4 probe (dash lines) are indicated.  Positions of EcoRV (RV) sites and NcoI (N) sites are shown.  (B) The 
histograms show flow cytometric analyses of GFP+ cells within the gated hCD4+ cell population after 0, 2 
or 4 days of STI571 treatment of cell lines containing a single integrated pMX-INV substrate (diagramed in 
Fig. 2-6A). C) Southern blotting with C4 probe or GFP probe of NcoI+EcoRV digested or EcoRV-digested 
DNA from STI571 treated (2 or 4 days) v-abl pro-B lines containing pMX-INV.  Results were obtained from 
cell pools with diverse substrate integrations. Bands reflecting pMX-INV, UR, CE, CJ, SE-CE (red box), SJ-
CE (blue box) and pMX-DEL-SJ UR, SE (red box) are indicated. (D) Additional DNA-PKcsKD/KD cells clones 
with a single integrated pMX-INV substrate. (E) Schematic of pMX-DEL-SJ retroviral recombination 
substrates designed to assay deletional SJ V(D)J recombination(Zha et al., 2011a). Diagrams indicate un-
rearranged substrate (UR), signal end (SE) intermediates and signal joints (SJ).  The RSS (triangle), GFP 
probe (solid lines) and C4 probe (dash lines) are indicated.  Positions of EcoRV (RV) sites are shown.  (F) 
Southern blotting with C4 probe or GFP probe of EcoRV-digested DNA from STI571 treated (2 or 4 days) 
v-abl pro-B lines containing pMX-DEL-SJ substrates.  Results were obtained from cell pools with diverse 
substrate integrations. Similar results were obtained with single integration clones.  Bands reflecting pMX-
DEL-SJ UR, SE (red box), SJ are indicated. 
Table 2-1: DNA-PKcsKD/KD mutation blocks lymphocyte development 
Total thymocyte and calculated CD4-CD8-double negative (DN) and CD4+CD8+double positive (DP) 
thymocyte, single positive T cell numbers as well as naïve B (B220+IgM+) in the thymus and spleen. Each 
value represents the average ± standard deviation from at least three mice between 3 to 6 weeks of age 
for each genotype.  
 
Table 2-2: Lymphocyte development is blocked at the early progenitor stage in DNA-PKcsKD/KD mice.  
(B) The percentage of pro-B (B220+IgM-CD43+), pre-B (B220+IgM-CD43-) and mature B (B220+IgM+CD43-
) cells in total bone marrow from different genotypes. Each value listed represents the average ± standard 
deviation from at least three mice between 3 to 6 weeks of age of each genotype. (C) IR sensitivity of v-abl 




2.4: End-ligation is abrogated in DNA-PKcsKD/KD Cells in an ATM-independent manner 
To further elucidate the role of DNA-PKcs in NHEJ, we examined lymphocyte development, where 
defects in end-processing and end-ligation can be readily distinguished (Lieber, 2010). To ascertain 
whether the V(D)J recombination defects are caused by failure of CE hairpin-opening (e.g., DNA-PKcs-/-) 
(Gao et al., 1998a; Rooney et al., 2002; Taccioli et al., 1998), end-ligation (e.g., XRCC4-/-)(Barnes et al., 
1998; Frank et al., 1998; Gao et al., 1998b) or both, we generated v-abl kinase transformants from fetal 
liver-derived DNA-PKcsKD/KD B cells (Bredemeyer et al., 2006). In wild type v-abl-transformed B cells, the 
29 
 
v-abl kinase inhibitor STI571 induces RAG expression and successful rearrangement of the chromosomally 
integrated inversional V(D)J recombination substrate pMX-INV (Fig. 2-6A), as evidenced by GFP 
expression (Fig. 2-6B) and the accumulation of SJ and CJ products in Southern Blot analyses (Fig. 2-6C) 
(Zha et al., 2011b). Consistent with the blockade in lymphocyte development in vivo, the formation of CJs 
is abrogated in DNA-PKcs-/-, XRCC4-/- as well as DNA-PKcsKD/KD cells, leading to the accumulation of 
unrepaired 3’CEs (Fig. 2-6C, middle panel). End-ligation deficient XRCC4-/- cells also cannot form SJs, and 
thus accumulate SE-CE fragments (Fig. 2-6A and C, red box). DNA-PKcs-/- cells cannot form CJs owing to 
hairpin-opening defects, but form SJs efficiently, leading to the accumulation of the larger SJ-CEs fragments 
(Fig. 2-6A and C, blue box). DNA-PKcsKD/KD cells accumulate SE-CEs only, similar to XRCC4-/- cells, 
indicating severe end-ligation defects (Fig. 2-6C). Consistent with the end-ligation defects, < 5% of residual 
SJs recovered from DNA-PKcsKD/KD cells are precise, in contrast to >93% from DNA-PKcs+/+ cells (Table 2-
3). Similar results were obtained in several independent clones (Fig. 2-6D) and with a deletional SJ 
recombination substrate (pMX-Del-SJ, Fig. 2-6E). Together, these findings indicate that in the presence of 
DNA-PKcs protein, DNA-PKcs kinase activity is required for end-ligation during NHEJ. 
ATM and DNA-PKcs share a similar consensus phosphorylation sequence (SQ/TQ). We and others 
have previously shown that the redundant kinase activity of DNA-PKcs and ATM are critical for end-ligation, 
including SJ formation during V(D)J recombination (Callen et al., 2009; Gapud et al., 2011; Zha et al., 
2011b). Yet ATM protein levels and ATM-mediated phosphorylation of their shared substrate (.e.g. H2AX) 
were not altered in DNA-PKcsKD/KD MEFs or B cells in comparison to the DNA-PKcs-/- control (Fig. 2-7). The 
end-ligation defects in DNA-PKcsKD/KD cells cannot be explained by general inhibition of ATM-mediated 














Table 2-3: Chromosomal signal joints recovered from the integrated pMX-Del-SJ substrate. 
Ins : nucleotide insertion; GL: germ line flanking sequences. The number of total basepairs deleted from both 
sides of the junction is listed on the right (under Del). The total number of SJs sequenced, fidelity (precise 




2.5: DNA-PKcs physically blocks DNA ends 
End-ligation of naked DNA is mediated by core NHEJ factors, especially Lig4 and XRCC4. But we 
found that the expression of Lig4 and XRCC4, as well as the DNA damage -induced recruitment of Lig4 
are not affected in DNA-PKcsKD/KD cells, in comparison to DNA-PKcs-/- and DNA-PKcs+/+ controls (Fig. 2-
8A-B). Given the kinase independent recruitment of DNA-PKcs to DSBs (Uematsu et al., 2007), we 
hypothesized that DNA-PKcs protein might physically block end-ligation at the ends in the absence of auto-
phosphorylation. To test this hypothesis, we deleted Ku, which is required for the recruitment of DNA-PKcs 
to DNA ends in vivo (Falck et al., 2005). Strikingly, complete deletion of Ku (Ku70-/- or Ku80-/-, but not Ku70+/- 
or Ku80+/-), fully rescues the embryonic development of DNA-PKcsKD/KD mice (Fig. 2-8C). Moreover, DNA-
PKcsKD/KDKu70-/- mice were identical to their Ku70-/- littermates and significantly bigger than DNA-
PKcsKD/KDp53-/-(+/-) mice (Fig. 2-8D-E), implying rescue of the repair function beyond simple elimination of 
Figure 2-7: ATM-independent and chromatin-independent function of DNA-PKcs in end-ligation. 
Western blot for DNA-PKcs, ATM, phosphorylated H2AX, total H2AX, phosphorylated KAP-1, total KAP-
1, and α-tubulin in irradiated (10 Gy) with or without pre-incubation with 15 µM ATM kinase inhibitor 
(KU55933, Tocris Bioscience) or 5µM DNA-PKcs kinase inhibitor (NU7441, Tocris Bioscience) or both. 
Cell lysates were collected 2 hours after irradiation. Primary antibodies were used at the following dilutions: 
anti-DNA-PKcs (1:1000, Thermo), anti-ATM (1:500, MAT3, Sigma), anti-γH2AX (1:1,000, Millipore), anti-
H2AX (1:1,000, Millipore), anti-KAP-1 (1:1,000, Cell Signaling), anti-phospho-KAP-1(S824) (1:1,000, 




the checkpoints (p53 null). Rescue by Ku70 deficiency supports a model in which the DNA-PKcs protein 
physically blocks end-ligation at the DNA ends in the absence of auto-phosphorylation.  
Figure 2-8: Ku deficiency rescues the DNA-PKcsKD/KD mouse 
(A) Western blot for Lig4 and XRCC4 in DNA-PKcs+/+, DNA-PKcs-/-, DNA-PKcsKD/KD, Lig4-/-, and XRCC4-/- v-abl 
transformed B cell lines. Primary antibodies were used at the following dilutions: anti-XRCC4 (1:500, Santa 
Cruz), anti-Lig4 antibody (1:500, a generous gift from Dr. David Schatz) and anti-β-actin (1:10,000, Sigma). (B) 
Laser induced recruitment of GFP-Lig4 in immortalized MEFs. (C) Genotype distribution from inter-crossing 
Ku70+/- (or Ku80+/-) DNA-PKcs+/KD mice. (D)  The body weight (grams) of 15 day old mice of each genotype. The 
bar indicates the average and standard deviations. ***: p<0.01. *: p>0.5, using student t-test.  (E) 
Representative flow cytometric analyses of bone marrow, spleen and thymus from WT, DNA-PKcsKD/KDKu70 -/- 




2.6: DNA-PKcs protein, but not its kinase activity, is required for hairpin opening in vitro 
Given the known role for DNA-PKcs in end processing, i.e. hairpin opening, we asked about the 
requirement of DNA-PKcs kinase activity in this setting. Two independent assays –TdT-mediated PCR (Fig. 
2-9A) and urea denaturing gel electrophoresis (Fig. 2-9C) were employed to determine the 3’CE hairpin 
status as a measurement for end-processing (Zha et al., 2011a). TdT adds poly-A tracks to open CEs 
(oCEs), but not hairpin-sealed CEs (hCEs), and the poly-A track provides a template for subsequent PCR 
amplification (Fig. 2-9A). Therefore, the hairpin opened 3’CEs in XRCC4-/- cells can be easily detected by 
TdT-mediated PCR, but the hairpin CEs in DNA-PKcs-/- cells cannot be amplified (Fig. 2-9A and B). To our 
surprise, 3’CEs in DNA-PKcsKD/KD cells generated robust Tdt-mediated PCR products indicative of open 
CEs (Fig. 2-9B). Efficient hairpin opening in DNA-PKcsKD/KD cells was further validated using urea 
denaturing gel electrophoresis, which resolves hairpin (hCEs; larger) and open (oCEs; smaller) CE 
fragments by size (Fig. 2-9C-D). At first glance, this appears to be inconsistent with in vitro reconstitution 
assays (with DNA-PKcs, KU and Artemis), which showed that ATP hydrolysis, and thus DNA-PK “kinase 
activity” is required for hairpin-opening (Ma et al., 2002). In this context, we found that hairpin opening in 
DNA-PKcsKD/KD cells is blocked by ATM kinase inhibitor (Fig. 2-9B and D), indicating ATM and DNA-PKcs 
kinase activities are redundant for end-processing in vivo. Interestingly, ATM kinase inhibitor, but not DNA-
PKcs inhibitor, delays CJ formation in WT cells as measured by the accumulation of 3’CE, supporting an 
important role of ATM kinase in directly regulating hairpin opening even in DNA-PKcs+/+ cells (Bredemeyer 
et al., 2006; Lee et al., 2013; Zha et al., 2011a). Together with the lack of hairpin opening in DNA-PKcs-/- 
cells, our data reveals that the DNA-PKcs protein, but not its kinase activity, is required for hairpin opening 





Figure 2-9: Coding end hairpin is opened in DNA-PKcsKD/KD lymphocytes. 
(A) Diagram of the Tdt-mediated ligation PCR assay. The probe is an oligo probe derived from the hCD4 
sequence. (B) T-PCR results from STI571 treated XRCC4-/-, DNA-PKcs-/- and DNA-PKcsKD/KD cells. (C) 
Southern and (D) T-PCR results from DNA-PKcsKD/KD cells with pMX-INV treated with STI571 with or without 






Figure 2-10: Artemis is required for hairpin opening in DNA-PKcsKD/KD cells.  
(A) Diagram of Crispr/Cas9 mediated cuts in Artemis. The red arrows indicate the primers used to screen 
for the deletion. The gel on the right shows a representative PCR-identified homozygous deletion of 
Artemis exon1 in DNA-PKcsKD/KD cells. (B) Urea denaturing blot analysis of Artemis deficient DNA-
PKcsKD/KD cells +/- the ATM inhibitor (KU55933, 15µM). (C) T-PCR of DNA-PKcsKD/KDArtemis-/- with 
ectopic expression of Artemis phosphorylation mutants. (D) Representative recruitment and quantification 




2.7: ATM mediated phosphorylation of DNA-PKcs regulates end-processing through Artemis 
recruitment   
ATM kinase activity promotes many nuclease activities, including MRE11 and CtIP (Helmink et al., 
2011; Zha et al., 2011a). Using Crispr-Cas9 mediated deletion (Fig. 2-10A), we showed that hairpin opening 
in DNA-PKcsKD/KD cells is mediated by the Artemis endonuclease, with deletion of Artemis completely 
blocking hairpin opening and ATM kinase inhibitor sensitivity (Fig. 2-10B). But, surprisingly, hairpin opening 
in DNA-PKcsKD/KD cells does not require any of the 9 canonical phosphorylation sites at the C-terminal of 
Artemis (Goodarzi et al., 2006) (Fig. 2-10C), suggesting DNA-PKcs is the phosphorylation target required 
for end-processing. So how does phosphorylation of DNA-PKcs regulate end-processing? In DNA-PKcs+/+ 
MEFs, laser induced DSBs rapidly recruit Artemis to the site of damage. This rapid recruitment of Artemis 
is largely abolished in DNA-PKcs-/- MEFs (Fig. 2-10D-E), indicating the DNA-PKcs protein regulates the 
recruitment of Artemis.  Consistent with normal hairpin opening, recruitment of GFP-Artemis to laser-
induced DSBs is largely normal in DNA-PKcsKD/KD cells. So we then tested whether ATM-mediated 
phosphorylation of DNA-PKcs regulates end-processing through Artemis recruitment. Strikingly, GFP-
Artemis recruitment in DNA-PKcsKD/KD cells is completely blocked by ATM kinase inhibitor (Fig. 2-10D and 
E), indicating redundant phosphorylation of DNA-PKcs by ATM or DNA-PKcs regulates end-processing by 
modulating the recruitment of Artemis to DSBs. 
 
2.8: Identification of novel DNA-PKcs auto-phosphorylation sites 
The studies described so far in this chapter have reinforced a critical role for DNA-PKcs 
phosphorylation in regulating NHEJ- both during end-ligation and end-processing. Moreover, our findings 
suggest that at least two classes of phosphorylation sites exist on DNA-PKcs: restricted intermolecular 
auto-phosphorylation sites (required for end-ligation) and the sites that can be trans-phosphorylated by 
ATM (regulating end-processing). To better understand the molecular mechanism of this regulation, we set 
to determine the nature of these two types of phosphorylation sites on DNA-PKcs using Mass Spectrometry. 
Our model suggests that only DNA-PKcs on the DNA ends would be phosphorylated. DNA-PKcs, and KU 
are among the most abundant protein in human cells, so the percentage of DNA-PKcs that can be 
phosphorylated is likely very small. As a result, DNA-PKcs phosphorylation is rarely noted in large scale 
37 
 
proteomic studies in human cells despite the abundance of DNA-PK protein. Mouse cells, however, contain 
significantly lower DNA-PK/Ku protein levels, so the percentage of DNA-PKcs phosphorylation is 
significantly higher. For this technical reason, we decided to take advantage of the kinase dead DNA-PKcs 
mouse model. This method gave us the unique advantage of determining phosphorylation sites in an 
unbiased fashion on endogenous proteins. To do this, we targeted an HA, Flag double tag into the 
endogenous DNA-PKcs locus in DNA-PKcs+/+ or DNA-PKcsKD/KD ES cells (Fig. 2-11A). Targeting was 
confirmed by southern blotting, and the protein expression of DNA-PK protein and the HA and Flag tags 
was confirmed by western blotting (Fig. 2-11B and C). DNA-PKcs protein (WT or KD) was purified from 
DNA-PK+/HAF (DNA-PKcs+/+ (or KD/KD)) ES cell lysate using the Flag tag with or without a high dose irradiation 
(30Gy) (Fig. 2-11 C and D). We chose to purify the DNA-PKcs protein immediately after irradiation (~15 
minutes) based on rapid recruitment and activation of DNA-PKcs, which peaks within 15 mins (Uematsu et 
al., 2007). The purified sample was analyzed by tandem mass spectrometry for total, as well as 
phosphorylated, peptides. Two different digestions were used (Trypsin alone or Trypsin and Chymotrypsin) 
to maximize coverage within the large (4028aa) DNA-PKcs. In average, more than 50-60% of peptides 
identified were mapped to DNA-PKcs, a testimony for the purity of the protein prep and an average 
coverage rate of 50-70% on DNA-PKcs protein were recovered.  Unfortunately, due to the size of the 
digestion fragment (predicted to be greater than 80 amino acids), we did not recover any peptide 
(phosphorylated or not) in the S2056 cluster of auto-phosphorylation sites. While we clearly identified IR-
dependent phosphorylation events in the peptides containing the well-described T2609 cluster (thought to 
be mediated by ATM) (Davis et al., 2014), the 2nd fragment suggests that S(P)2608 and S(V)2646 were 
found to be phosphorylated, rather than T(P)2609. Verification of the MS spectrum confirmed this site 
alignment in all samples (Fig. 2-12 A-C).  Notably, the S(P) 2608 and S(V)2646 sites are not the traditional 
SQ/TQ motifs for PI3KK, but rather bear a signature for CDK or even the MAPKinase family (Table 2-
4)(Endicott et al., 1999; Songyang et al., 1994). While further biochemical validation remains pending, the 
kinase dependent nature of the S(P) 2608 and S(V)2646 sites suggests that they might also be indirectly 
affected by DNA-PKcs auto-phosphorylation. Interestingly, S(P) 2608 is actually within the T2609 cluster, 
and this site is an S(Q) motif in humans (Fig. 2-12 D), which perhaps underscores the potential importance 
of this particular motif and of the broader T2609 cluster. The revelation of potential SP/SV phosphorylation 
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sites through these analyses highlights the importance of this cluster, which will be discussed more fully in 
Chapter 4. 
Perhaps most importantly, we identified 2 potential novel auto-phosphorylation SQ sites: S2485 
and S2491 (Table 2-4, Fig. 2-12A and B). These sites have the signature SQ motif, which is characteristic 
of PI3K kinases. Moreover, the phospho-peptides can only be found upon IR in DNA-PK+/+ cells, but not 
DNA-PKKD/KD cells. Interestingly, these SQ sites, S2485 and S2491, are in a previously unreported cluster 
Figure 2-11: HA/F targeting of the DNA-PKcs+/+ and DNA-PKcsKD/KD allele. 
(A) The schematic diagram represents the murine Prkdc (DNA-PKcs) locus (top), targeting vector (2nd 
row), targeted allele (DNA-PKcsF/HAN, 3rd row), and the neo-deleted mutant allele (DNA-PKcs F/HA, bottom). 
The 5’ probe is marked as a black line. The exons and loxP sites are shown as solid boxes and open 
triangles, respectively. Restriction site designation: A=AflII.  The map is not drawn to scale. (B) Southern 
Blot analyses of AflII-digested DNA from representative DNA-PKcs+/F/HAN ES cells. (C) Representative Flag 
immunoprecipitation of the DNA-PKcs protein, showing enrichment in the IP/elution fraction. (D) 
Representative enrichment of a 460kDa band on a coomassie stained SDS-PAGE gel after Flag 





that is well conserved (Fig. 2-12E). Indeed, SQ2485 is actually an SE site in humans, potentially 
underscoring the importance of this site to DNA-PKcs phosphorylation (Fig. 2-12E).  
 
Figure 2-12: Mass spectrometry spectrum and site conservation 
Representative spectrum of site 840 (A), 2491 (B), and 2646 (C) in wild type mass spectrometry samples 
without IR (left panel) and with IR (right panel). (D) Conservation of the S2485 and S2491 DNA-PKcs 
phosphorylation sites. (E) Conservation of the T2609 cluster of DNA-PKcs phosphorylation sites. 
Asterisks indicate the three sites mutated in the DNA-PKcs3A/3A mouse (Zhang et al., 2011) (Discussed 







Prior work restricted the role of DNA-PKcs to end processing during NHEJ. Using the kinase-dead 
mutant of DNA-PKcs described in this chapter, we uncovered a critical role of the DNA-PKcs protein, and 
especially of its regulation by DNA-PKcs kinase activity, in the end-ligation phase of NHEJ. Further, we 
have shown that these dual roles are regulated by two distinct classes of DNA-PKcs phosphorylation: a 
primarily ATM-dependent phosphorylation of DNA-PKcs that promotes end-processing, and an auto, and 
likely intermolecular, phosphorylation of DNA-PKcs that permits end-ligation (Fig 2-13). Through 
phosphorylation, DNA-PKcs acts as a molecular switch to control the dynamics of NHEJ. 
 We can now propose an updated model of NHEJ, which reflects a role of DNA-PKcs in determining 
whether end-ligation should occur through intermolecular auto-phosphorylation (Fig 2-13). First, Ku70/80 
dimers bind DNA ends and recruit DNA-PKcs. Here, DNA-PKcs has a dual role- to facilitate end processing 
and to restrict premature end-ligation. To facilitate end-processing, ATM-mediated phosphorylation of DNA-
PKcs results in Artemis recruitment and end-processing. Next, intermolecular auto-phosphorylation of DNA-
PKcs triggers conformational changes of DNA-PKcs (which is possibly coupled with release from DNA 
ends) to allow end-ligation to occur. Without DNA-PKcs, Artemis cannot be recruited, so end-processing 
Table 2-4: Summary of phospho-peptides recovered from Mass spectrometry analysis. 
NF: Not found. -: Peptide present but not phosphorylated. +: Peptide phosphorylated.  
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cannot occur, but end-ligation is permitted through direct interaction between the Lig4-XRCC4 complex and 
Ku70/80. In the presence of kinase dead DNA-PKcs, intermolecular auto-phosphorylation cannot occur so 
DNA-PKcs is stuck on the ends, blocking ligation. However, since ATM kinase can still phosphorylate DNA-
PKcs, end processing still occurs. Taken together, the distinct roles of these two types of DNA-PKcs 
phosphorylations are likely important for both ensuring DNA strand alignment and end-ligation fidelity and 
preventing premature and fruitless ligation in the absence of end-processing. In this context, DNA-PKcs 
and Artemis co-evolved in vertebrates with the development of adaptive immuno-system, while 




KU/Lig4/XRCC4 are conserved from yeast to man. We propose that the appearance of DNA-PKcs is in part 
to guard ligation fidelity and regulate end-processing, within the NHEJ pathway.   
 What is the broader relevance of DNA-PKcs phosphorylation? In this chapter we showed that DNA-
PKcsKD/- mice also died before birth, but DNA-PKcs+/KD mice had no measurable defects (Fig. 2-2C), 
suggesting expression of wild type (WT) DNA-PKcs can relieve the inhibitory effects imposed by the 
catalytically inactive DNA-PKcs protein. This lack of a dominant negative phenotype suggests that a WT 
DNA-PKcs molecule with intact kinase activity can release a “stuck” kinase dead DNA-PKcs molecule by 
trans- autophosphorylation. 
Further, intermolecular-auto phosphorylation events have been reported for DNA-PKcs and other 
PI3KK kinases like ATM and ATR (Meek et al., 2007) (Bakkenist and Kastan, 2003; Liu et al., 2011). Indeed, 
ours and other findings on the role of phosphorylation-dependent structural changes in PI3KKs (Daniel et 
al., 2012; Yamamoto et al., 2012) underscores a common mechanism for the regulation of PI3KK function 
through post-translational modifications and therefore has broad implications in the clinical management of 
diseases related to DNA repair and the DNA damage response and the development and use of specific 
kinase inhibitor. Importantly we note that inhibitors might mimic a “kinase dead” rather than null, leading to 
more severe DNA repair defects than the complete loss of the protein. 
 Altogether, we identified a novel phosphorylation dependent structural function of DNA-PKcs and 
showed that there are at least two types of DNA-PKcs phosphorylation – intermolecular, 
autophosphorylation and ATM-mediated trans-phosphorylation. Together, these two types of 
phosphorylation regulates the NHEJ process and ensures the ligation of a pair of ends (rather than single 
ended DSBs) (Cui et al., 2005). We also described mass spectrometry assays in this chapter to better 
identify particular sites relevant for DNA-PKcs phosphorylation. Our preliminary findings identified 2 
potential, novel SQ DNA-PKcs auto-phosphorylation sites and two potential phosphorylation sites known 
to be within the ATM-mediated T2609 cluster (Davis et al., 2014). Phosphorylation of the T2609 cluster 
promotes end-access, including end-resection (Cui et al., 2005). The role of the T2609 cluster will also be 
discussed further in Chapter 4. 
Masked in a DNA-PKcs null background where other kinases may compensate, the DNA-PKcs 
KD/KD mouse model provides a novel system to further understand the complex picture of cNHEJ. In Chapter 
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3, we will explore the potential consequences of DNA-PKcs becoming “stuck” on DNA ends outside of 
cNHEJ. In Chapter 4, we will further discuss this end-protection role of DNA-PKcs, as well as the role of 
the T2609 cluster.  Altogether, our studies provide a novel perspective on the role of DNA-PKcs beyond 
simple end joining during cNHEJ. 
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1: Background and Significance 
 
 In the previous chapter, we showed that in contrast to the normal development of DNA-PKcs-/- 
mice, mice expressing DNA-PKcs KD as the sole species (DNA-PKcsKD/- or DNA-PKcsKD/KD) died during 
embryonic development with severe neuronal apoptosis. Through the characterization of the DNA-
PKcsKD/KD mice and cells, we uncovered a novel structural function for DNA-PKcs in DNA end ligation during 
cNHEJ. These studies also revealed a critical contribution of ATM kinase in end processing through 
phosphorylation of DNA-PKcs. Together, these results established end ligation and end processing steps 
during cNHEJ are regulated by two separate types of DNA-PKcs phosphorylation: intermolecular “auto”-
phosphorylation (end ligation) and ATM or DNA-PKcs-mediated phosphorylation (end processing). Deletion 
of KU70 or KU80, which is necessary for the recruitment of DNA-PKcs to DNA ends, rescued the embryonic 
lethality of DNA-PKcsKD/KD mice (Fig. 2-8C-E). Loss of the C-terminal of KU80 (KU80-CTD), which is 
required for DNA-PKcs recruitment (but not cNHEJ), restored end-ligation in DNA-PKcsKD/KD cells (Jiang et 
al., 2015), indicating that the DNA-PKcs protein caps the DNA ends and physically blocks end-ligation in 
the absence of auto-phosphorylation.  
 The capping model prompted us to ask whether DNA-PKcs might regulate other DNA repair 
pathways. In addition to cNHEJ, DNA DSBs can also be repaired by the alternative end-joining (A-EJ) 
pathways. A-EJ is defined as end-ligation in the absence of cNHEJ factors (i.e. XRCC4 or KU) and 
preferentially utilizes micro-homologies (MHs) at the junction. In contrast to cNHEJ, A-EJ requires 
significant end-resection to expose the flanking MH. Given that the KD DNA-PKcs protein blocks cNHEJ at 
the DNA end, we hypothesize that the KD DNA-PKcs protein might also physically block end-resection, and 
thus prevent a subset of A-EJs. In lymphocytes, A-EJ contributes significantly to oncogenic IgH-Myc 
translocations in pro-B cell lymphomas developed in XRCC4-/-p53-/- mice (Gao et al., 2000; Zhu et al., 2002). 
To determine whether the KD DNA-PKcs protein blocks A-EJ, we characterized tumor development in DNA-
PKcsKD/KDp53-/- mice. Unexpectedly, a large subset of DNA-PKcsKD/KDp53-/- mice died tumor free before the 
age when XRCC4-/-p53-/- mice developed pro-B cell lymphomas. While these results uncovered an 
unexpected structural function of DNA-PKcs beyond end-joining that will be discussed in the next chapter, 
they also limited our ability to measure A-EJ using oncogenic translocations as a model system. Activated 
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B lymphocytes undergo class switch recombination (CSR) by joining DSBs in highly repetitive and C/G rich 
switch regions, providing another physiological system to study A-EJ. Indeed, up to 25-50% of CSR in 
XRCC4-/- or KU-/- B cells can be achieved by A-EJ (Boboila et al., 2010; Yan et al., 2007a). Therefore, we 
measured CSR in DNA-PKcsKD/KD B cells along with DNA-PKcs-/- and XRCC4-/- B cell controls, all with 
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knockin productive IgH and IgL alleles to rescue early B cell development. We also adapted a High 
Throughput Genome Translocation Sequencing (HTGTS) method (detailed below) (Hu et al., 2016), which 
allows us to analyze thousands of CSR junctions and compare the accepter site location, orientation, 
sequence composition as well as mutation rate simultaneously. Activated DNA-PKcsKD/KD B cells underwent 
CSR at a rate similar to XRCC4-/- B cells, and significantly worse than DNA-PKcs-/- B cells. HTGTS revealed 
an exhaustion of the switch region and greatly increased MH usage in DNA-PKcsKD/KD B cells, XRCC4-/- 
and unexpectedly also DNA-PKcs-/- B cells. Interestingly, the rate of mutation in the 5’S region consistently 
decreased in end-joining deficient B cells. Taken together, our results uncovered an important role of the 
DNA-PKcs protein in end-synapsis during cNHEJ and in mutation that was previously unrecognized.  
 
2 Results 
2.1: DNA-PKcsKD/KDp53-/- mice die at a young age (~22days) tumor free 
 The absence of p53 rescued the embryonic lethality associated with loss of XRCC4 or Ligase4, or 
expression of the DNA-PKcs KD protein. Yet, the rescued p53 deficient XRCC4 or Ligase 4-deficient mice 
routinely succumbed to pro-B cell lymphomas with IgH-Myc translocations and amplifications reminiscent 
of human Burkett’s lymphomas by ~10 weeks of age (Gao et al., 2000). The translocation joins the DSBs 
in the IgH locus (i.g. JH4) that accumulate due to NHEJ defects during V(D)J recombination, to a region 
downstream of c-Myc oncogene using extensive MHs, through a mechanism likely mediated by the A-EJ 
pathway. Then, p53-deficiency allows for the manifestation of amplifications and the development of 
lymphomas through a breakage-fusion-bridge (BFB) mechanism (Zhu et al., 2002). Given the end-ligation 
Figure 3-1: Tumor free survival in DNA-PKcsKD/KDp53-/- mice.  
(A) Tumor free survival of DNA-PKcs-/-p53-/- (n=31), XRCC4-/-p53-/-(n=9), DNA-PKcsKD/KDp53-/- (n=19), and 
DNA-PKcsKD/KDp53+/- mice (N=34). 3/34 DNA-PKcsKD/KDp53+/- mice were analyzed for development, and 
are censored from the curve (marked by upward ticks), survival percentages and cohort calculations (final 
cohort size=31). P values of the DNA-PKcsKD/KDp53-/- tumor cohort are 0.21 (not significant, XRCC4-/-p53-/-
), and 0.001 (DNA-PKcs-/-p53-/-) and <0.0001 (DNA-PKcsKD/KDp53+/-), as determinedby a Mantel-Cox/Log 
rank test for statistical significance. The open circles mark pro-B lymphomas, the open squares mark 
thymic lymphomas, the closed triangles mark sarcomas, and the closed circle indicates no tumor found. 
(B) Representative FACS analysis of BM (left) and LN (tumor, right) from DNA-PKcs-/-p53-/-, XRCC4-/-p53-
/-, and DNA-PKcsKD/KDp53-/- mice. (C) Kaplan-Meier (K-M) survival curve of DNA-PKcs-/-p53-/- (n=31) and 
DNA-PKcs-/-p53+/- (n=14) mice. P value is 0.0018), as determined by a Mantel-Cox/Log rank test for 
statistical significance. (D) Representative FACs analysis of a Thymic lymphoma (bottom panel), shown in 




defects and the accumulation of V(D)J recombination breaks in DNA-PKcsKD/KD B cells (Chapter 2), we 
reasoned that pro-B cell lymphomas might also occur in DNA-PKcsKD/KDp53-/- mice and would reflect a role 
of the KD DNA-PKcs protein in A-EJ and A-EJ-mediated IgH-Myc translocations. Notably, DNA-PKcs-/-p53-
/- mice also routinely succumbed to lymphomas (Nacht et al., 1996). While the translocation junctions are 
not well characterized in DNA-PKcs-/-p53-/- lymphomas, the related Artemis-/-p53-/- mice developed pro-B 
cell lymphomas with IgH-cMyc or IgH-nMyc translocations including both blunt and MH mediated joints 
(Rooney et al., 2004). 
To test whether the KD DNA-PKcs protein blocks A-EJ mediated chromosomal translocations, we 
established and followed a cohort of DNA- PKcsKD/KDp53-/- mice (n=19), and parallel cohorts of XRCC4-/-
p53-/- (n=9) and DNA-PKcs-/-p53-/- mice (n=31)(Fig. 3-1A). Due to the small stature of the XRCC4-/-p53-/- 
mice, a number of them went missing around weaning age. This issue was rectified after a new cage change 
protocol was adapted and the early batch was excluded from the following analyses. Overall, 3 XRCC4-/-
p53-/- mice analyzed succumbed to B220+IgM-CD43+ pro-B cell lymphomas with enlarged lymph nodes and 
splenomegaly  (Fig. 3-1B), while another 6 mice died at similar ages consistent with potential pro-B cell 
lymphomas with a median survival of 69 days (Fig. 3-1A). The majority of DNA-PKcs-/-p53-/- mice (n=31) 
also succumbed to pro-B cell lymphomas with a median age of 73 days (Fig. 3-1A).  Eleven DNA-PKcs-/-
p53-/- mice analyzed all developed B220+IgM-CD43+ pro-B cell lymphomas (Fig. 3-1B). DNA-PKcs-/-p53+/- 
mice (n=14) significantly outlived DNA-PKcs-/-p53-/- littermates with a median survival of 120 days 
highlighting an important role of p53 in suppressing pro-B cell lymphomas in the DNA-PKcs deficient 
background (Fig. 3-1C). In contrast to DNA-PKcs-/-p53-/-  or XRCC4-/-p53-/- mice, only 4 out of 19 (~21%) of 
DNA-PKcsKD/KDp53-/- mice developed B220+IgM-CD43+ pro-B cell lymphomas at 10-14 weeks, the age 
similar to the DNA-PKcs-/-p53-/- mice (Fig. 3-1A and B; Fig. 3-2). An additional 2 DNA-PKcsKD/KDp53-/- mice 
died at ages consistent with possible pro-B cell lymphomas, bringing the total pro-B cell lymphoma related 
deaths to at most 6/19 (31.5%; in contrast to ~100% in XRCC4-/-p53-/- or DNA-PKcs-/-p53-/-, p value = 
0.0008). The vast majority (13/19, ~68%) of DNA-PKcsKD/KDp53-/- mice died by 3-4 weeks without apparent 
tumors – i.e. no major growth in chest cavity (i.e. thymic lymphoma), enlarged lymph nodes, or 
splenomegaly. Histology analyses of 2 ~11 week old DNA- PKcsKD/KDp53-/- mice failed to identify any 
evidence of medulloblastoma, a type of brain tumor that occurs in ~50% of XRCC4-/-p53-/- mice at the time 
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of lymphoma related death (Frank et al., 1998; Yan et al., 2006). Histology analyses of a 3 week old DNA-
PKcs-/- mouse suggests a lack of lymphocytes and reveals an apparent compensatory increase of mature 
Red Blood Cell (RBC) clusters in the bone marrow (Fig. 3-3A). Three 3-4 week old DNA-PKcsKD/KDp53-/- 
mice (2 analyzed at time found dead, a third as part of the CSR HL cohort (see below, not counted among 
the 19 mice of the tumor cohort) also have red blood cell clusters and the absence of mature lymphocytes 
in the bone marrow as in the DNA-PKcs-/- mouse (Fig. 3-3A). Further, megakaryocytes, although present, 
seems to be less frequent in the bone marrow from DNA-PKcsKD/KDp53-/- mice (Fig. 3-3A). For comparison, 
the bone marrow of DNA-PKcs5A/5A mice (discussed in Chapter 4) with bone marrow failure is completely 
devoid of hematopoietic lineage cells (Fig. 3-3A). Complete blood counts (CBCs) were performed in one 
Figure 3-2: Histological analysis of a pro-B lymphoma from a DNA-PKcsKD/KDp53-/- mouse.  
Left panel: WT control spleen. Middle panel: spleen of mouse with pro-B lymphoma. Right panel: LN (tumor) 








DNA- PKcsKD/KDp53-/- mouse and 7 DNA- PKcsKD/KDp53+/- mice. The results are similar and are plotted 
together. The CBCs of DNA- PKcsKD/KDp53+/-(-/-) mice are consistent with relatively isolated lymphocytopenia 
(Fig. 3-3B). The peripheral RBC counts is normal, if not slightly increased in DNA- PKcsKD/KDp53+/- (-/-) (Fig. 
3-3C), without a significant increase in hemoglobin (Fig. 3-3D). As expected from lymphocytopenia, the 
hematocrit % (indicating the % of the blood – by volume composed of RBCs) also increased (Fig. 3-3E). 
Finally, DNA- PKcsKD/KDp53+/- (-/-) also have normal platelet (PLT) levels, confirming an intact megakaryocyte 
lineage (Fig. 3-3F). Altogether, these analyses suggest that the DNA- PKcsKD/KDp53-/- mice do have not 
anemia. The early lethality in DNA-PKcsKD/KDp53-/- mice, but not in XRCC4-/-p53-/- mice, suggests that the 
KD DNA-PKcs protein impairs other cellular functions beyond cNHEJ. But the rarity of the DNA-
PKcsKD/KDp53-/- lymphomas renders it difficult to determine the role of DNA-PKcsKD/KD in A-EJ using IgH-
Myc translocations as a model system.  
Meanwhile, we noted that most DNA-PKcsKD/KDp53+/- mice outlive DNA-PKcsKD/KDp53-/- mice with a 
median survival of 110 days (vs. 31 days in DNA-PKcsKD/KDp53-/- mice) (Fig. 3-1A). While smaller than DNA-
PKcsKD/KDp53-/- mice (Jiang et al., 2015), DNA-PKcsKD/KDp53+/- mice display isolated SCID with otherwise 
normal hematopoiesis. At ~13-15 weeks of age, 5 out of 31 (16%) developed likely p53-deficiency 
dependent sarcomas and thymic lymphomas (Fig. 3-1A and D). Analyses of three additional 14-week-old 
DNA-PKcsKD/KDp53+/- mice with hunched posture and shortness of breath failed to identify clonal tumors or 
visible enlargement (Fig. 3-1A). Notably, XRCC4-/-p53+/- mice died at a younger age than XRCC4-/-p53-/- 
mice, consistent with partial and limited rescue by heterozygous loss of p53. The longer life expectancy of 
DNA-PKcsKD/KDp53+/- mice in comparison to DNA-PKcsKD/KDp53-/- mice is unexpected. In this context, p53 
deficiency is synergistically lethal with defects in the ATR-CHK1 pathway, which regulates replication 
related DNA damage responses. Taken together, our results suggested that DNA-PKcs, and especially the 
kinase dead form of DNA-PKcs, might have a structural function in replication related events beyond 
cNHEJ. In the next chapter, we will further explore this possibility with a DNA-PKcs 5A mouse model.  
Figure 3-3: RBC compensatory increase in DNA-PKcsKD/KDp53+/- (-/-) mice. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 **** , N.S. (Not significant). P value determined by student’s t 
test. (A) Histological analysis of bone marrow (sternum) from WT, DNA-PKcs-/-, DNA-PKcs5A/5A, DNA-
PKcsKD/KDp53-/- and DNA-PKcsKD/KDp53+/- mice. This DNA-PKcsKD/KDp53+/- was found dead without tumor. 
Complete blood counts of lymphocytes (LY; B), RBCs (C), Hemoglobin (Hg, D), hematocrit percentage 





 2.2: DNA-PKcsKD/KDp53-/- B cells display CSR defects comparable to XRCC4-deficient B cells 
 Given the low numbers of pro-B cell lymphomas developed in DNA-PKcsKD/KDp53-/- mice, we 
focused on CSR as a mean to assess the phosphorylation-dependent structural function of DNA-PKcs in 
A-EJ. To circumvent the V(D)J recombination and early development defects in DNA-PKcsKD/KD B cells and 
Figure 3-4: DNA-PKcsKD/KDp53-/- B cells perform CSR at similar levels as XRCC4-/-p53-/- B cells.  
P < 0.05 *, <0.01 **, <0.001 ***, <0.0001 **** , N.S. (Not significant). P value determined by student’s t 
test. (A) Representative CSR switch percentage (defined as B220+IgG1+) on day 4 of stimulation. 
Quantification of B220+IgG1+ B cells on day and 4 of stimulation, as a percent of the control. (C) 
Representative Cell Trace Violet proliferation stain in p53-/- and PKcsKD/KDp53-/- B cells stimulated for CSR. 
(D) Quantification of B220+IgG1+ B cells on day and 4 of stimulation, as a percent of the control in p53+/+, 
p53+/-, and p53-/- stimulated B cells. (E) Quantification of of B220+IgG1+ B cells on day and 4 of stimulation, 





determine the impact of KD DNA-PKcs in CSR among mature B cells, we introduced germ-line knock-in 
alleles harboring productive V(D)J rearrangements at both the IgH (Sonoda et al., 1997) and Ig (Pelanda 
et al., 1996) loci, referred to together as HLk/k. Ku70, XRCC4 or Lig4-deficient mature B cells generated 
using this approach (Boboila et al., 2010; Pan-Hammarstrom et al., 2005; Rucci et al., 2010; Yan et al., 
2007b), and germline XLF-deficient B cells (Li et al., 2008b; Zha et al., 2007) all have reduced CSR (~25-
50% of wild type levels) with residual CSR mediated by the A-EJ pathway biased towards MH, with almost 
all MH in Lig4-/- or XRCC4-/- cells, and a more moderate dependence on MH in XLF-/- or KU-/- cells. The 
different degree of MH usage in different genetic backgrounds suggests that more than one type of A-EJ 
Figure 3-5: DNA-PKcsKD/KDp53-/- and XRCC4-/-p53-/- junctions show a similarly wide junctional 
usage distribution. 
(A) Diagram of the PCR cloning strategy from the Sμ and Sγ1 junctions. As described previously (Li et al., 
2008a; Zha et al., 2007), primers (indicated by arrows) anneal in the Sμ and Sγ1 regions and amplify 
junctions formed between these regions. The location of the junction within the known primer bait sites 
gives junctional usage information (B). Junctions that form closer to the primers are peripheral junctions, 
and reflect poor DNA damage response. (C) Summary of CSR junctions recovered from p53+/-, DNA-
PKcsKD/KDp53-/- and XRCC4-/-p53-/- stimulated B cells.  
54 
 
pathway might exist. P53 deficiency is also included to rescue the embryonic development of DNA-
PKcsKD/KD mice.  
 Purified CD43- splenic B cells were activated with anti-CD40 and IL4 to initiate CSR to IgG1 and 
IgE. CSR to IgG1 was measured by flow cytometry at different days after stimulation. In the HL background, 
wild type B cells and p53 deficient B cells achieve 40-60% surface IgG1+ by day 4 (Fig. 3-4A).  XRCC4-/-
p53-/-HL B cells switched at ~25-30% of the wild type levels (p= 1.68347E-03) (Fig. 3-4A and B), consistent 
with previous publications (Yan et al., 2007a). Also consistent with previous publications, DNA-PKcs-/- B 
cells switched at ~80% of the wild type levels (p= 3.86504E-02) (Fig. 3-4A and B) (Manis et al., 2002). 
Under the same condition, DNA-PKcsKD/KDp53-/- B cells switch at ~30% of the control levels, similar to 
XRCC4-/-p53-/- B cells (p= 8.95695E-05 and 0.87, compared to wild type and XRCC4 deficient B cells, 
respectively (Fig. 3-4A-B). Defects in CSR could be caused by reduced germline  
transcription through the switch regions or cell proliferation defects in addition to DNA repair defects. Given 
the growth defects of DNA-PKcsKD/KD MEFs previously documented (Fig. 2-4), we monitored proliferation 
using a Cell Trace Violet (CTV) dye. While overall DNA-PKcsKD/KD B cells proliferate at slightly reduced 
levels, the CSR efficiency in population with similar cell division is also ~25% of the wild type levels and 
consistent with overall switching efficiency (Fig 3-4C). Given the unexpected early lethality of the DNA-
PKcsKD/KDp53-/- mice, we initially performed the CSR assay in 18-21 day old DNA-PKcsKD/KDp53-/- mice.  
Later, when we discovered that DNA-PKcsKD/KDp53+/- mice have much longer life expectancy, we performed 
additional CSR analyses in 6-8 week old DNA-PKcsKD/KDp53+/- mice (both HL). Consistent with previous 
studies, we found that p53 deficiency does not affect CSR to IgG1 in anti-CD40 and IL-4 activated B cells 
(Franco et al., 2006) (Fig. 3-4D). Moreover, the level of CSR is comparable in the young KD DNA-PKcs 
p53 null cohort (18-21day) and the adult KD DNA-PKcs p53 heterozygous cohorts (6-8 weeks) (Fig. 3-4E). 
Age matched and wild type or heterozygous (for DNA-PKcs or p53 status) littermate controls (all with HL) 
were stimulated in parallel and used to determine the relative CSR frequency in each experiment.  Together, 
these data suggest that while the absence of DNA-PKcs (null) has only moderate effects on CSR, DNA-
PKcs has a critical structural function during CSR that is regulated by its own kinase activity and is largely 
55 
 
independent of cell growth. It also indicates that the extent of CSR defects in DNA-PKcsKD/KD cells is 
comparable to XRCC4 deficiency, and consistent with the lack of cNHEJ in DNA-PKcsKD/KD cells.   
 
2.3: Preliminary analyses of CSR junctions uncovered an increase of MH usage in DNA-
PKcsKD/KDp53-/- B cells as in XRCC4-/- B cells 
 To determine whether the residual CSR in DNA-PKcsKD/KD B cells is mediated by the A-EJ pathways 
that preferentially use MHs at the junction, as in XRCC4-/- B cells, we cloned and sequenced the switch 
junctions between Sµ-S1 by PCR using primers located in the 5’ end of Sµ and the 3’ end of S1 as 
Figure 3-6: Diagram of HTGTS library preparation (adapted from (Hu et al., 2016)). 
Steps of the HTGTS flow through. (1) Linear PCR using a biotinylated primer specific to the Sμ bait site. 
(2) Streptavidin purification of the biotinylated linear PCR product. (3) Ligation of a double stranded adapter 
sequence, with a 5-nucleotide 3’ overhang (random N’s), to the purified linear PCR product. (4) Nested 
PCR with a primer specific to the adapter and a primer specific to the bait site, forming a double stranded 
DNA product. (5) Enzyme blocking using a restriction site in the bait site to remove germline (GL) 




previously described (Li et al., 2008a; Zha et al., 2007). To avoid PCR amplification artifacts, only unique 
junctions were analyzed and annotated. In parallel, we analyzed the Sµ-S1 junction of p53+/- and XRCC4-
/-p53-/- B cells. Consistent with CSR defects and the extensive use of the distal switch regions, junctions 
from both DNA-PKcsKD/KD and XRCC4-/- B cells showed a significantly wider and more peripheral distribution 
in both the Sµ and S1 regions (Fig. 3-5A and B). As expected 6/11 (55%) of Sµ-S1 junctions from p53+/- 
B cells are blunt and 4/11(36%) have MH, consistent with previously published results on wild type and p53 
deficient B cells (Boboila et al., 2010; Yan et al., 2007a). Meanwhile, none of the 17 Sµ-S1 junctions from 
the XRCC4-/- cells are blunt and 15/17 (88%) contain MHs, supporting a critical contribution of MH mediated 
A-EJ in the residual CSR in XRCC4-/- B cells. In this context, 3/20 (15%) of Sµ-S1 junction in DNA-
PKcsKD/KD cells are blunt, while 11/20 (55%) contain MHs, suggesting an increased MH usage similar to, 
but perhaps not as extensive as, XRCC4-/- cells. Notably, 6/20 (30%) of Sµ-S1 junctions in DNA-PKcsKD/KD 
cells contain insertions >30nt, while similarly large insertions are rare in junctions from both wild type (0%) 
and XRCC4-/- (12%) B cells. Standard BlastN analyses and Blat searches failed to identify the source of 
the insertion (see next section for additional discussion) (Fig. 3-5C). While we were conducting these 
analyses, the High-Throughput Genome-wide Translocation Sequencing (HTGTS) method was developed 
and published by the Alt lab, which allow for the analysis of thousands of CSR junctions at a time.  
 
2.4: High-throughput genome-wide translocation sequencing (HTGTS) and its application in class 
switch recombination analyses 
CSR junctions are traditionally recovered using cloning methods, which is difficult due to the 
repetitive nature of the switch region. To overcome these limitations, the High-Throughput Genome-wide 
Translocation Sequencing (HTGTS) method was recently adapted for CSR junction analyses (Chiarle et 
al., 2011; Dong et al., 2015; Hu et al., 2016). HTGTS can unbiasedly identify genome-wide "prey" DSB 
junctions to a specific "bait" DSB. This method greatly increases the number of junctions that can be 
analyzed (from <100 to >1000) and widens the analyses beyond the IgH locus (including translocations 
genome-wide). Briefly, HTGTS uses a linear PCR from a specific bait site. In the case of CSR, the bait site 
is located at the telomeric end of Sµ (closer to JH4) (Fig. 3-6). After linear amplification, the resultant single-
stranded DNA is streptavidin purified and ligated to an adapter followed by PCR amplification with a pair of 
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primers specific for the adaptor and the original bait site. A restriction enzyme specific to the bait site 
germline sequence is used to eliminate germline sequences from the preliminary library. A final round of 
PCR is used to add the Illumina sequencing primers. After PAGE-mediated size selection, the library is 
paired-end sequenced on the Illumina MiSeq (2 x 300 bp) with about 1x106 reads per library. Linear PCRs 
using this 5’Sµ bait site will recover internal deletions (within Sµ), productive CSR joints (to downstream 
the switch regions), as well as other, nonproductive joints to elsewhere in the IgH region, including inverted 
joints, and outside of the IgH region (intra and inter chromosomal translocations). HTGTS analyses can 
also reveal the location and orientation of the prey DNA breaks (deletion vs inversion) (Dong et al., 2015), 
junctional sequence characteristics (MH, blunt, insertions), and also mutation patterns as discussed below.  
 
Figure 3-7: Increased frequency of inversion events in XRCC4-/-, DNA-PKcs-/-, and DNA-PKcsKD/KD 
junctions. 
(A) Schematic overview of the IgH locus. Sμ, Sγ1 and bio-primer (bait site location) are noted in 
particular. (B) Frequency of HTGTS junction prey-break sites in the (-) and (+) strand orientation, and 
in the IgH and nonIgH regions. 
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2.5: HTGTS revealed a critical role of DNA-PKcs in suppressing chromosomal translocations and 
inversions 
For each genotype mentioned below, several independent libraries were generated on DNA 
extracted from independent stimulated B cells and analyzed individually. The pooled libraries (based on 
genotype) were showed in the final graphs and the average and standard derivation calculated based on 
each individual library were plotted in the graphs.  
HTGTS allows us to precisely map the location of the prey-break sites. The prey-break site could 
be generally divided as those within the broadly defined IgH locus (including all switch regions, D-J and a 
large part of V regions, 400kb in total length) and outside the IgH locus (all other locations). Using a bait 
site within the 5’ Sµ (telomeric side) (Fig. 3-7A), most prey-break sites from wild type B cells (93%) are 
within the IgH locus, with only 7% of junction falling outside of IgH, and almost all, outside of chromosome 
12 (790/791) – reflecting true inter-chromosomal translocations. About 90% of the prey-break sites from 
DNA-PKcs null cells were within the IgH region, consistent with a low frequency of chromosomal 
translocations in DNA-PKcs null B cells determined by early cytogenetic analyses (Franco et al., 2008). 
While p53-deficiency (90% within IgH) did not significantly increase inter-chromosomal translocations 
detected by HTGTS, XRCC4-deficiency led to significant increases of the non-IgH prey-break sites (22%) 
(Fig. 3-7B).   
In addition to location, HTGTS also reveals the orientation of the prey. We defined the prey as plus 
(+) if the prey is read from the junction in a centromere to telomere direction, and as minus (-) if in a telomere 
to centromere direction (Fig. 3-8A). The murine IgH locus resides on the minus strand near the telomeric 
end of chromosome 12 and our bait site is on the telomere-to-centromere (minus) direction in Sµ (Fig. 3-
7A and Fig. 3-8A). Thus, the productive CSR joints from Sµ (relatively closer to the telomere) to Sg1 or S 
(closer to the centromere) are in the (-) orientation (Fig. 3-8A).  Notably, bait site (-) joints with upstream (-
) strand sites, with upstream (+) strand sites, or with downstream (+) strands sites are indicative of excision 
circles, inversions, and dicentric inversions, respectively (Fig. 3-8A), and all of which would be non-
productive. Consistent with the orientation bias towards productive CSR previously documented (Dong et 
al., 2015) in wild type cells, most prey break sites within the IgH region are in the (-) orientation (82% vs. 
9%, 9:1) (Fig. 3-7B). Notably, the (+) IgH prey break sites include both inversions as well as inter-sister 
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chromosomal CSR between the homologous chromosome 12. Consistent with the 53BP1 dependent 
orientation bias that is restricted to the switch region, the prey-break sites outside the IgH region were 
evenly divided between (+) and (-) in wild type B cells (~3.5% vs 4.5%). P53 deficiency alone did not 
significantly alter the (-) orientation bias within IgH preys-break sites (79% vs 11%, 7.2:1). Meanwhile, 
XRCC4-deficiency, and surprisingly DNA-PKcs- deficiency (null), greatly increased the frequency of the (+) 
strand prey-break sites within the IgH ((-):(+)= 2:1 for XRCC4-/- and =3:1 for DNA-PK-/-) (Fig. 3-7B). This 
was particularly surprising for the DNA-PK-null cells, given the moderate reduction of surface IgG1+ cell 
percentage. These and other findings (see below) suggest that the DNA-PKcs protein has a greater role in 
CSR than previously appreciated. Consistent with a great a reduction of IgG1+% cells in DNA-PKcsKD/KD B 
cells, 52% of all junctions from 2 different mice reside outside of IgH.  The ratio of (-) vs (+) junction with 
IgH is only 1.8 vs 1, similar to the 2:1 in XRCC4 deficient cells and much less than the 8:1 in wild type cells.) 
(Fig. 3-7B). Together, these findings suggest that more 50% of the breaks in S joined with breaks in 
another chromosome, and withinthe IgH locus, about 1/3 of the junctions are inversions or inter-
chromosomal translocations (relative to 7/8 in wild type cells). This distribution provides an explanation for 
the poor CSR efficiency in DNA-PKcsKD/KD cells.  
 
2.6: HTGTS revealed differential usage of Sγ1 vs Sε within IgH 
To compare the junction distribution and mutation in similar sequence contexts, we focused our 
analyses on the IgH region. When the prey sites fall into the (-) strand on Sμ, it suggests an internal deletion.  
Similarly, productive CSR events to Sγ1 and Sε would result in prey sites at the (-) strand of Sγ1 and Sε, 
respectively (Fig. 3-8B). Notably, here we define a broader region for Sμ (10kb), Sg1 (30kb) and Sε (10kb) 
to include all coding exons and intergenic regions to accommodate the extensive deletion in XRCC4-/- and 
DNA-PKcs mutant backgrounds (see below). In addition, since all of the controls and experimental mice 
have HL knocked into the Sv129 background, which have a 12kb Sγ1 region (in contrast to the ~7Kb in the 
C57/BL6 background- mm9 genome), we replaced the JH4-Cα (the last exon of Cα) of the mm9 with the 
AJ851868.3 sequence, which contains the JH4-Cα sequence from the 129Sv strain. This new genome is 
referred to as mm9Sr (standing for Switch region Replacement).  This replacement enhanced the mapping 
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of the Switch region junctions in all libraries tested. All following analyses were performed on the mm9sr 
genome.  
Consistent with productive CSR, ~75% of IgH junctions fall outside of the Sμ region and a moderate 
portion (~20%) are in the Sγ1 region in the wild type and p53 null backgrounds. Unexpectedly, half of the 
total IgH junctions from wild type cells are in the Sε region. Junctions within all IgH regions in the wild type 
and p53 null background show a similar preference for (-) strand orientation (i.e. productive joins), with less 
than 15% in the (+) orientation, and most of that in the Sμ (5%) (Fig. 3-8C).  In the meantime, more than 
50% of XRCC4-/- junctions fall within the Sμ region, with only ~30% within the Sγ1 region (and 15% on the 
productive S1 (-) orientation compared to ~20% S1(-) in wild type cells). Meanwhile there is sharp 
decrease in junctions involving the Sε region (~5%) in junctions from XRCC4-/- cells. XRCC4-/- junctions 
within IgH also show a sharp increase in (+) strand usage (~1/3 of junctions in each region), reflecting either 
increased inversions or more likely inter-chromosomal joins with homology Chr12 (Fig. 3-8C). As 
documented in previous studies, the inter-homology joints have a nearly even split between (+) and (-) 
strands (Dong et al., 2015). IgH junctions from DNA-PKcs-/- B cells also show an increase of S junctions. 
But the junctions involving S1, especially the potentially productive S1(-) is even higher than those in wild 
type cells (26%, vs 18% in wild type cells). Meanwhile the frequency of IgH junctions in Sε (especially S (-
)) dropped precipitated in DNA-PKcs-/- B cells (Fig. 3-8C). The sharp drop of S, but not S1 joins in the 
DNA-PKcs null cells provides an explanation for the moderate G1 switch defects and severe switch defects 
to other constant regions previously noted (Manis et al., 2002). Finally, the distribution of IgH junctions from 
DNA-PKcsKD/KD B cells are similar to those from XRCC4-/- B cells, with >65% of junctions in Sμ, ~13% of 
junctions within Sγ1 (9% in potentially productive S1(-)), and <5% in Sε). IgH Junctions from DNA-
PKcsKD/KD B cells also have much increased (+) strand usage as those from XRCC4-/- B cells (Fig. 3-8C). 
Together, these data revealed a distribution of IgH junctions among S, S1 and S that closely matched 
with the known switching frequency in the genotypes tested. Specifically, in end-joining deficient cells, more 
than 50% of junctions are S internal deletion, and very few (<5%) are distal S junctions. Notably, more 
than 40% junctions in wild type and p53 deficient B cells reside in S, suggesting robust S switching under 
the in vitro stimulated conditions. Probably most unexpected is the severe reduction of S, but not S1 
61 
 
junctions in DNAPKcs-/- cells, providing the first molecular explanation for the unexplained and biased 
impact of DNA-PKcs-deficiency (null) on different switch region.  Finally, the analyses of each switch 
regions confirmed the increased inversion/inter-homology switch observed for all IgH junctions in DNA 
repair deficient XRCC4-/-, DNAPKcs-/- and DNA-PKcsKD/KD B cells holds true for each switch region tested.  
Figure 3-8: Increased usage of Sμ junctions in XRCC4-/-, DNA-PKcs-/-, and DNA-PKcsKD/KD junctions. 
(A) Schematic of strand orientation and junction type of prey break sites. (B) Schematic of possible 
productive joins from the break site to the Sγ1 and Sε regions. (C) Frequency of HTGTS junctions in the (-
) and (+) strand orientation, and in the IgH regions, subdivided into Sμ, Sγ1, and Sε. The junctions plotted 
represent the pool of junctions derived from 4 DNA-PKcs+/+, 2 p53-/-, 4 XRCC4-/-p53-/-, 4 DNA-Pkcs-/-p53+/- 







Next, we examined the distribution and orientation of the prey-break sites within Sµ, S1, and S.  
Of the Sµ junctions derived from DNA-PKcs+/+ and p53-/- cells, most prey-break sites are located near the 
bait sites and show strong (-) strand bias, favoring focal internal deletions (Fig. 3-9).  As discussed earlier, 
S junctions derived from XRCC4-/- and DNA-PK-/-, and DNA-PKcsKD/KD B cells show (+) strand bias, 
especially immediately centromeric to the bait site. Also notably, the (-) orientation S junction (reflecting 
deletion) spreads further centromestric in XRCC4-/-, DNA-PKcs-/- and DNA-PKcsKD/KD cells, indicative of 
larger internal deletions with some even into the coding region of Sµ (Fig. 3-9). This wider usage is 
consistent with continued cutting by AID and exhaustion of the Switch region in the absence of functional 
repair.  
Similarly, further spreading of the (-) strand junction away from S is also noted in the S1 and S 
region junctions derived from XRCC4-/-, DNA-PKcs-/- and DNA-PKcsKD/KD cells (Fig. 3-10 and 3-11). 
Analyses of the AID hot spots (RGYW) within S1 suggests the peak of both (-) and (+) strand breaks nicely 
correlated with the RGYW hotspots in S1. While S junctions derived from XRCC4-/-, DNA-PKcs-/- and 
DNA-PKcsKD/KD cells all show strong (+) usage, only the S1 junctions from XRCC4-/- and DNA-PKcsKD/KD 
B cells, but not those from DNA-PKcs-/- cells show the (+) strand bias (Fig. 3-10). Again, the robustness of 
S1 switch in DNA-PKcs-/- cells is standing out from all the other switch regions, even S, suggesting a 
strong DNA-PKcs-independent mechanism promotes S to S1 switching in DNA-PKcs-deficient (null) 
cells. Notably, in the Sε region, junctions derived from DNA-PKcs-/- cells show similar wide distribution like 
those from XRCC4-/- or DNA-PKcsKD/KD cells. Taken together, these results identified exhaustion of switch 
regions (S1, S and S) in repair deficient B cells in general and highlight a unique, and DNA-PKcs-




Figure 3-9: Distribution of CSR junctions within 10kb of the Sμ locus. 
Schematic of region is drawn at the top. For each genotype, number of junctions are indicated for the 
(+) strand (blue) and (-) strand (red). Percent of junctional usage from the end of Sμ to the end of the 
10kb window indicated with red arrows. The junctions plotted represent the pool of junctions derived 
from 4 DNA-PKcs+/+, 2 p53-/-, 4 XRCC4-/-p53-/-, 4 DNA-Pkcs-/-p53+/- and 2 DNA-PKcsKD/KDp53-/- mice (all 





Figure 3-10: Distribution of CSR junctions within 30kb of the Sγ1 locus. 
Schematic of region is drawn at the top. For each genotype, number of junctions are indicated for the (+) 
strand (blue) and (-) strand (red). Percent of junctional usage from the end of Sγ1 to the end of the 30kb 
window indicated with red arrows. The junctions plotted represent the pool of junctions derived from 4 DNA-






Figure 3-11: Distribution of CSR junctions within 10kb of the Sε locus. 
Schematic of region is drawn at the top. For each genotype, number of junctions are indicated for the (+) 
strand (blue) and (-) strand (red). Percent of junctional usage from the end of Sε to the end of the 10kb 
window indicated with red arrows. The junctions plotted represent the pool of junctions derived from 4 DNA-




2.7: DNA-PKcsKD/KD, DNA-PKcs-/-, and XRCC4-/- junctions are characterized by 3-6bp 
microhomologies 
 Residual CSR joining in cNHEJ deficient B cells has previously been shown to be mediated by A-
EJ (Boboila et al., 2010; Yan et al., 2007a). More than one A-EJ pathway have been proposed to explain 
the different junctional features in Ku70 deficient, vs. XRCC4 deficient cells (Boboila et al., 2010). To 
understand which A-EJ pathways might be used to support the residual CSR in DNA-PKcsKD/KD B cells, we 
analyzed the junction sequences. In DNA-PKcs+/+ cells, the junctions from the IgH region, regardless of 
orientation (+ or -) show a strong enrichment for blunt junctions and junctions with 1-3nt MH (25% in each 
category and nearly 75% total) (Fig. 3-12A). Very few sequences with large insertion (>10) are found in IgH 
prey break sites derived from DNA-PKcs+/+ cells. In contrast, the non-IgH prey break sites have frequent 
insertions (~20%) and a narrower focus on blunt junction with less MH or insertions (Fig. 3-12A). The 
consistent preference for small MH (1-4) in IgH junctions in DNA-PKcs+/+ cells likely reflects the repetitive 
and highly GC rich nature of Ig Switch regions and might explain why MH-mediated A-EJ can contribute to 
up to 25% CSR. Given the different pattern seen in IgH and non-IgH junctions, we focused our analyses 
on joins recovered from the IgH. As noted for the junctions from DNA-PKcs+/+ cells, IgH junctions derived 
from p53 null cells is also composed of ~25% blunt, 25% 1nt MH, and another 25% with 2-3nt MH, all 
possible within cNHEJ (Fig. 3-12B). In contrast, there is clearly a shift to slightly longer MH in IgH junctions 
derived from XRCC4-/- B cells, with only 5% blunt, 12% with 1ntMH, 42% with 2-3 ntMH, and a remarkable 
25% with ≥4nt MH, a range that is exceeds the number of MH in cNHEJ (Fig. 3-12B). Despite the different 
degree of CSR defects, both IgH junctions derived from DNA-PKcs-/- and DNA-PKcsKD/KD cells share the 
increased usage of MH with XRCC4-/- junctions, although possibly slightly more moderately (Fig. 3-12B). 
Altogether, these results uncovered a prominent role for DNA-PKcs as a whole in c-NHEJ and suggest that 
in DNA-PKcs-/- cells, MH mediated A-EJ effectively promoted IgG1 switching. It remains unclear why and 
what feature of IgG1 allows this in DNA-PKcs-/- cells, but not in XRCC4-/- or DNA-PKcsKD/KD cells. Given the 
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synapsis function of DNA-PKcs previously proposed, it is also possible that S1 might be able to 
fold/synapse with 5’S better than other switch region. Finally, the similar degree and extent of MH usage 
in DNA-PKcsKD/KD cells vs XRCC4-/- cells, suggests that the A-EJ pathway, and by extension, the end-
resection necessary for A-EJ were not measurably affected by the stalled DNA-PKcs KD protein. In this 
context, CtIP and MRN mediated endonuclease incision has been implicated in the initiation of end-
Figure 3-12: XRCC4-/-, DNA-PKcs-/-, and DNA-PKcsKD/KD junctions are all marked by an increase in 
MH usage at the junctions 
(A) The frequency of junctions with microhomologies (MH, -), Blunt (BLU, 0), and insertions (+) in the IgH 
region or non-IgH region or IgH region at (+) or (-) orientation from a DNA-PKcs+/+ mouse (with over 5000 
overall junctions). (B)  The frequency of junctions with microhomologies (MH, -), Blunt (BLU, 0), and 
insertions (+) in the IgH region (both + and – orientation). The junctions plotted represent the pool of 
junctions derived from 4 DNA-PKcs+/+, 2 p53-/-, 4 XRCC4-/-p53-/-, 4 DNA-Pkcs-/-p53+/- and 2 DNA-




resection and might be able to overcome any end-blocking. Finally, large insertions (>5nt) are rare in all 
IgH junctions regardless of genotype. Junctions with small insertions (1-5nt) accounts for ~12% of IgH 
junctions from wild type cells, and decreased to ~5% in XRCC4-/-, DNA-PKcs-/-, or DNA-PKcsKD/KD cells. 
Notably, several polymerases including pol  are implicated in A-EJ. The lack of insertion in switch region 
junctions might reflect a unique feature of the Switch region rendering it is difficult to map long insertions. 
Alternatively, there might be several different A-EJ pathways, and only one is preferentially activated in 
CSR that is independent of polymerase.  
 
Figure 3-13: DNA-PKcsKD/KD HTGTS CSR junctions do not have a strong mutational pattern in the 
IgH region. 
(A) Diagram of the bait site and nucleotide counting scheme for mutational analysis (left). Summary of 
junctions within the IgH region analyzed for mutational distribution, including total number of reads and 
nucleotides. (B) Distribution of original nucleotide frequency in the junctions from each genotype considered 
(IgH junction only, in the (-) orientation). (C) Frequency of mutations from each nucleotide (A, T, C, or G) 
per mutated reads. (D) Overall frequency of mutations per 10,000 nucleotides (nt). (E) Frequency of IgH 
reads containing mutations in the bait portion (Prey portion is NOT considered in the mutation analyses). 
(F) Mutations in a particular nucleotide per 10,000 of that nucleotide type. (i.e. rate of mutation among 







2.8: Mutation analyses in the Sμ bait sites in DNA-PKcsKD/KD B cells 
 Junctions recovered through HTGTS share a common bait site immediately downstream of the 
nesting primer at the 5’ (telomeric) end of S. We therefore analyzed the mutation frequency and pattern 
in this 5’ S region. The nesting primer binding site was excluded from these analyses to avoid PCR bias. 
(Fig. 3-13A). Notably, each junction has a different length of the bait site sequence ranging from 35nt to 
more than 100nt with an average around 50nt. Only junctions with the prey at the IgH locus were included 
in the analyses to avoid uncertainty introduced by the inter-chromosomal translocations. As for the 
junctions, several independently derived libraries from independently activated B cells of each genotype 
were first analyzed individually and then pooled together to determine the overall pattern, average and 
standard errors. First, we determined the composition of A, C, T, G in the original sequence and found them 
to be comparable in all libraries analyzed of all different genotype. We note that we only analyzed the (-) 
strand in the orientation of S transcription (Fig. 3-13B). Then we plotted the frequency of mutation at each 
dNTP type and found C/G are clearly preferentially mutated over A and T, with even more bias toward C/G 
mutation in wild type and p53 null B cells than any of the repair mutants (which also have p53 deficiency). 
Notably, the Illumina MiSeq has a reported mutation rate of ~10nt/10,000. The DNA-PKcs+/+ junctions have 
an average mutation rate of 25 mut/10,000. Between different genotypes, the average tmutation rate 
(mut/10,000 bases) and frequency of reads with mutation are both higher in junctions derived from DNA-
PKcs+/+ and p53-/- cells, and lower in those from XRCC4-/- and DNA-PKcsKD/KD cells. Junctions from DNA-
PKcs-/- cells have a normal frequency of reads with mutations, but an overall lower mutation rate, suggesting 
fewer mutation per reads among the mutated reads (Fig. 3-13E). When the mutation is broken down to 
each dNTP type, it is apparent that G is most frequently mutated in junctions from DNA-PKcs+/+ and p53-/- 
B cells, and it is also this reduction of the G mutation that accounts for the lower mutation rate in junctions 
derived from XRCC4-/- and DNA-PKcsKD/KD cells (Fig. 3-13F). Altogether, these data suggest that there is a 
slight reduction of mutations from G in the XRCC4-/- and DNA-PKcsKD/KD cells. While further analyses are 
necessary to validate these initial findings, our results demonstrate HTGTS as a promising tool for mutation 





 In the previous chapter, we uncovered an unexpected and critical role of DNA-PKcs in end ligation 
during NHEJ. Here, we further characterized the KD DNA-PKcs protein as having a broader role in 
regulating end access and repair. We showed that the DNA-PkcsKD/KDp53-/- mouse is actually more severe 
than DNA-PKcs-/-p53-/- mice, which develop pro B cell lymphomas at 8-12 weeks, in that the majority die by 
3 weeks. We also found that DNA-PkcsKD/KDp53-/- B cells have similar CSR efficiency as XRCC4-/-p53-/- B 
cells, suggesting that A-EJ as a whole is not significantly impaired.  
 Consistent with previous studies, we found that XRCC4-/- junctions have elevated MH usage 
relative to WT and p53 deficient control junctions. Additionally, we confirmed that p53 deficiency alone has 
little to no effect on mutation rate or other junctional characteristics. Further, we also showed that DNA-
PkcsKD/KDp53-/- junctions have similarly increased MH usage as XRCC4-/- junctions, suggesting that A-EJ is 
not blocked in the presence of DNA-PKcs KD protein, at least in the context of A-EJ. In addition, we have 
revealed that DNA-PKcs-/- junctions are also characterized by a similar degree of elevated MH usage, 
indicating that A-EJ is also elevated in a DNA-PKcs deficient background. This reveals a previously 
unrecognized and important role for the DNA-PKcs protein in cNHEJ during CSR, since junctions recovered 
in this DNA-PKcs-/- background are marked by A-EJ MHs despite largely normal CSR efficiency. Further, 
this reveals a unique characteristic of S1 in supporting CSR in the absence of DNA-PKcs, likely due to its 
larger size. 
 How might A-EJ overcome the KD DNA-PKcs protein, which is stuck on the ends? There are two 
possible scenarios that this could occur. First, resection may occur normally despite this block. This could 
happen if there is sufficient residual end access for the resection machinery to function. Perhaps the 
initiation of resection would cause the release of KU and thus of DNA-Pkcs. Second, the more likely 
scenario is that there is an endonucleocytic or DNA knicking event to cleave the DNA upstream of the stuck 
DNA-PK holoenzyme (KU and KD DNA-PKcs), to effectively get around the blockage. While KU blocks 
end-resection by Exo1 nuclease(Mimitou and Symington, 2010), recent studies suggest that the presence 
of KU and other proteins at the DNA ends, actually stimulates the endonuclease activity of Mre11 
complex(Reginato et al., 2017; Wang et al., 2017), which might initiate end-resection by clipping off the 
DNA ends together with the KU and DNA-PKcs-KD proteins. In case of CSR, the continued action of AID 
and the processing of de-aminated cytosine might provide another mechanism to create peripheral 
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breaks/nicks without end resection. Accordingly, in both DNA-PKcs KD cells and in XRCC4-deficient cells, 
as well as to a lesser extent in DNA-PKcs-deficient cells, we observed extensive use of the downstream 
(distal) regions in both Smu and Sg1. Further, it has been shown that while AID generates lesions during 
the G1 cell cycle phase, unresolved breaks are carried into S/G2 (Hasham et al., 2012), when the MRN 
complex is more active, and therefore more likely to be available to process these blocked ends. This could 
explain the difference in A-EJ usage in CSR and V(DJ) recombination, since unresolved breaks generated 
during V(D)J recombination lead to cell cycle arrest and so are not carried over into S phase. 
In addition to MH usage and the status of A-EJ, junctional characterization also uncovered 
information about translocations and inversional events. Interestingly, the frequency of inter-chromosomal 
translocations (~7%) detected by HTGTS in wild type cells is much higher than previously reported by 
cytogenetic analyses. This might reflect an important role of the cell cycle checkpoint in preventing cells 
carrying such translocations from entering mitosis. This model might also explain why p53 deficiency does 
not lead to an increased number of inter-chromosomal translocation in HTGTS, but does result in more 
translocations in metaphase analyses. XRCC4-/-and DNA-PkcsKD/KDp53-/- junctions both showed an 
increase usage of (+) strands in the IgH junctions (likely representing inversional or translocation events), 
as well as non-IgH translocation junctions. This increase makes sense given the level of genomic instability 
(which increases the number of breaks available to translocate) in both of these genetic backgrounds due 
to the severe impairment of cNHEJ (Chapter 2). DNA-PkcsKD/KDp53-/- junctions appear to have a slight 
increase in these translocations events compared to XRCC4-/-junctions, although it is unclear whether this 
represents a true increase. If real it could indicate a greater degree of genomic instability in the DNA-
PkcsKD/KDp53-/- background than has been appreciated. While our analyses have found no blockage of A-
EJ in the CSR context, it remains a possibility that it is impaired outside of the IgH locus. Further, there 
could be additional pathways of DNA repair that are defective in the DNA-PkcsKD/KDp53-/- mouse. This could 
potentially explain the early lethality (~3 weeks) of the DNA-PkcsKD/KDp53-/- mouse model, and contributes 
to the idea that the DNA-PKcs protein may affect DNA repair pathways outside of the G1 cell cycle phase 
(ie S phase).  
Finally, we surprisingly found that the mutation frequency was reduced in junctions from repair 
deficient backgrounds. Since AID acts on cytosine, this result suggests there might be a more direct action 
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of AID on the template strand of the germline transcript. While initially counter intuitive, the identification of 
robust anti-sense transcript and the important role of RNA exosome complex in CSR suggests that both 
strands might act as non-template strand depending on the orientation of the transcription. Notably G 
mutations are preferable in both WT and p53 null, and are reduced consistently in all DNA-PKcs mutants 
as well as in XRCC4 deficient cells. Maybe the processing of the C lesion is differentially regulated in NHEJ 
deficient cells or the competition between ligation and joining in the switch region alters this mutation 
pattern. Further analyses in the IgV region are warranted to determine whether NHEJ factors have a direct 
role in SMH. 
 In the next chapter, we explore this possibility. To do so, we generated and characterized a mouse 
model expressing a DNA-PKcs protein with alanine substitutions, which allows us to separate the structural 
function of DNA-PKcs in cNHEJ from its role in end-protection, which might shed light on the early lethality 
of the DNA-PKcsKD/KDp53-/- mice. For example, at single ended DSBs “intermolecular” auto-phosphorylation 
between DNA-PKcs molecules are not available. DNA-PKcs, if not properly removed, might affect end-
resection and therefore compromise homologous recombination, which relies on end resection. Further, 
the improved survival of DNA-PKcsKD/KDp53+/- mice is reminiscent of ATR and Chk1 deficient mice, in which 
p53 complete deficiency is more severe than p53 heterozygous deficiency, and suggests a role for the KD 
DNA-PKcs protein in S phase.  
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1: Background and Significance 
 Using the KD DNA-PKcs mouse model, we uncovered previously unappreciated structural roles for 
DNA-PKcs in regulating cNHEJ and A-EJ, which were discussed in chapter 2 and 3 respectively. Briefly, 
we showed that DNA-PKcs auto-phosphorylation is necessary for cNHEJ in part by relieving the physical 
blockade imposed by DNA-PKcs protein at the DNA ends. As a result, the ligation phase of cNHEJ is 
completely abrogated in a mouse model expressing only kinase dead (KD) DNA-PKcs protein (DNA-
PKcsKD/KD or DNA-PKcsKD/-). Meanwhile end-processing, especially hairpin opening by Artemis 
endonuclease in DNA-PKcsKD/KD cells is normal and fully depends upon the kinase activity of the related 
ATM kinase, indicating that phosphorylation of DNA-PKcs regulates the interplay between end-processing 
and end-ligation during cNHEJ. Despite similar cNHEJ defects in XRCC4-/- and DNA-PKcsKD/KD mice, the 
majority of DNA-PKcsKD/KDp53-/- mice (nearly 70%, Fig 3-1A) died at 3-4 weeks without apparent tumor, 
while all XRCC4-/-p53-/- mice succumbed to pro-B cell lymphomas at 8-10 weeks of age. These and other 
findings suggest that the DNA-PKcs has a structural function beyond cNHEJ. Using B cell immunoglobulin 
CSR, we showed that kinase dead DNA-PKcs protein does not significantly block the micro-homology 
mediated A-EJ pathway as a whole. 
 Still unexplained is the early lethality of the DNA-PKcsKD/KDp53-/- mice, in comparison to the XRCC4-
/-p53-/- control. The “inter”-molecular auto-phosphorylation of DNA-PKcs during cNHEJ requires at least two 
DNA-PKcs molecules on each side of a DSB, but what may be happening in the context of a single ended 
DSB? Single ended DSBs naturally occur under physiological conditions, including at the end of leading 
strand telomeres during replication and at collapsed replication forks. In this regard, DNA-PKcs has been 
implicated in leading strand telomere end capping and DNA-PKcs deficiency leads to variable degrees of 
telomere chromatid fusions (Bailey et al., 2004; Bailey et al., 1999; Espejel et al., 2002; Gilley et al., 2001; 
Williams et al., 2009). DNA-PKcs was also implicated in telomere length regulation (Espejel et al., 2002). 
Notably, single ended DSBs most frequently occur during replication, while our previous studies of cNHEJ 
in the context of V(D)J recombination and post-mitotic neurons almost exclusively focused on G1/G0 phase 
cells(Jiang et al., 2015). While cellular proliferation is required for B cell class switch recombination, the 
DSBs at Switch regions were thought to be initiated in G1 cells (Franco et al., 2006). Given these and other 
observations, we proposed that DNA-PKcs has a structural function during DNA replication, especially at 
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single ended DSBs. Specifically, we propose that DNA-PKcs protects single ended DSBs from direct end 
processing and aberrant end-ligation mediated by cNHEJ. In this chapter, we will discuss the end-protection 
function of DNA-PKcs in the context of a new model mouse with alanine substitutions in one of the DNA-
PKcs phosphorylation clusters.   
 While characterizing the DNA-PKcsKD/KDp53-/- cohort, a DNA-PKcs “3A” mutant mouse was 
generated and characterized (Lee et al., 2013a; Zhang et al., 2011a), The 3A mutation abolished 3 out of 
5 conserved Threonine (TQs) site within the T2609 phosphorylation cluster of DNA-PKcs (Fig.4-1A). DNA-
PKcs3A/3A mice succumbed to p53 dependent bone marrow failure at 3-4 weeks, a time that is remarkably 
similar to DNA-PKcsKD/KDp53-/- mice (Fig. 3-1A). The lack of neuronal apoptosis and embryonic lethality in 
the DNA-PKcs3A/3A mice, and the efficient formation of CJ and SJ in DNA-PKcs3A/3A B cells further suggested 
the 3A mutation in the T2609 cluster did not abolish end-joining as the KD-DNA-PKcs mutation does. Thus, 
the DNA-PKcs 3A mutation might represent a separation of function mutant that isolates the role of DNA-
PKcs in cNHEJ/A-EJ from its role in replicating cells. While defects in the Fanconi anemia pathway and 
telomere instability have been proposed to explain the bone marrow failure of the DNA-PKcs3A/3A mice, mice 
deficient for core Fanconi anemia pathway members (e.g. FAND2) do not display bone marrow failure until 
>6 month of age (in contrast to 3-4 week in DNA-PKcs3A/3A mice) (Houghtaling et al., 2003; Langevin et al., 
2011). Similarly, only late generation (G4 and later) telomerase deficient (mTR−/−) mice display 
hematopoietic stem cell defects (Niedernhofer, 2008; Rudolph et al., 1999) and concurrent pleotropic aging 
(in contrast to the isolated bone marrow failure in the DNA-PKcs3A/3A mice). Together, these findings suggest 
that DNA-PKcs might have a yet undetermined structural function in replicating cells, especially 
hematopoietic stem cells.  
Figure 4-1: Generation of the DNA-PKcs 5A Allele. 
(A) The amino acid sequence around the T2609 cluster in 6 different vertebrate species including human 
and mouse. The TQ sites are boxed for easy identification. *Site mutated in the DNA-PKcs3A/3A mouse. (B) 
The schematic diagram represents the murine Prkdc (DNA-PKcs) locus (top), targeting vector (2nd row), 
targeted allele (DNA-PKcs5AN, 3rd row), and the neo-deleted mutant allele (DNA-PKcs 5A, bottom). The 5’ 
probe is marked as a black line. The exons and loxP sites are shown as solid boxes and open triangles, 
respectively. The exon containing the 5A mutation is marked as a red box. Restriction site designation: The 
Spe1 sites used for the primary screen are marked. The map is not drawn to scale. (C) Southern blot 
analyses of Spe1-digested DNA from DNA-PKcs+/+ and DNA-PKcs+/5AN ES cells. (D) Western blot for total 
DNA-PKcs in mouse thymocytes. Anti-DNA-PKcs antibody from Thermo Scientific (MA513404) was used 
at 1:1000. (E) Genotypes obtained by inter-crossing DNA-PKcs+/5A mice. (F) Weight (gram) at 9 days of 







The T2609 cluster is primarily phosphorylated by the ATM kinase in human cells, representing a 
potential cluster that mediates hairpin opening during V(D)J recombination. While DNA-PKcs3A/3A B cells 
are capable of V(D)J recombination, including hairpin opening, end-ligation as well as part of hairpin 
opening in DNA-PKcs3A/3A B cells are abolished by specific inhibitors to DNA-PKcs or ATM (Lee et al., 
2013b). Meanwhile, ATM inhibition only partially attenuated CJ formation in DNA-PKcs+/+ B cells and DNA-
PKcs kinase inhibitor alone did not measurably affect CJ or SJ formation in WT B cells (Bredemeyer et al., 
2006b; Gapud et al., 2011). Given that both ATM and DNA-PKcs might phosphorylate DNA-PKcs at the 
T2609 cluster and that there are two additional TQ sites within the murine T2609 cluster, we further 
hypothesized that the remaining TQ sites might be responsible for residual end-joining or hairpin opening. 
We also hypothesize that the completely non-phosphorylatable mutant (5A) at the T2609 cluster might be 
able to reveal the structural function of DNA-PKcs during replication that was overshadowed by the early 
embryonic lethality in the KD DNA-PKcs mice. Thus, we generated and characterized a novel mouse model 
in which all 5 TQ sites in the T2609 cluster were replaced by AQ (Fig.4-1A): referred to as DNA-PKcs 5A 
thereafter. Despite reduced DNA-PKcs-5A protein levels, all DNA-PKcs5A/5A mice succumbed to p53-
dependent early bone marrow failure and display epidermal hyperpigmentation like the DNA-PKcs3A/3A 
mice. Also like the DNA-PKcs3A/3A B cells, DNA-PKcs5A/5A B cells carry out V(D)J recombination efficiently 
in an ATM kinase activity-dependent manner. Yet, DNA-PKcs5A/5A murine embryonic fibroblasts (MEF, 
primary as well as immortalized) proliferate normally and display very moderate spontaneous genomic 
instability and almost no detectable sensitivity to a large spectrum of genotoxic agents. In contrast, DNA-
PKcs5A/5A embryonic stem (ES) cells display significant telomere instability without telomere fusions as well 
as spontaneous proliferation defects manifested as smaller colony size, reduced S phase and hyper 
activation of the p53 pathway without DNA damage induced phosphorylation of p53 at Ser15. This unique 
phenotype in DNA-PKcs5A/5A ES cells, but not in MEFs and the potential DNA damage-independent 
activation of p53 prompted us to test whether ribosome stress, which is known to activate p53 independent 
of DNA damage, is elevated in DNA-PKcs5A/5A ES cells. Preliminary analyses uncovered rDNA instability in 
DNA-PKcs5A/5A ES cells with a corresponding significant increase in red blood cell volume in 3 week old 
DNA-PKcs5A/5A mice, consistent with macrocytic anemia characteristic for Diamond Blackfan Anemia 
(“DBA”), a rare form of anemia caused by defects in ribosomal biogenesis and hyperactivation of p53. In 
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this chapter, we will discuss our current results, on-going experiments and future plans for the 
characterization of the DNA-PKcs5A/5A mouse model.   
 
2: Results 
2.1: Generation of DNA-PKcs5A/5A mouse model 
To fully characterize the role of the T2609 DNA-PKcs phosphorylation cluster, we designed a 
targeting vector, which replaced all 5 Threonine within the TQ motifs in the T2609 cluster (Fig.4-1A) Alanine. 
All of the 5 TQ sites are mapped in a single exon (Exon 58) of murine DNA-PKcs (Prkdc locus) and within 
400nt from each other. We synthesized a DNA sequence spanning Exon 58 with Alanine substitutions 
(Genewiz) (Fig. 4-1A and Fig.4-2) and integrated it into the extended 3’ arm (4.4kb). A 5’ arm (3kb) was 
included upstream, separated by a Neo-Resistance (NeoR) gene flanked by a pair of FRT sites (Fig.4-1B). 
The linearized plasmids were electroporated into murine ES cells (129Sv background) and NeoR+ clones 
were isolated, screened by Southern blotting with SpeI digestion and a 5’ probe and a neo probe (Germline 
=14.7kb and targeted =5.8kb). The integration of the mutation was sequence confirmed (Fig.4-1C and Fig. 
4-2) and the correctly targeted ES cells were injected for germline transmission. The resultant DNA-
PKcs+/5AN mice (N for neo positive) were crossed with constitutively FLIpase expressing ROSA26AFLIP/FLIP 
mice (Jax stock number 003946, also in 129Sv background) to remove the NeoR cassette and allow the 
expression of the DNA-PKcs-5A allele. This allele is hereafter referred to as “5A” for 5 Threonine-to-alanine 
substitutions. DNA-PKcs-5A protein is expressed in the thymus of DNA-PKcs5A/5A mice at a level that is 
Figure 4-2: Sequencing confirmation of DNA-PKcs+/5AN targeting. 




much lower than WT DNA-PKcs (Fig.4-1D). Despite the reduced DNA-PKcs 5A protein level, DNA-
PKcs5A/5A mice share similar phenotypes with the DNA-PKcs3A/3A mice, which expresses a normal level of 
DNA-PKcs proteins (Zhang et al., 2011b).  
 
2.2: DNA-PKcs5A/5A mouse is viable and normally size at birth, but deteriorates rapidly in a p53-
dependent manner.  
DNA-PKcs+/5A mice were born at the expected ratio, fertile and of normal size. DNA-PKcs5A/5A mice 
were also born at the expected Mendelian ratio, similar to the previously characterized DNA-PKcs3A/3A mice 
(Fig.4-1E) (Zhang et al., 2011b). Shortly after birth, at 7-10 days of age, DNA-PKcs5A/5A mice are 
indistinguishable from DNA-PKcs+/5A and DNA-PKcs+/+ littermates by weight or by general appearance 
(Fig.4-1F). This is in sharp contrast to the DNA-PKcsKD/KDp53+/- (or p53-/-) mice, which are significantly 
smaller at birth (Fig. 2-2) (Jiang et al., 2015).  Yet in the next ~15 days, DNA-PKcs5A/5A mice gradually fall 
behind, stop gaining weight and rapidly deteriorate by weaning (~21 days post birth). By 3 weeks age, the 
weight of DNA-PKcs5A/5A mice is only ~75% of their WT littermates and visibly smaller (Fig.4-3A). Loss of 
one or both p53 alleles fully rescued the post-birth growth retardation in DNA-PKcs5A/5A mice (Fig.4-3A). 
Complete deficiency of DNA-PKcs (DNA-PKcs-/-) does not affect the viability and survival of mice within 2 
months of birth (Fig.4-3B). Adult DNA-PKcs-/- mice have a median lifespan of 142 days with a combination 
of opportunistic infection and autoimmune disorders- likely due to severe combined immunodeficiency 
(SCID). In contrast, 50% of DNA-PKcs5A/5A mice died by 24 days of age. And ~95% of the DNA-PKcs5A/5A 
mice succumbed by 40 days of age. The life expectancy of the DNA-PKcs5A/5A mice is slightly longer (~6 
days) than previous published DNA-PKcs3A/3A (t1/2=18 days), likely due to the lower expression level of the 
mutant DNA-PKcs protein in the DNA-PKcs5A/5A mice (Zhang et al., 2011b). Heterozygous and homozygous 
p53 deficiency both rescued the early lethality of DNA-PKcs5A/5A mice, and extended the median survival 
age to 81 and 103 days, respectively (Fig.4-3B). Notably, the time of death of the DNA-PKcs5A/5A mice is 
very similar to that of DNA-PKcsKD/KDp53-/- mice (68% lethality by 5 weeks) (Fig.4-3B) (discussed below- 
although we did not find severe bone marrow depletion in DNA-PKcsKD/KDp53-/- mice analyzed). Like the 
previously characterized DNA-PKcs3A/3A mice, DNA-PKcs5A/5A mice also have epidermal hyperpigmentation 
that is most notably in the paws and tails (Fig.4-3C). This is a sign of p53 hyper-activation that is found in 
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various mouse models (McGowan et al., 2008; Murase et al., 2009), which is also fully rescued by p53 
deficiency.  
 
2.3: p53-dependent pancytopenia in ~3 week old DNA-PKcs5A/5A mice. 
 To better understand the cause of death in the young DNA-PKcs5A/5A mice, we performed complete 
blood counts (CBC) of peripheral blood from 3 week old DNA-PKcs+/+ (n=6), DNA-PKcs5A/5A (n=3) and DNA-
PKcs5A/5Ap53+/- (n=3) mice. Both the absolute number (million or kilo per ul) of total White blood cells (WBC) 
as well as the individual subtypes, lymphocytes (LY k/ul), monocytes (MO, k/ul), platelets (PLT, k/ul), and 
Figure 4-3: Post birth survival and characterization of the DNA-PKcs5A/5A mouse. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 ****, N.S. (Not significant). (A) Total weight of a mix of male and 
female mice at 3 weeks of age. P value is determined by student’s t test. (B) Survival of DNA-PKcs5A/5A 
mice up to 80 days. N is indicated on graph, and N includes mice that have been censored. Censored mice 
are marked by an upward tick and are NOT counted towards survival percentages. Mice are censored if 
euthanized for non-end point reasons (i.e. development analysis). DNA-PKcs5A/5A cohort is significantly 
different from every other cohort (p<0.0001 for all but DNA-PKcsKD/KD, and p=0.0004 compared to DNA-
PKcsKD/KD), determined by a Mantel-Cox/Log rank test for statistical significance. (C) Representative images 





red blood cells (RBC, million/ul) from 3 week old DNA-PKcs+/+ mice (n=6) are consistent with the recently 
published normal hematology profiles of p0 (new born) to p35 day old laboratory mice (Fig.4A-E) (White et 
al., 2016). CBCs of DNA-PKcs5A/5A mice revealed severe pancytopenia affecting all lineages, with over a 
Figure 4-4: p53-dependent pancytopenia and bone marrow failure in ~3 week old DNA-PKcs5A/5A 
mice. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 ****, N.S. (Not significant). P value is determined by student’s 
t test. CBC analyses of absolute white blood cells (WBC, K/ul) (A), Lymphocytes (LY, k/ul) (B), Monocytes 
(MO, k/ul) (C), platelets (PLTk/ul) (D), red blood cells (RBCs,milliom/ul) (E),  and hemoglobin (Hg, g/dL) 





10-fold reduction in all nucleated WBC, including lymphocytes and monocytes (Fig.4A-C). This 
“pan”cytopenia is different from the isolated reduction in lymphocyte number in cNHEJ deficient mice (e.g. 
DNA-PKcs-/- and DNA-PKcsKD/KD) with V(D)J recombination defects. Most critically (and likely life threating), 
the PLT counts are reduced from ~320k/ul in DNA-PKcs+/+ mice to barely 80k/ul in DNA-PKcs5A/5A mice (a 
75% reduction) (Fig.4-4D) and the RBC levels dropped from ~7 million/ul in DNA-PKcs+/+ to 3.5 million/ul 
in DNA-PKcs5A/5A mice (Fig.4-4E). Correspondingly, hemoglobin (Hb) levels also dropped from ~12 g/dL in 
DNA-PKcs+/+ mice to ~ 6 g/dL in DNA-PKcs5A/5A mice (Fig.4-4F). As previously documented for DNA-
PKcs3A/3A mice, heterozygous loss of p53 fully rescued the pancytopenia in the DNA-PKcs5A/5A mice. DNA-
PKcs5A/5Ap53-/- mice also display normal levels of blood cells (Fig.4-4A-F). In contrast to the DNA-
PKcsKD/KDp53+/-(-/-) mice previously characterized, p53 deficiency also fully rescued peripheral lymphocyte 
counts, suggesting that unlike the DNA-PKcs KD protein (Fig. 2-5), the DNA-PKcs 5A protein does not 
block early lymphocyte development or V(D)J recombination. The lack of peripheral lymphocytes in DNA-
PKcs5A/5A is likely caused by defects in hematopoiesis or early progenitors, rather than by defects in V(D)J 
recombination within the committed lymphoid progenitors.  De novo hematopoiesis is very active in the first 
3 weeks after birth. In this time, the level of high affinity fetal hemoglobin phases out and is replaced by 
adult hemoglobin with lower oxygen carrying ability. Therefore, the increases of red blood cell number and 
hemoglobin is critically important at this transition (Sankaran and Orkin, 2013). As a consequence, in normal 
laboratory mice the RBC counts increased from ~3 million/ul at birth to ~ 8 million/ul (adult level) by 21-28 
days. The Hb level increases accordingly from 7g/dL at day 7 to 15g/dL at day 28. The normal size of DNA-
PKcs5A/5A mice at 7 days of age and severe growth retardation and pancytopenia at 3 weeks prompted us 
to examine early hematopoiesis and the megakaryocyte transition (see later) in the DNA-PKcs5A/5A mice.   
 
2.4: p53-dependent bone marrow failure in DNA-PKcs5A/5A mice.  
Histology analyses of the sternum bone marrow cavity from 3 week old DNA-PKcs+/+, DNA-
PKcs5A/5A and DNA-PKcs5A/5A p53+/- mice were performed. DNA-PKcs+/+ controls have an intact bone 
marrow with normal cell lineages (i.e. megakaryocytes, myeloid and other hematopoietic lineages) and 
regular formation of bone trabeculae (Fig.4-4G). In contrast, bone marrow of DNA-PKcs5A/5A mice is mostly 
depleted with minimal residual hematopoietic cells. The majority of the DNA-PKcs5A/5A marrow is now filled 
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by fat cells (Fig.4-4G). In addition to the lack of hematopoietic cells, the bone structure in the DNA-PKcs5A/5A 
mice is significantly smaller with less trabeculae, while the layers of osteoblast and osteocytes remain 
largely intact (Fig.4-4G). DNA-PKcs5A/5Ap53+/- bone marrow shows nearly complete morphological rescue, 
though at a somewhat reduced cellularity. The bone marrow from DNA-PKcs5A/5Ap53-/- mice shows a fully 
intact bone marrow with packed nucleated hematologic cells, suggesting a full rescue (Fig.4-4G). Together, 
these studies indicated that DNA-PKcs5A/5A mice display p53-dependent bone marrow depletion, which 
resulted in pancytopenia at early age.   
Figure 4-5: Hematopoietic stem cell deficiency in 3 week old DNA-PKcs5A/5A mice. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 ****, N.S. (Not significant). P value was determined by student’s 
t test. (A) Representative flow cytometry of the HSC compartments in the bone marrow of 3 week old mice. 
Images are gated on the lineage negative population (negative for CD3e, CD4, CD8a, Ter119, B220, Gr1, 
and Mac1) and subdivided into LK and HSPC (LSK) populations as shown. (B) Quantification of frequency 
of progenitor (LK) cells in the lineage negative population at 3 weeks. (C). Quantification of frequency of 





Figure 4-6: Hematopoietic stem cell deficiency in E14.5 DNA-PKcs5A/5A embryos. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 ****, N.S. (Not significant). P value determined by student’s t 
test. (A) Representative flow cytometry of the HSC compartment in the fetal livers of E14.5 embryos. 
Images are gated on the lineage negative population (negative for CD3e, CD4, CD8a, Ter119, B220, Gr1, 
and Mac1) and subdivided into LK and HSPC (LSK) populations as shown (top panel). The HSPC (LSK) 
population was then further subdivided to analyze the multipotent progenitor population (MPP) and the 
LT-HSC population (bottom panel) (B) Quantification of frequency of progenitor (LK) cells in the lineage 
negative population at E14.5. (C). Quantification of frequency of HSPC (LSK) cells in the lineage negative 
population at E14.5. D) Quantification of frequency of MPP cells in the lineage negative population at 
E14.5. (E). Quantification of frequency of LT-HSC cells in the lineage negative population at E14.5. 
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2.5: Bone marrow failure in DNA-PKcs5A/5A mice display early hematopoietic stem cell deficiency. 
 Next, we analyzed the hematopoietic stem and progenitor cells (HSPC) from bone marrow and 
fetal liver of DNA-PKcs5A/5A and control mice by stage specific markers (Osawa et al., 1996). These markers 
are Lin-Sca1+cKit+ (LSK) and the Lin-Sca1-cKit+ (LK) cells within the Linage-negative (Lin-) bone marrow 
population (Lineage markers include CD3e, CD4, CD8a, Ter119, B220, Gr1, and Mac1) (Fig.4-5A), 
representing the hematopoietic stem and progenitor cells (HSPC) (LSK) and early progenitors (LK), 
respectively. At 3 weeks, DNA-PKcs+/+ mouse bone marrow contains an average of ~18% LK cells and 
~2.5% LSK cells among all lineage negative cells (Fig.4-5A-C). Consistent with the bone marrow depletion 
found by histology analyses, bone marrow from age matched DNA-PKcs5A/5A mice is depleted of LK (ave.= 
~0.7%) and LSK (all <0.03%) cells (Fig.4-5A-C). Heterozygous p53 deficiency is unable to fully rescue 
HSPC percentage in the DNA-PKcs5A/5A mouse, which contains ~2.9% LK cells and <0.1% LSK cells (Fig.4-
5A-C), while complete loss of p53 rescued both LK and LSK percentage in the bone marrow. The severe 
reduction of LK and LSK cell frequencies in DNA-PKcs5A/5Ap53+/- mice provides an explanation for the 
reduced cellularity of DNA-PKcs5A/5Ap53+/- bone marrow and the often variable and suboptimal CBC results 
from 3 week old DNA-PKcs5A/5Ap53+/- mice (Fig.4-4).  
 Given the complete depletion of HSPC in 3 week old DNA-PKcs5A/5A mice, we analyzed the fetal 
liver HSPC from E14.5 DNA-PKcs5A/5A mice. Whenever possible, we used littermates as the matched 
control (with the genotype of DNA-PKcs+/5A or DNA-PKcs+/+). Fetal liver HSPC from DNA-PKcs+/+ and DNA-
PKcs+/5A embryos showed similar frequency of LK (50.13 ± 5.90 (N=3) for DNA-PKcs+/+ and (52.22 ± 3.41 
(N=5) for DNA-PKcs+/5A) and LSK (4.34 ± 1.49 (N=3) for DNA-PKcs+/+ and 3.79 ± 0.77 (N=5) for DNA-
PKcs+/5A) cells, and were plotted together as a control (Fig.4-6A-E). In contrast to the complete depletion of 
HSPC at 3 weeks of age, E14.5 fetal bone marrow from DNA-PKcs5A/5A mice show partial depletion with a 
moderate reduction of LK% (40% vs 52% in control) and a much more severe depletion of LSK cells (0.8% 
vs 4.3% in control). The severe reduction of the more immature LSK population (~5 fold) and the relatively 
moderate reduction of LK (~20%) suggests that the stem and immature populations are preferentially 
depleted in the bone marrow of DNA-PKcs5A/5A mice (Fig.4-6A-C). Both heterozygous and complete loss of 
p53 fully rescued the HSPC frequency in E14.5 fetal liver of DNA-PKcs5A/5A mice (~46% LK and ~4% LSK 
in DNA-PKcs5A/5Ap53+/-, and 39% LK and ~4% LSK in DNA-PKcs5A/5Ap53-/- fetal livers) (Fig.4-6A-C). The 
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complete rescue of HSPC at E14.5 days and partial rescue by 18-22 days by heterozygous loss of p53 
highlights the age-dependent, progressive nature of the bone marrow failure in DNA-PKcs5A/5A mice.  
 The presence of significant HSPC (LSK cells) in the fetal liver allows further analyses of the more 
primitive HSPC subtypes. Specifically, the HSPC (LSK cells) include the Multipotent Progenitor Population 
(MPP, CD48-CD150-) and the more primitive long-term HSC (LT-HSC, CD48-CD150+) (Oguro et al., 2013) 
(Fig.4-6A,D,E). MPP and LT-HSC represent ~24% and ~40% of all Lin- cells in control fetal livers (Fig.4-6D 
and E). Meanwhile, the Lin- cells from DNA-PKcs5A/5A fetal livers contain only ~3% MPP and ~4% HSC 
(Fig.4-6D and E). The lack of fetal liver HSPC and LT-HSC in DNA-PKcs5A/5A mice explains the rapid decline 
of hematopoiesis, and especially of red blood cell production, in young DNA-PKcs5A/5A mice.  While the 
complete loss of p53 (DNA-PKcs5A/5Ap53-/-) fully rescued the frequency of MPP and HSC in the Lin- cells of 
DNA-PKcs5A/5A fetal livers (~45% and ~61%, respectively) (Fig.4-6D and E), the frequency of fetal liver 
HSC, but not MPP, in Lin- cells remains significantly reduced in DNA-PKcs5A/5Ap53+/- embryos compared to 
controls (Fig.4-6D and E). The preferential depletion of immature/primitive HSPC in the bone marrow and 
fetal liver, and the preferential loss of committed progenitors within the lymphoid lineage of DNA-PKcs5A/5A 
mice supports stem cell exhaustion as the primary cause of anemia in DNA-PKcs5A/5A mice (Fig.4-4). 
  
2.6: Development committed lymphoid progenitors are not affected in DNA-PKcs5A/5A mice 
 DNA-PKcs has a well characterized role in cNHEJ, and cNHEJ is required for V(D)J recombination, 
which assembles the functional antigen receptor gene products in progenitor B and T lymphocytes. 
Complete loss of DNA-PKcs (DNA-PKcs-/-) abrogates hairpin opening and expression of kinase dead DNA-
PKcs blocks end-ligation, both of which cause complete failure during V(D)J recombination and therefore 
abrogate lymphocyte development. While the related DNA-PKcs3A mutation did not abrogate end-joining or 
V(D)J recombination, it renders chromosomal V(D)J recombination in DNA-PKcs3A/3A cells sensitive to both 
ATM and DNA-PK specific inhibitors (Lee et al., 2013a). To determine whether the DNA-PKcs 5A mutation 
affects cNHEJ, we analyzed lymphocyte development and V(D)J recombination in DNA-PKcs5A/5A, the 
rescued DNA-PKcs5A/5Ap53+/- (-/-) mice and control DNA-PKcs-/- mice and pro-B cells. The cellularity and 
weight of lymphoid organs, namely the spleen and thymus, are severely reduced in 3 week old DNA-
PKcs5A/5A mice (Fig. 4-7A and B). Further flow cytometry analyses with lineage specific and development 
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stage specific markers (Fig. 4-8) revealed a reduced frequency of Myeloid (Gr1+) and B cells (B220+) in the 
bone marrow of DNA-PKcs5A/5A mice (Fig. 4-7C and D). Given the empty bone marrow revealed by histology 
analyses, the reduction of absolute B cell and myeloid cells are even more severe than revealed by FACS 
analyses. Notably, despite this severe reduction of B cell number, the ratio of bone marrow mature B cell 
(B220+ IgM+) vs immature B cells (B220+IgM-) is not significantly affected in DNA-PKcs5A/5A mice (Fig. 4-
7E). In contrast, loss of DNA-PKcs (DNA-PKcs null) abrogates V(D)J recombination, blocks B/T cell 
development, and leads to over a 20-fold reduction of mature B vs immature B cell ratio (Fig. 4-7E).  
Moreover, there is a compensatory increase in the frequency of myeloid cells (Gr1+) in the bone marrow 
from DNA-PKcs-/- mice (Fig. 4-8).  
Mature T cells have a much longer half-life than myeloid cells and even naïve B cells in the 
periphery. To this end, the frequency of mature CD4+ single positive or CD8+ single positive T cells actually 
increased in the thymus and spleen of DNA-PKcs5A/5A mice than in control, although the absolute number 
of mature T cells likely decreased in both Spleen and thymus of the DNA-PKcs5A/5A mice, given the severe 
reduction of total cellularity (Fig.4-7F and G).  Heterozygous loss of p53 consistently, yet moderately 
improved the B, T and myeloid cell cellularity in DNA-PKcs5A/5A mice. Complete loss of p53 further rescued 
B, T and myeloid cell frequency in the bone marrow as well as peripheral lymphoid organs. Taken together, 
the severe reduction of all mature lineages – including B, T and myeloid cells and the preferential depletion 
of immature B/T cells relative to the mature counterpart in DNA-PKcs5A/5A mice support hematopoietic stem 
cell exhaustion in DNA-PKcs5A/5A mice. Our findings also showed that p53 deficiency rescues the 
hematopoietic defects in a dose dependent manner (Fig.4-7C-E, Fig. 4-8). Importantly, in DNA-
PKcs5A/5Ap53+/- mice, the ratio of mature vs immature B and T cells is not reduced, suggesting that the DNA-
PKcs 5A mutation does not severely affect V(D)J recombination and cNHEJ. Together, these finds reinforce 
the notion that 5A mutation compromised HSC/HSPC development, but not the development of committed 




Figure 4-7: Characterization lymphocyte development and progenitor maturation in of 3 week old 
DNA-PKcs5A/5A mice. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 ****, N.S. (Not significant). P value determined by student’s t 
test. (A) Spleen weight at 3 weeks of age . (B) Thymocyte absolute cell counts at 3 weeks of age. (C) 
Quantification of Gr1+ cells in the bone marrow of 3 week old mice. Gr1+ cell percentage is measured by 
flow cytometry. (D) Quantification of B220+ cells in the bone marrow of 3 week old mice. B220+ cell 
percentage is measured by flow cytometry. (E) Ratio of B220+IgM+: B220+IgM-  B cells in the bone marrow 
of 3 week old mice. B220+ and IgM+ cell percentage is measured by flow cytometry. (F) Absolute number 
of DP (CD4+CD8+) T cells in the thymus. Calculated by taking the lymphocyte percentages from flow 
cytometry and multiplying by the total thymocyte cell count. (G) Absolute number of SP (CD4+CD8-) T 
cells in the thymus. Calculated by taking the lymphocyte percentages from flow cytometry and multiplying 






2.7: V(D)J recombination in DNA-PKcs5A/5A cells is hypersensitive to ATM inhibition 
 To determine the impact of the DNA-PKcs 5A protein  on chromosomal V(D)J recombination, we 
generated v-abl kinase transformed pro-B cell lines from the bone marrow of 4 week old DNA-
PKcs5A/5Ap53+/- mice as previously described (Bredemeyer et al., 2006a). Several attempts to derive v-abl 
kinase transformed B cells from 3 week old DNA-PKcs5A/5A mice were unsuccessful, likely due to the severe 
depletion of bone marrow and progenitors. Treatment with a v-abl kinse inhibitor – STI571, arrests v-abl 
transformed pro-B cells in the G1 phase of the cell cycle, induces the expression of the RAG endonuclease, 
which initiates V(D)J recombination at the endogenous IgK locus as well as at a chromosomally integrated 
inversional V(D)J substrate (pMX-INV) (Fig.4-9A). pMX-INV contains a GFP expression cassette flanked 
Figure 4-8: Lymphocyte developmental flow cytometry analysis of 3 week old DNA-PKcs5A/5A mice. 





by a pair of recombination signal sequences (RSSs). The ORF of the GFP is situated in the opposite 
orientation of the transcriptional promoter. Successful V(D)J rearrangement inverts the GFP and leads to 
the expression of GFP protein, which can be monitored by FACS (Fig.4-9B). The appearance of CJ and SJ 
products as well as the accumulation of broken CEs and SEs can be monitored by Southern blotting 
analyses (Fig.4-9C) (Bredemeyer et al., 2006a; Zha et al., 2011b). Consistent with the lack of stage specific 
development defects in DNA-PKcs5A/5A mice, STI571 induced robust expression of GFP in several 
independent clones of DNA-PKcs5A/5A B cells (Fig.4-9B). The formation of both SJ and CJ products can 
also be detected by Southern blotting (Fig.4-9C). As previously noted for DNA-PKcs3A/3A cells (Lee et al., 
2013a), efficient end-ligation in DNA-PKcs5A/5A cells requires ATM kinase activity and is abolished by 
specific ATM kinase inhibitor (KU55933, 15uM) (Fig.4-9B and C). Specifically, ATM kinase inhibition leads 
to prominent accumulation of SE-CE intermediates (instead of SJ-CE), suggesting end-ligation, but not just 
haprin opening is abrogated (Fig.4-9C). Together, these findings suggest that DNA-PKcs5A/5A cells have no 
apparent defects in cNHEJ and V(D)J recombination, yet cNHEJ in DNA-PKcs5A/5A cells are sensitive to 
ATM inhibition. Given the complete hairpin opening defects in DNA-PKcs null cells and the lack of end-
ligation in DNA-PKcsKD/KD cells, it is tempting to suggest that the DNA-PKcs 5A protein might not affect the 
kinase activation of DNA-PKcs.   
 
2.8: Class switch recombination in DNA-PKcs5A/5Ap53+/- B cells is transiently delayed and 
preferentially utilizes MHs at the junctions.  
  Immunoglobulin Class switch recombination (CSR) requires cell proliferation and can be mediated 
by cNHEJ or A-EJ. CSR is often more sensitive to DNA-repair defects than V(D)J recombination (e.g. XLF 
deficiency) and provides an independent measure for physiological DSB repair. Therefore we determined 
CSR in purified splenic B cells (CD43-) from 6-8 week old DNA-PKcs5A/5Ap53+/-(or-/-)  mice and wild type and 
p53+/- controls. Cytokine treatment (a combination of anti-CD40 (1ng/ml) and IL4 (20ng/ml)) activates the 
germline transcription of Sg1 and Se and initiates CSR to IgG1 and IgE. By day 3 and day 4 of activation, 
20-25% and 30-40% wildtype B cells become surface IgG1 positive, indicating successfully CSR (Fig.4-




Figure 4-9: V(D)J recombination in DNA-PKcs5A/5A B cells is proficient and sensitive to ATM kinase 
inhibitor. 
(A) Schematic of pMX-INV retroviral recombination substrates designed to assay inversional V(D)J 
recombination (Zha et al., 2011a). Diagrams indicate un-rearranged substrate (UR), coding/signal end 
(CE/SE) intermediates and coding/signal joints (CJ/SJ).  The RSS (triangle), GFP probe (solid lines) and 
C4 probe (dash lines) are indicated.  Positions of EcoRV (RV) sites and NcoI (N) sites are shown.  (B) The 
histograms show flow cytometric analyses of GFP+ cells within the gated hCD4+ cell population after 0, 2 
or 4 days of STI571 (+/- ATM inhibitor KU55933 at 15uM final concentration) treatment of cell lines 
containing a single integrated pMX-INV substrate (diagramed in Fig. 2-6A). (C) Southern blotting with C4 
probe or GFP probe of NcoI+EcoRV digested or EcoRV-digested DNA from STI571 treated (2 or 4 days) 
v-abl pro-B lines containing pMX-INV.  Results were obtained from cell pools with diverse substrate 




B cells can be activated effectively and achieve 30-40% B220+IgG1+ cells by day 4, but show a moderate 
yet significant delay at day 3, with only ~10-15% B220+IgG1+ B cells (p=0.03) (in contrast to ~25% in 
controls) (Fig.4-9A-B).  
 Given that HTGTS detects a significantly broader usage of the Sμ and Sγ1 region and greatly 
increased the usage of MH in DNA-PKcs-/- B cells with at most a moderate reduction of CSR efficiency, we 
decided to analyze the CSR junctions in DNA-PKcs5A/5Ap53+/-(or -/-) B cells using HTGTS as detailed in 
chapter 3. Briefly “translocation junctions” from a single bait site at 5’S to various targets were analyzed 
by high throughput sequencing. Altogether, we analyzed 2197 junctions from B cells derived from 3 
independent DNA-PKcs5A/5Ap53+/-(or -/-) mice and 1721 junctions from two control p53+/- mice. As discussed 
in chapter 3,  nearly 90% of all junctions isolated from wild type and p53-/- or p53+/- B cells are joined with a 
target (referred as “Prey”) in IgH (defined as a 400kb region including all D, J elements and Constant 
regions). We further define the orientation of Prey junction as (+) if it is read from centromere to telomere 
after the junction, or as (–) if it is read from telomere to centromere, since the IgH locus resides on the (-) 
strand of murine chromosome 12 and the bait at 5’ S reads from telomere to centromere. The normal 
internal deletion and class recombination represents junctions at the (-) orientation. Indeed, nearly 80% of 
all IgH junctions from WT and p53 deficient B cells are in the (-) orientation. The (+) orientated IgH junctions 
includes both inversions and some inter-sister chromatid translocations (between IgH and another 
chromosome 12). In contrast, inter-chromosomal translocations (to another chromosome beyond 
chromosome 12) outside of the IgH locus is composed of about equal amount of (+) and (-) junctions (Fig.4-
10C). DNA-PKcs-/- junctions show a similar IgH:nonIgH distribution as these controls, but with an increase 
in junctions in the (+) orientation (~70% IgH(-) and ~20%IgH(+) (Fig.4-10C). DNA-PKcs5A/5A junctions are 
similar to DNA-PKcs-/- junctions, showing a slight increase in the frequency of IgH (+) strand junctions 
(~60% IgH (-) and ~20% IgH (+)) but also an increase overall in nonIgH junctions (i.e. inter-chromosomal 
translocations) (Fig.4-10C).  In this context, the distribution of IgH, and nonIgH and the orientation within 
IgH in the DNA-PKcs5A/5A junctions are improved (closer to normal) in comparison to those from the DNA-
PKcsKD/KD B cells (Chapter 3), which is consistent with greater DSB repair defects and a further decreased 
frequency of IgH junctions (Fig.4-10C). Within the IgH junction, as characterized in chapter 3, ~50% of IgH 
junctions in control backgrounds were located in Sε, ~25% in Sμ, and ~20% in Sγ1 (Fig.4-10D). IgH 
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junctions from both DNA-PKcs-/- and DNA-PKcs5A/5A B cells have a greatly increased Sμ portion (~50%), 
and a marked reduction in junctions involving Sε (~10-15%%) (Fig.4-10D). Junctions from DNA-PKcs5A/5A 
cells have a much lower S1 portion (~20% with about 16% in (-) orientation) than those from DNA-PKcs-/- 
cells (30% with about 26% on the potentially productive (-) orientation) (Fig.4-10D). Again, the distribution 
of IgH junctions from DNA-PKcs5A/5A cells are much less affected as those from DNA-PKcsKD/KD, discussed 
in detailed in chapter 3 and showed here for comparison (Fig.4-10D).  
 As mentioned in chapter 3, the blunt-MH usage in non-IgH junctions has much less MHs than the 
IgH ones from the same genetic background, likely reflecting the repetitive and CG rich feature of IgH switch 
regions. For this reason, on the IgH junctions were analyzed and compared here. Analyses of the junctional 
sequence of all IgH junctions revealed that in WT or p53-deficient (alone) cells, ~25% junctions are blunt, 
another 25% with 1nt MH and another 25% with 2-3nt MH. In contrast, less than 15% of junctions from 
DNA-PKcs-/- and DNA-PKcs5A/5A cells were blunt and another 15% have 1nt MH. A prominent 40% of 
junctions have 2-3nt MH and cumulatively nearly 20% of junctions from DNA-PKcs-/- and DNA-PKcs5A/5A B 
cells have >4 nt MH (in contrast to ~10% in WT and p53-deficient alone). The overall insertion within IgH 
junctions did not differ in any of the mutants analyzed (Fig.4-10E). 
  Next, we mapped the junction within and around each specific switch region. The (+) and (-) 
orientated junctions were plotted above (blue) and below (red) the center line respectively. Since the 
location of bait is within the 5’ Sμ (telomeric), the majority of the Sμ joins from WT and p53 deficient B cells 
are located near the bait site within only~9% beyond the core Sμ region (Fig.4-11A). Meanwhile, nearly 
18% of Sμ junctions from DNA-PKcs5A/5A B cells fall beyond the core Sμ, similar to the previously discussed 
DNA-PKcs-/- cells (see chapter 3) (Fig.4-11). DNA-PKcs5A/5A junctions show a similarly wider distribution 
within Sγ1, with 1.3% forming downstream of Sγ1 (versus 0.04-0.23% in control junctions) (Fig.4-12), and 
within Sε (8.4% in DNA-PKcs5A/5A junctions versus ~5% in control junctions (Fig.4-13). Altogether, the wider 










 In addition to junctional orientation and distribution, we can use the common bait sequence to study 
mutation patterns (Fig.4-14A, left panel). We analyzed the mutation within the bait 5’ Sμ (excluding nesting 
PCR site to avoid PCR bias) in all junctions involving IgH (both (-) and (+) orientation) from DNA-PKcs+/+, 
p53+/-(-/-), DNA-PKcs-/-, and DNA-PKcs5A/5A B cells. The number of total IgH reads analyzed and the total 
number of nucleotides considered are listed in the table in Figure 4-14A, right panel. For this analysis, we 
only considered the (-) strand (5’ Sμ). Since each junction has a unique length, which might affect the 
overall AGCT composition, we first analyzed the nucleotide composition of bait sequences actually counted. 
It is largely similar across all genotypes with a roughly equal presentation of A, C, G and less T (Fig.4-14B). 
Yet, of the mutations identified, the majority of them (>70%) involve C and G, consistent with the cytosine 
deaminase activity of AID during CSR (Fig.4-14C). DNA-PKcs-/- cells display an apparently less frequent 
C/G mutation (Fig.4-14C).  Illumina Miseq has an estimated error rate for about 1/10,000 and similar 
technical mutation rate were also reported in switch regions (Yeap et al., 2015). Overall mutation rate in 
WT and p53 deficient controls is ~2.5/10000nt with a moderate decrease in DNA-PKcs-/- as well as DNA-
PKcs5A/5A cells (2/10,000mt and 1.5/10,000 respectively) (Fig.4-14D). Considering the decreased overall 
mutation rate DNA-PKcs-/- and DNA-PKcs5A/5A cells, the lower C/G mutation frequency in DNA-PKcs-/- cells 
appears to reflect a true deduction in C/G mutation (see below). While the percentage of reads with mutation 
also decreased DNA-PKcs5A/5A cells, it did not change in DNA-PKcs-/- cells (Fig.4-14E), suggesting the 
mutation load in each mutated read in is comparable in DNA-PKcs5A/5A cells and reduced in DNA-PKcs-/- 
cells. Thus, DNA-PKcs 5A and null backgrounds might affect CSR differently, with 5A impacting the 
percentage of “mutable” reads, and DNA-PKcs null reducing the mutation load on each sequence. Since 
mutation rate might reflect changes in AID activity, it is possible the initial delay of CSR in DNA-PKcs5A/5A 
cells reflects a slightly compromised ability for AID to modify the switch region (either due to AID itself or 
Figure 4-10: Class switch recombination is transiently delayed with wider junctional distribution. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 ****, N.S. (Not significant). P value determined by student’s t test. 
(A) Representative CSR switch percentage (defined as B220+IgG1+) on day 3 and 4 of stimulation. 
Quantification of B220+IgG1+ B cells on day 3 and 4 of stimulation. (C) Frequency of HTGTS junctions in 
the (-) and (+) strand orientation, and in the IgH and nonIgH regions. We defined the junction as + 
orientation if it reads from the centromere to the telomere, and as negative, if it reads from the telomere to 
the centromere. The IgH region is defined as 400kb including part of V, all D, all J segments and the entire 
switch region. (D) Frequency of HTGTS junctions in the (-) and (+) strand orientation, and in the IgH 
regions, subdivided into Sμ, Sγ1, and Sε. (E) Frequency of junctions with microhomologies (MH, -), Blunt 




the chromatin/transcriptional stage or downstream mutation mechanism). Next, we break down the 
mutations to each parental nucleotide and calculated the mutation rate per 10000nt for A, C, T and G 
separately (i.e. the rate of G mutation among 10,000Gs). As characterized in chapter 3, mutation rate and 
distribution in wild type and p53 deficient cells are very similar and G nucleotides (especially G->A 
mutations) are significantly more frequently mutated than all other nucleotides (Fig.4-14F). Similar 
enrichment for mutations from G is also noted in previous studies with Sanger sequencing (Chen et al., 
2001) and potentially reflects preferential deamination of cytosine at the template strand by AID or reduced 
2nd phase processing of the dU:dG mismatch by UNG. Previously studies noted a further increase in G 
mutation in pol knockout B cells (Zan et al., 2005). In DNA-PKcs-/- and DNA-PKcs5A/5A cells, the G 
nucleotide mutation rate decreased most prominently, while the mutation rate for A, T and C did not change 
(Fig.4-14F). While the exact cause of these changes in pattern remains debatable, we can consider a few 
possibilities. For one, the junctions we obtained reflect successful joins and tend to be peripheral to the 
switch region, which might bias the G mutation rate. Analyses of the mutation rate in the non-joined junction 
might be necessary to determine whether the mutation rate might be different in joined vs non-joined 
junctions, especially in repair deficient background. Alternatively, whether DNA-PKcs mutation affects AID 
targeting and whether AID might act on single strand DNA generated from resection in addition to those in 
the R-loop might also affect mutation rate. Finally, the direct impact of DNA-PKcs mutation on AID activity 
or the accessibility of AID to chromatin DNA might need to be determined. Taken together, CSR analyses 
of DNA-PKcs5A/5A cells reveal a phenotype that is consistent with true end-joining deficiency, comparable 
to DNA-PKcs null and independent of DNA-PKcs kinase activity (see V(D)J Recombination section), 
suggesting the end-synapsis function of DNA-PKcs protein can be separated from its role in hairpin 




Figure 4-11: Distribution of CSR junctions within 10kb of the Sμ locus 
Schematic of region is drawn at the top. For each genotype, number of junctions are indicated for the 
(+) strand (blue) and (-) strand (red). Percent of junctional usage from the end of Sμ to the end of the 





Figure 4-12: Distribution of CSR junctions within 30kb of the Sγ1 locus 
Schematic of region is drawn at the top. For each genotype, number of junctions are indicated for the (+) 
strand (blue) and (-) strand (red). Percent of junctional usage from the end of Sγ1 to the end of the 30kb 





Figure 4-13: Distribution of CSR junctions within 10kb of the Sε locus 
Schematic of region is drawn at the top. For each genotype, number of junctions are indicated for the (+) 
strand (blue) and (-) strand (red). Percent of junctional usage from the end of Sε to the end of the 10kb 







2.9: DNA-PKcs5A/5A MEFs proliferate normally and have moderate genomic instability  
While CSR analyses reveal clear end-joining defects in DNA-PKcs5A/5A B cells, the magnitude of 
the end-ligation defects seem insufficient to explain the early bone marrow failure in DNA-PKcs5A/5A mice. 
To determine the overall impact of the DNA-PKcs 5A mutation on genomic stability, we derived primary 
MEFs from E14.5 DNA-PKcs5A/5A embryos.  Several independently derived DNA-PKcs5A/5A primary (P3) 
MEFs grew effectively in culture (Fig.4-15A) and have a normal frequency of BrdU+ (S phase) cells  (Fig.4-
15B and C), suggesting that the DNA-PKcs 5A mutation does not affect the proliferation of cells in culture. 
Next, we performed telomere fluorescent in situ hybridization (T-FISH) in early passage (P2) primary MEFs 
to understand whether there is spontaneous genomic instability in the DNA-PKcs5A/5A cells that might 
explain the early bone marrow failure. T-FISH can recognize two types of breaks – chromosomal breaks 
that involve both sister-chromatids and chromatid breaks that only involve one of the two chromatids. While 
chromatid breaks usually occur during or after DNA replication, chromosomal breaks often resulted from 
replication of an unrepaired DSBs in G1 phase cells (Franco et al., 2006).  Accordingly, most cNHEJ 
deficient cells (including DNA-PKcsKD/KD cells) accumulate a large number of chromosomal breaks. Several 
independently derived DNA-PKcs+/+, DNA-PKcs-/-, and DNA-PKcs5A/5A MEFs were analyzed. All together 
7% of metaphases from DNA-PKcs+/+ MEFs display chromatid or chromosomal breaks (Fig.4-16A), with an 
average of 0.02 chromatid breaks and 0.06 chromosome breaks per metaphase (Fig.4-16B). As expected 
from previous analyses in chapter 2 (Fig. 2-3), ~16% of metaphase from DNA-PKcs-/- MEFs and 39% 
metaphase from DNA-PKcsKD/KD MEFs display abnormalities (Fig.4-16A). Consistent with the cNHEJ 
defects in DNA-PKcs null and DNA-PKcsKD/KD cells, the vast majority of the breaks in both cell types were 
chromosomal breaks (Fig.4-16B). Meanwhile, 17/65 (26%) of metaphases from DNA-PKcs5A/5A cells display 
Figure 4-14: DNA-PKcs5A/5A HTGTS CSR junctions do not have a strong mutational pattern in the 
IgH region. 
(A) Diagram of the bait site and nucleotide counting scheme for mutational analysis (left). For mutation 
analyses, we counted the mutation after the nesting PCR primer until the end of bait sequence. There is a 
clear difference between mutation frequency in IgH junction vs non-IgH junction even if only the bait 
sequence is compared (See chapter 3), so only IgH junction (both + and – orientation) were counted. The 
number of independent libraries, reads and nucleotide number analyzed for mutational distribution, 
including total number of reads and nucleotides. (B) Distribution of nucleotide (ACTG) frequency in the bait 
portion used to calculate mutation frequency. (C) Frequency of mutations from each nucleotide (A, T, C, or 
G) in all mutations obtained. (D) Overall frequency of mutations per 10,000 nucleotides (nt). (E) Frequency 
of all IgH junctions containing >0 mutations. (F) Mutations in a particular nucleotide per 10,000 of that 




abnormalities (Fig.4-16A), with more chromatid breaks (0.23 per metaphase) than chromosomal breaks 
(0.14 breaks per metaphase) (Fig.4-16B), suggesting a potential role of DNA-PKcs in replicating or post-
replicating genomic stability maintenance. While previously studies noted telomere, and telomere-
chromatid fusions in particular, in DNA-PKcs3A/3A cells, we did not observe a consistent or significant 
increase of telomere fusion in DNA-PKcs5A/5A primary MEFs, suggesting telomere fusion alone is not a 
uniform consequence of the DNA-PKcs 5A mutation. 
  
Figure 4-15: Normal proliferation and cell cycle distribution in primary DNA-PKcs5A/5A MEFs. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 ****, N.S. (Not significant). P value determined by student’s t test. 
(A) Proliferation of primary (P3) MEFs. Number (n) of each genotype is indicated on the graph. Each “N” 
was done in triplicate. (B) Cell cycle staining in the indicated genotypes. S phase is measured as a percent 




2.10: DNA-PKcs5A/5A MEFs are not hypersensitive to genotoxic agents 
 We next determined whether DNA-PKcs5A/5A MEFs were hypersensitive to selective genotoxic 
agents. A previous study has suggested that DNA-PKcs3A/3A MEFs- both immortalized and primary are 
hypersensitive to cross link agents, especially MMC in MEFs deficient for the Fanconia Anemia pathway 
(Pichierri et al., 2004). Yet, several independently derived immortalized (by SV40 T antigen) DNA-PKcs5A/5A 
MEFs show no hypersensitivity to IR (Fig.4-17A), which preferentially induces breaks repaired by the 
cNHEJ pathway and MMC (Fig.4-17B), which creates inter-strand crosslinks, while control FAND2-/- MEFs 
display consistent sensitivity to MMC that is characteristic for Faconia Anemia. DNA-PKcs5A/5A primary (P3) 
MEFs also do not show sensitivity to MMC, a cross link agent or etoposide , a topoisomerase II inhibitor 
that generates DSBs with covalently blocked ends (Fig.4-17C and D). Control DNA-PKcs-/- cells also display 
Figure 4-16: Moderate genomic instability in primary DNA-PKcs5A/5A MEFs. 
(A) The frequency of P2 MEF metaphases with cytogenetic abnormalities measured by T-FISH. (B) The 
frequency of chromosomal (gray) or chromatid (black) breaks per metaphase in ES cells of different 
genotypes. . Abbreviations: Ab- Abnormal, MP- metaphase, Csm.- Chromosome, Ctd.- Chromatid, Brk- 
Break. All images were processed with Metafer (Metasystem Inc). Chromosome breaks were defined by 
loss of telomere signal from both sister-chromatids or fusion of both chromatids (Fig. 2-3A). Chromatid 
breaks were defined by loss of telomere signal from one of the two sister-chromatids or a clearly broken 
DAPI signal in the middle of one chromatid (Fig. 2-3A).  We note that chromosomal gaps could not be 
reliably identified with the T-FISH assay; therefore, it is possible that the actual frequency of chromatid or 




sensitivity to IR and Etoposide, as expected from DSB repair defects. Altogether, these data suggest that 
DNA-PKcs5A/5A MEFs do not have severe DSBs repair defects that could explain the severe and early bone 
Figure 4-17: DNA-PKcs5A/5A MEFs lack significant sensitivity to DNA damage agents. 
(A) IR sensitivity of immortalized, SV40 MEFs of indicated genotypes. 2 independent DNA-PKcs5A/5A lines 
were tested, each in triplicate. (B) MMC sensitivity of immortalized, SV40 MEFs of indicated genotypes. 
One DNA-PKcs5A/5A line was tested in triplicate. (C) MMC sensitivity of primary (P3) MEFs of indicated 
genotypes. 2 independent DNA-PKcs5A/5A lines were tested, each in triplicate. (D) Etoposide sensitivity of 





marrow failure.  
 
2.11: Other phenotypes of DNA-PKcs5A/5A mice and cells 
While the normal growth and the lack of hypersensitivity to any specific DNA damage agents in 
DNA-PKcs5A/5A MEFs are inconsistent with specific DSB repair defects, the increased spontaneous genomic 
instability, especially chromatid breaks in DNA-PKcs5A/5A MEFs seems to hint at spontaneous genomic 
instability in general. So what might be the source of the genomic instability? Given these results, we started 
to consider other means, by which the DNA-PKcs 5A protein render heightened genomic instability in 
hematopoietic stem cells or stem cells in specifically. Those attempts and results were summarized and 
discussed in the following sections.  
 
2.12: ATM is not hyper-activated in DNA-PKcs5A/5A cells 
 DNA-PKcs5A/5A B cells show hypersensitivity to ATM inhibition, suggesting that ATM activity might 
be altered in DNA-PKcs5A/5A cells. A recent study from the Tanya Paull lab identified two clusters on ATM 
that can be phosphorylated by DNA-PKcs and suppresses ATM kinase activity (Zhou et al., 2017). In 
collaboration with Dr. Paull, we showed that DNA-PKcs null MEFs display hyper activation of ATM, 
evidenced by increased ATM auto-phosphorylation at S1987 and increased phosphorylation of ATM 
substrates- Kap1 (S842) and Akt. (S473) (Fig.4-18) (Zhou et al., 2017). We therefore asked whether hyper-
activation of ATM in the absence of DNA-PKcs activity might underlie the early bone marrow failure in DNA-
PKcs5A/5A cells. We therefore compared the repair kinetics after IR in immortalized DNA-PKcs+/+, DNA-
PKcs-/-, and DNA-PKcs5A/5A with a focus on ATM specific substrates. Robust phosphorylation of Kap1 
(S842) is apparent in DNA-PKcs+/+ MEFs 15 minutes after 10Gy IR, and it returns to baseline by 4 hours. 
AKT (S473) is only phosphorylated at 4 hr after IR. While remaining controversial, ATM can contribute to 
S473 phosphorylate of AKT (Fraser et al., 2011) (Fig.4-18). While the initiation of Kap1 phosphorylation is 
similar in DNA-PKcs-/- cells as in DNA-PKcs+/+ cells, the resolution of phospho-Kap1 (S842) takes much 
longer, likely due to compromised NHEJ. Moreover the level of Kap1, Akt phosphorylation and ATM auto-
phosphorylation (S1987) are much higher in DNA-PKcs null cells, reflecting potential hyper-activation of 
ATM in the absence of DNA-PKcs kinase activity (Fig.4-18). Meanwhile, while DNA-PKcs5A/5A cells also 
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have delayed resolution of Kap1-p, the intensity of pKAP1, pAKT and auto-phosphorylated ATM did not 
increase, suggesting that ATM is not hyper activated in DNA-PKcs5A/5A cells (Fig.4-18). Moreover, 
heterozygous loss of ATM did not recue the early lethality of DNA-PKcs5A/5A mice. All 5 ATM+/-DNA-
PKcs5A/5A mice succumbed by 23 days of age. No ATM-/-DNA-PKcs5A/5A mice were found at birth. Given the 
early embryonic lethality of ATM-/-DNA-PKcs-/- mice (<= E6.5) (Gurley and Kemp, 2001), we did not further 
pursue this breeding. Together, these studies exclude hyper-activation of ATM as a cause of early bone 
marrow failure in DNA-PKcs5A/5A mice. Although awaiting definitive proof, the lack of ATM hyper activation 
and the normal V(D)J recombination and lymphocyte development in DNA-PKcs5A/5A mice suggests that 
the DNA-PKcs 5A mutant likely retains sufficient kinase activity.  
Figure 4-18: ATM is not hyperactive in DNA-PKcs5A/5A MEFs. 
Western blot for ATM, S1987 phosphorylated ATM, S473 phosphorylated AKT, phosphorylated 
H2AX, total H2AX, phosphorylated pT21 RPA, phosphorylated KAP-1, total KAP-1, and vinculin in 
irradiated immortalized SV40 MEFs (10 Gy). Cells lysates were collected at indicated hours after 




2.13: Paxx deficiency does not rescue DNA-PKcs5A/5A mice 
 Next, we asked if the bone marrow failure in DNA-PKcs5A/5A mice could be due to hyper-NHEJ 
activity, which aberrantly fuses single ended DSBs generated during normal DNA replication. Paxx is a 
newly identified member of the cNHEJ repair pathway (Craxton et al., 2015; Ochi et al., 2015; Xing et al., 
2015) that promotes cNHEJ in part by stabilizing KU at the DNA ends (Liu et al., 2017). Given that DNA-
PKcs, either WT or 5A, are recruited by KU, we postulated that PAXX deficiency might recue the bone 
Figure 4-19: Paxx deficiency does not rescue the bone marrow failure in DNA-PKcs5A/5A mice. 
(A) Representative flow cytometry of the HSC compartment in the bone marrow of 3 week old mice. Images 
are gated on the lineage negative population (negative for CD3e, CD4, CD8a, Ter119, B220, Gr1, and Mac1) 
and subdivided into LK and HSPC (LSK) populations as shown. (B) Representative flow cytometry analyses 
of the bone marrow, spleen, and thymus for B, T and Myeloid cell development.  
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marrow failure of DNA-PKcs5A/5A mice by reducing the amount of KU-DNA-PKcs at the DNA ends and/or 
preventing abnormal end-joining. To test this, we generated 5 Paxx-/-DNA-PKcs5A/5A mice. Unfortunately 
2/5 Paxx-/-DNA-PKcs5A/5A died by 3 weeks of age, inconsistent with significant rescue. FACS analyses of 
bone marrow and peripheral lymphoid organs from 21 days old Paxx-/-DNA-PKcs5A/5A mice (n=3) confirmed 
the lack of LK or HSPC (LSK cells) (Fig.4-19A). Bone marrow myeloid cell and B cell frequency from Paxx-
/-DNA-PKcs5A/5A mice are as low as control DNA-PKcs5A/5A mice (Fig.4-19B). Overall, Paxx deficiency does 
not rescue bone marrow failure and the resulted early lethality in DNA-PKcs5A/5A mice.  
 
2.14: DNA-PKcs5A/5A ES cells have proliferation defects, genomic instability and moderate DNA 
damage drug sensitivities 
 HSPC analyses of DNA-PKcs5A/5A mice suggests that the bone marrow failure is caused by 
exhaustion of hematopoietic stem and progenitor cells. During the early stage of differentiation and in the 
first 3 weeks after birth, murine HSC expands and progenitor cells divide rapidly to give rise to mature, 
lineage specific hematopoietic cells. We hypothesized that defects in the DNA-PKcs5A/5A mouse would be 
the strongest in naturally hyper-proliferative cells, especially cells with “Stem” cell properties. In addition to 
proliferation, stem cells have unusually high levels of ribosomal activity to produce protein building blocks 
necessary for the rapid proliferation. To test this, we derived DNA-PKcs5A/5A murine embryonic stem cells 
from super ovulated DNA-PKcs+/5A egg donors. A total of 6 DNA-PKcs5A/5A, 7 DNA-PKcs+/5A and 7 control 
DNA-PKcs+/+ ES cells were derived. First, we assessed genomic instability in these ES cells by TFISH. Like 
in primary DNA-PKcs5A/5A MEFs, ES metaphase show an increase in overall genomic instability relative to 
wild type controls, with ~25-40% abnormal metaphase in DNA-PKcs5A/5A, versus ~7% in DNA-PKcs+/+ 
(Fig.4-20A). Again, metaphase from DNA-PKcs5A/5A ES cells consistently have more chromatid breaks than 
chromosomal breaks (Fig.4-20B). Notably telomere instability, which is characterized by two separate 
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telomere dots at each sister chromatid end (Fig.4-20C), is significantly increased in DNA-PKcs5A/5A ES cells 
(Fig.4-20B). Together these findings validate spontaneous genomic instability in DNA-PKcs5A/5A ES cells.  
Figure 4-20: Moderate genomic instability in DNA-PKcs5A/5A ES cells. 
A) The frequency of ES cell metaphases with cytogenetic abnormalities measured by T-FISH. (B) The 
frequency of chromosomal (light gray) or chromatid (black) breaks and fragile telomeres (dark gray) per 
metaphase in ES cells of different genotypes. . Abbreviations: Ab- Abnormal, MP- metaphase, Csm.- 
Chromosome, Ctd.- Chromatid, Brk- Break, F.Tel- Fragile telomere. All images were processed with 
Metafer (Metasystem Inc). (C) Chromosome breaks were defined by loss of telomere signal from both 
sister-chromatids or fusion of both chromatids (Fig. 4-20C). Chromatid breaks were defined by the loss of 
telomere signal from one of the two sister-chromatids or a clearly broken DAPI signal in the middle of one 
chromatid (Fig. 4-20C).  We note that chromosomal gaps could not be reliably identified with the T-FISH 
assay; therefore, it is possible that the actual frequency of chromatid or chromosome breaks might be even 









Figure 4-21: Moderate, but variable, sensitivity of DNA-PKcs5A/5A ES cells to DNA damage agents. 
(A) HU sensitivity of ES cells of indicated genotypes (plated on an irradiated MEF feeder layer). 1 DNA-
PKcs+/+ line and 2 independent DNA-PKcs5A/5A lines were tested, each in triplicate. (B) Representative 
Etoposide sensitivity of ES cells of indicated genotypes (plated on an irradiated MEF feeder layer). 3 
independent DNA-PKcs+/+ and 4 independent DNA-PKcs5A/5A lines were tested, each in triplicate. (C) 
Representative IR sensitivity of ES cells of indicated genotypes (plated on an irradiated MEF feeder layer). 
3 independent DNA-PKcs+/+ and 4 independent DNA-PKcs5A/5A lines were tested, each in triplicate. 




Figure 4-22: Proliferation defects in DNA-PKcs5A/5A ES cells. 
P < 0.05  *, <0.01 **, <0.001 ***, <0.0001 ****, N.S. (Not significant). P value determined by paired t test. 
(A) Representative colony size and variability of untreated ES cells. (B) Quantification of colony size using 
ImageJ and the Colony Area plugin.(C) Cell cycle staining in the indicated genotypes. S phase is measured 
as a percent of BrDU+ cells. (D) Quantification of S phase percentage of (B) done in a paired analysis, to 
allow for experimental variability. (E) Schematic of Ku80 CrispR deletion scheme. Black boxes indicate 
exons. Red arrows indicate primers and inverted black triangles represent hCas9 and gRNA cutting sites. 
(F) Expected results of sequential PCR screens. Screen 1 (left panel) distinguishes a 0.6kb targeted band 
from a 2kb germline band. Screen 2 (right panel) distinguishes between the homozygous and heterozygous 




 We next performed clonogenic sensitivity assays with ES cells plated on a layer of irradiated MEF 
feeder cells. These assays showed that like the MEFs, DNA-PKcs5A/5A ES cells lack consistent sensitivities 
to various genotoxic agents, including HU (Fig.4-21A), Etoposide (Fig.4-21B), and IR (Fig.4-21C). Similar 
results were obtained on feeder-free clonogenic assays to HU (Fig.4-21D), Etoposide (Fig.4-21E), MMC 
(Fig.4-21F), and CPT (Fig.4-21G). While performing these clonogenic sensitivity assays, we noticed that 
size of DNA-PKcs5A/5A ES cell colonies are much more variable and often smaller than littermate DNA-
PKcs+/+ control ES cells, even in untreated conditions (Fig.4-22A). Quantification of the overall colony 
covered area with an ImageJ plugin Colony Area quantitatively confirmed that the colonies formed by DNA-
PKcs5A/5A ES cells were significantly smaller than those formed by DNA-PKcs+/+ controls (Fig.4-22B). 
Meanwhile cell cycle analyses with BrdU labeling for S phase cells, revealed a moderate, yet consistent 
reduction of the frequency of BrdU+ cells (~53% for DNA-PKcs5A/5A ES cells vs ~60% for DNA-PKcs+/+) 
(Fig.4-22C and D), suggesting the smaller colony size is caused by less proliferation. Flow cytometry 
analyses (forward scatter) suggest that the size of individual DNA-PKcs5A/5A ES cells is not significantly 
different from DNA-PKcs+/+ controls. DNA-PKcs is recruited to the DNA ends by the KU7/80 heterodimer. 
To determine whether DNA-PKcs 5A blocks cell growth when it is recruited to DNA ends by KU, we 
transfected a pair of gRNA/CRISPR9 into two independent DNA-PKcs5A/5A ES cells. Ligation and deletion 
between the two gRNA/CRISPR cut sites leads to complete deletion of KU80, which is further validated by 
two independent PCR screens (Fig.4-22E and F).  Remarkably, deletion of Ku80, restored the colony size 
and uniformity in DNA-PKcs5A/5A ES cells (Fig.4-22A and B), suggesting that the DNA-PKcs 5A protein 
blocks additional repair at the DNA ends in a KU dependent manner. In ongoing experiments, we crossed 
DNA-PKcs+/5A mice with Ku70 null mice to determine whether KU deficiency would rescue the bone marrow 
failure in DNA-PKcs5A/5A mice.  
 
2.15: Evidence supports nucleoli stresses mediated activation of p53 in DNA-PKcs5A/5A cells and 
mice  
While the moderate spontaneous genomic instability in DNA-PKcs5A/5A MEFs and ES cells, and 
slightly delayed CSR and ATM kinase dependent V(D)J recombination in DNA-PKcs5A/5A B cells is 
consistent with potentially mild defects in cNHEJ, they could not explain the lethal anemia in DNA-PKcs5A/5A 
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mice.  As Ku-/- or even XLF-/- mice with much more severe cNHEJ defects do not succumbed to anemia. 
These and other observations, including the lack of MMC sensitivity, prompted us to explore other 
mechanisms that might explain the p53-dependent anemia in DNA-PKcs5A/5A mice.  In addition to DNA 
damage, p53 can also be activated by nucleoli stress. Rapidly proliferating cells upregulate ribosomal 
biogenesis to fulfill the need for protein synthesis. Yet, disturbances during ribosome biogenesis might 
cause accumulation of “free” ribosome proteins (Zhang and Lu, 2009). Among them, RPL5, RPL11 and 
RPL23 can bind to MDM2 and prevent MDM2-mediated degradation of p53 and eventually lead to cell cycle 
arrest. In this context, defects in ribosome protein or ribosomal biogenesis cause Diamond Blackfan Anemia 
(DBA) and Shwachman-Diamond Syndrome (SDS) characterized by p53-dependent bone marrow failure.  
Figure 4-23: Macrocytic anemia in 3 week old DNA-PKcs5A/5A mice. 
CBC Analysis of MCV (A) and MPV (B) readings in 3 week old mice. (C) Western blot of unchallenged ES 
cells assessed for phosphorylated p53 (S18), total p53 and p53 substrates. DNA-PKcs+/+ ES cells with 




In addition to ~40% reduction of Hemoglobin levels (Fig.4-4F), CBC analyses of the peripheral 
blood from 3 week old DNA-PKcs5A/5A mice uncovered a significant increase of mean corpuscular volume 
(MCV), which reflects the average volume of the RBC (Fig.4-23A). Reduced hemoglobin together with 
increased MCV suggests macrocytic anemia in DNA-PKcs5A/5A mice. Meanwhile MPV, a measure of platelet 
size is not significantly altered in DNA-PKcs5A/5A mice (Fig.4-23B), suggesting a RBC specific phenotype. 
Figure 4-24: Nucleoli stress in DNA-PKcs5A/5A cells. 
(A) rDNA loci number distribution in ES metaphases. (B) Frequency of ES metaphase with 8 rDNA loci. (C) 
Examples of structural abnormalities in rDNA loci. (D) Quantification of structural abnormalities per 





Macrocytic anemia, early onset bone marrow failure (Fig.4-4), and hyperpigmentation (Fig.4-3B) have all 
been documented for DBA and the related SDS. The anemia in DBA and SDS is caused by ribosomal 
biogenesis defects that trigger p53 hyper-activation, which is independent of DNA damage. P53 is 
phosphorylated at the conserved S15 (corresponding to Ser18 of murine p53) upon DNA damage, but not 
in response to nucleoli stress. In collaboration with Dr. Wei Gu’s lab, we measured p53 phosphorylation 
status. Despite high p53 protein levels, unchallenged DNA-PKcs+/+ ES cells do not have phospho-p53 
signal, and have only low levels of p21- a target of p53 and important for G1/S checkpoint regulation. IR 
induced robust p53 phosphorylation in DNA-PKcs+/+ ES cells within 2 hours (Fig.4-23C). Unchallenged 
DNA-PKcs5A/5A ES cells also do not have phospho-p53 signal, but they accumulate p21 at levels similar to 
irradiated DNA-PKcs+/+ ES cells. Together with the decreased S/G1 ratio in DNA-PKcs5A/5A  cells (Fig.4-
22C), these findings suggest that p53 is activated in DNA-PKcs5A/5A cells in a DNA damage independent 
manner (Fig.4-23C).  
Both DBA and SDS are caused by nucleoli stress. To investigate causes of the potential nucleoli 
stress in DNA-PKcs5A/5A mice, we developed an rDNA specific FISH probe to examine rDNA loci stability 
directly. The probe including most 28S rDNA and part of the intragenic region of mouse rDNA repeats 
reliably identified an average of 8 rDNA locus in 129Sv ES cells. Preliminary analyses of DNA-PKcs5A/5A 
ES revealed increased variability of rDNA loci counts (Fig.4-24A), with only 33% of metaphases from DNA-
PKcs5A/5A ES cells having 8 rDNA loci (compared to ~80% in wild type metaphase) (Fig.4-24B). While similar 
frequency of ES cells gain rDNA loci (<8), more than 50% of DNA-PKcs5A/5A ES cells have lost major rDNA 
clusters (<8 or even <7), in contrast to <5% in DNA-PKcs+/+ controls. The high frequency of rDNA cluster 
loss might explain the variable clone size, especially the increase of small colonies in DNA-PKcs5A/5A ES 
cells. The relative loss of rDNA (5.8s, 18s and 28s) in comparison to the 5s rDNA encoded at a separate 
locus, might trigger defects in ribosome assembly and the accumulation of free 5s 
rDNA/RPL5/RPL11complex, which have been showed to sequester MDM2 and robustly activate p53 
(Golomb et al., 2014; Zhang and Lu, 2009). Alternatively, DNA-PKcs has been implicated in the 
transcriptional silencing of RNA Pol I (generates rDNA) during the DNA damage response (Kobayashi, 
2014) or by direct damage in the highly repetitive and A/T rich rDNA locus and could potentially directly 
affect rDNA stability (Fig.4-24C and D). Altogether, these data imply nucleoli stress as a potential cause of 
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p53 hyper-activation in DNA-PKcs5A/5A cells. Ongoing experiments will measure nucleoli stress, as well as 
transcription of pol I at the rDNA locus in DNA-PKcs5A/5A cells. 
 
3: Discussion 
 The DNA-PKcsKD/KD mouse model proved a powerful tool to characterize the roles of DNA-PKcs in 
NHEJ and A-EJ. In chapter 2, we uncovered a phosphorylation dependent structural role of the DNA-PKcs 
protein in mediating the switch between end ligation and end processing during cNHEJ. In chapter 3, we 
showed that KD-DNA-PKcs does not affect MH mediated A-EJ using immunoglobulin CSR as a model 
system. In this chapter, we characterized the DNA-PKcs 5A mutant, which lacks all 5 phosphorylation sites 
with the T2609 cluster. Like the previously characterized DNA-PKcs3A/3A mouse, the DNA-PKcs5A/5A mouse 
dies of bone marrow failure by ~3 weeks of age. Yet, cNHEJ and V(D)J recombination, although sensitive 
to ATM inhibition, are not measurably affected in DNA-PKcs5A/5A mice (Fig.4-9). Analyses of IgH CSR 
revealed a moderate delay of CSR and a preferentially usage of MH mediated junction in DNA-PKcs5A/5A B 
cells (Fig.4-10; Fig.4-14). Similar preferentially usage of MH is also found in DNA-PKcs-/- and DNA-
PKcsKD/KD cells, suggesting DNA-PKcs might regulate pathway choice between cNHEJ and A-EJ. 
Yet those moderate cNHEJ defects in DNA-PKcs5A/5A cannot explain the lethal pancytopenia in 
DNA-PKcs5A/5A mice. In contrast to the predominant chromosomal breaks in DNA-PKcs-/- and DNA-
PKcsKD/KD cells MEFs and ES cells, chromatid breaks represent the majority of cytogenetic abnormalities 
in DNA-PKcs5A/5A ES and MEFs. In particular, DNA-PKcs5A/5A ES cells, but not MEFs, display proliferation 
defects in culture. Altogether, these data show that DNA-PKcs has a potential role in the S phase, where 
defects would preferentially affect HSC and early progenitors. While defects in Franconia Anemia pathway 
(Zhang et al., 2011a) and telomere chromatid fusion (Zhang et al., 2016) have been proposed to explain 
the early bone marrow failure of DNA-PKcs3A/3A mice, we failed to detect consistent sensitivity to cross link 
agents (e.g. MMC) characteristic for FANC deficient cells or significant telomere fusion in DNA-PKcs5A/5A 
MEFs or ES cells (Fig.4-17 and Fig. 4-21). These findings prompted us to explore other mechanisms that 
can lead to p53 hyper activation. In this context, we considered nucleoli stress.  
 Ongoing work needs to be completed to further investigate this possibility. First, we are breeding 
DNA-PKcs5A/5AKu70-/- mice, to clarify the dependence on KU for DNA-PKcs activity, regardless of cell cycle. 
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Second, we are further investigating nucleoli stress in DNA-PKcs5A/5A cells. The macrocytic anemia (Fig.4-
23A), lack of phospho-p53 signal in unchallenged ES cells despite activation of downstream targets (Fig.4-
23C), and the presence of rDNA abnormalities in DNA-PKcs5A/5A ES cells together suggest that DNA-
PKcs/KU might affect ribosome biogenesis. Next steps include assessing rDNA copy number using qPCR 
and contour clamped homogenous electric field gel electrophoresis. In parallel, we will also cross the DNA-
PKcs5A/5A mice with the MDM2 C305 mutant mouse. This MDM2 mouse abolishes the p53-dependent 
response to ribosome biogenesis stress (Macias et al., 2010), and rescue would confirm a role for DNA-





















































 Despite being a large protein that has been implicated in multifaceted roles including the DNA 
damage response, DNA repair, telomere maintenance and even transcriptional regulation, the potentially 
far reaching functions of DNA-PKcs remain unresolved. DNA-PKcs evolved with vertebrates, and 
throughout its evolution only became more abundant (~50X more abundant in humans than in mice), 
potentially speaking to the importance of DNA-PKcs in more complex organisms. At the start of my thesis 
project, the role of DNA-PKcs in DNA repair was restricted to the end processing phase of cNHEJ. My 
research comprises a comprehensive perspective on DNA-PKcs, going deeper into its role during cNHEJ 
and adding new layers by exploring its role in A-EJ and potentially during the S phase. Altogether, this 
thesis has widened the understanding of the role of DNA-PKcs. While previously restricted to the end 
processing phase of cNHEJ, this body of work collectively shows that DNA-PKcs has three general 
functions: 1) End processing, 2) End ligation, and 3) End protection. Further, these distinct roles are 
regulated by varying types of phosphorylation. This thesis delved more deeply into the first two functions 
(end processing and end ligation) and opened the door onto the new territory of end protection. 
First, we explored more deeply the known role of DNA-PKcs during the end processing phase of 
cNHEJ. We used a mutation within the conserved PI3K kinase domain of DNA-PKcs to create a kinase 
dead version of DNA-PKcs to characterize the structural function of DNA-PKcs during cNHEJ. Using this 
kinase dead mouse model, we found that end processing does not strictly require DNA-PKcs 
autophoshorylation to complete hairpin opening. Instead, ATM kinase activity is required in the kinase dead 
DNA-PKcs background to facilitate end processing by the Artemis endonuclease. Second, we uncovered 
a novel role for DNA-PKcs in the end ligation phase of cNHEJ. Using this same kinase dead DNA-PKcs 
mouse model, we found that its participation in this novel end-ligation role or its known end-processing role 
depends on phosphorylation dependent regulation of DNA-PKcs. This phosphorylation is two-fold. First, 
ATM mediates DNA-PKcs activity during end processing, enabling hairpin opening in the absence of DNA-
PKcs kinase activity. Second, intermolecular, autophosphorylation of DNA-PKcs regulates a conformational 
change in the DNA-PKcs molecule that permits end access and ultimately end-ligation. This concept of a 
stuck or blocked DNA-PKcs molecule on DNA ends led us to consider a third, previously unconsidered, 




 We first considered an end protection role for DNA-PKcs during a subset of Alternative End Joining 
(A-EJ) that accounts for a large subset of junctions formed during Class Switch Recombination (CSR). This 
subset of A-EJ, which requires small regions of microhomologies, is also required to form translocation 
events. Thus, this type of end protection could be an important means of suppressing salvage repair 
pathways from mis-ligating DNA ends, giving rise to translocations and/or mutations. We expected that a 
stuck DNA-PKcs protein would block access to ends by the resection machinery required for A-EJ. 
However, we found that this is not the case in the context of the subset of A-EJ that occurs during CSR. 
However, while we found that the KD DNA-PKcs protein did not block A-EJ (had a similar elevated level as 
the XRCC4-deficient background), we did uncover an exciting role for the A-EJ pathway in DNA-PKcs 
deficient cells. In the DNA-PK null background, CSR junctions had elevated MH usage as XRCC4-deficient 
and KD DNA-PKcs junctions. This suggests that DNA-PKcs is more important to cNHEJ-mediated repair 
of switch regions breaks than previously appreciated. This could also potentially explain the lack of 
switching to other isotypes in the DNA-PKcs deficient background.  
 How does A-EJ overcome the “stuck” kinase dead DNA-PKcs protein? We hypothesize that the 
unique context of CSR provides the get-around to the blockage imposed by the KD-DNA-PKcs protein, 
allowing the A-EJ pathway a means to overcome the end protection role of the DNA-PKcs protein not readily 
available in other DNA break contexts. During CSR, AID continuously de-aminates cytosine nucleotides, 
creating a ready source of nicks that do not require resection, and perhaps creating a landing pad for the 
A-EJ machinery. 
 Finally, we considered an end protection role of DNA-PKcs outside of the known realms of cNHEJ 
and A-EJ. Specifically, we explored the potential role of DNA-PKcs outside of the G1/G0 cell cycle phase 
entirely. We created a mouse model that abolished all TQ phosphorylation sites within the T2609 cluster of 
DNA-PKcs. Despite dying by 3 weeks of bone marrow failure, DNA-PKcs5A/5A mice do not have severe end 
joining defects. However, we failed to find strong defects during V(D)J recombination or CSR, or to DNA 
damaging agents. Interestingly, the majority of abnormalities of DNA-PKcs5A/5A ES cells were chromatid 
breaks, suggesting an S phase defect. Further, DNA-PKcs5A/5A ES cells, but not MEFs, showed a 
proliferation defect. Together, we hypothesize that the DNA-PKcs5A/5A mutation has a role in the S phase, 
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where defects would be lead to chromatid breaks and preferential defects of ES cells and the 
HSC/progenitor compartment. Further, we are exploring a potential role for DNA-PKcs in nucleoli stress. 
 Specifically, we hypothesize that an end protection role of DNA-PKcs is particularly important 
during the nucleoli stress response, where a defect may be seen more strongly in highly proliferative cells. 
This could explain why the DNA-PKcs5A/5A mouse has particularly strong phenotypes in the hematopoietic 
stem cell (HSC), Red Blood Cell (RBC) and embryonic stem (ES) cell compartments. HSCs are known to 
have lower ribosome function than other hematopoietic cells, but any changes (gain or loss) in protein 
synthesis lead to proliferation defects. RBCs are also highly proliferative and require elevated protein 
synthesis. ES cells actually have lower levels of protein synthesis than their progeny, which has been 
suggested to promote ES cell maintenance. Despite the varying levels of protein synthesis in these cell 
types, they are all sensitive to changes in protein synthesis which could support a role for the 5A DNA-
PKcs protein in causing toxicity in these cells.  
 How could a DNA repair protein affect protein synthesis? What causes nucleoli stress? The nucleoli 
is the area in the nucleus where protein synthesis occurs, and thus where transcription machinery is active. 
As such, the nucleolus is also marked by high numbers of fragile sites in the rDNA, where stalled replication 
forks occur due to the collision of the transcription and replication machinery. Replication fork barriers 
(RRBs) exist in the rDNA to prevent these sorts of lesions, and are made of specific repeats of rDNA. 
Replisome protection (aka fork stalling) occurs by counteracting the Rrm3 helicase, and is required for fork 
arrest at RFBs. Repair of these stalled or collapsed forks at yeast rDNA loci causes array instability due to 
recombination driven gain or loss of rDNA copy numbers (Pliss et al., 2005).  
The ATM protein and the MRN complex (composed of Mre11, Rad50, and Nbs1) has been shown 
to be responsible for stabilizing and restarting stalled forks during replication stress (Trenz et al., 2006). 
Further, ATM has been shown to inhibit nucleolar transcription upon DSB induction (Shanbhag et al., 2010). 
Further, MRN (via the Mre11 protein), primes DNA at stalled forks by removing 5’ nucleotides to allow for 
Exo1 binding. Exo1 then performs the extensive 5’ end resection required for HR to begin (Mimitou and 
Symington, 2009), and ultimately to resolve stalled forks. While there is a clear role for ATM in modulating 
the cell’s response to stalled forks via MRN complex activation (Trenz et al., 2006), the role of DNA-PKcs, 
if any, is unclear. In vitro, it has been shown that DNA-PKcs can actually inhibit the Pol I transcription 
123 
 
machinery via phosphorylation of the Pol I transcription apparatus (Kuhn et al., 1995). Further, DNA-PKcs 
has been shown to inhibit Exo1-mediated resection, and this inhibition is dependent on the phosphorylation 
of DNA-PKcs (Zhou and Paull, 2013). Further, recent studies have suggested a role for DNA-PKcs at stalled 
replication forks (Lin et al., 2018; Ying et al., 2016), with a direct requirement for the kinase activity of DNA-
PKcs for fork restart. In addition, DNA-PKcs autophosphorylation at the S2056 cluster, which is blocked by 
BRCA1 to allow end processing/HR, has also been shown to be important in the pathway choice between 
cNHEJ and HR (Davis et al., 2014). Altogether, these data suggest that DNA-PKcs may be an important 
player in regulating the response to stalled forks.  
Given the nucleoli stress phenotype observed in the DNA-PKcs5A/5A model, we hypothesize that 
the DNA-PKcs protein may play an end protection role during periods of replication stress. In this model, 
the DNA-PKcs protein plays an end protection role at stalled forks to ensure proper pathway choice 
between cNHEJ and HR. This end protection role at stalled forks could be critical in the context of nucleoli 
stress, where fragile rDNA sites are common and complex responses may be required to respond to head 
to head transcription and replication machinery collisions. Here, DNA-PKcs may block end access to 
resection machinery until it receives an autophosphorylation signal to release. Autophosphorylation of DNA-
PKcs would then result in removal from DNA ends, as it does in the context of end ligation during cNHEJ. 
We would postulate that ATM may phosphorylate DNA-PKcs at the T2609 cluster to signal that the DNA-
PKcs protein should remain on the ends, possibly while the MRN complex assembles. ATM-mediated 
phosphorylation of the T2609 cluster would thus regulate retention of the DNA-PKcs protein on the ends. 
Further work needs to be done to test this model, since it is also entirely possible that DNA-PKcs is acting 
on transcription machinery, rather than in the direct response to replication stress.  
These proposed dynamics of phosphorylation could explain the phenotype of the DNA-PKcs5A/5A 
mice, and possibly of the DNA-PKcsKD/KDp53-/- mice. While the DNA-PKcs5A/5A mice and cells do not show 
strong repair defects, they do have moderate defects suggestive of replication stress issues, including 
fragile telomeres and a preponderance of chromatid breaks in ES cells. In our proposed model, cells 
expressing the 5A DNA-PKcs protein, which has intact auto-phosphorylation activity, would not receive 
ATM-mediated phosphorylation and would thus not be retained at the ends. Thus, there would be a loss of 
end protection, and possibly hyper-resection.  
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There is still the remaining question of why the DNA-PKcsKD/KDp53-/- mice die by ~3 weeks of age. 
Despite a similar time of death as the DNA-PKcs5A/5A mice, the DNA-PKcsKD/KDp53-/- mice do not show 
evidence of bone marrow failure or anemia. Interestingly, our mass spectrometry analyses of Flag tagged 
endogenous DNA-PKcs identified SP (Table 2-2 and Fig. 2-12D), but not TQ (which is just upstream of this 
SP site), phosphorylation within the T2609 cluster. Western blot analyses with phosphorylation specific 
antibodies suggest that the T2609 cluster was primarily phosphorylated by ATM in human cell lines and 
abolished by the ATM kinase inhibitor. Given our own findings from mass spectrometry, it remains possible 
that the 5A or the 3A mutation compromised SP phosphorylation by altering the recognition motif. If the SP 
motif is the critical phosphorylation residue within the T2609 cluster, then the lack of phosphorylation at this 
site in the DNA-PKcsKD/KDp53-/- mouse could potentially be the cause additional defects causing the more 
severe survival. Going forward, it would be interesting to create mutations at the SP site to formally test its 
importance. Further, the severity of the DNA-PKcsKD/KDp53-/- mouse suggests another repair pathway may 
be defective beyond the defects characterized in cNHEJ. This thesis established that A-EJ is largely intact 
in the DNA-PKcsKD/KDp53-/- background, at least in the context of the switch region and CSR. It remains 
possible that the A-EJ pathway is abrogated in other settings, but as a more minor pathway outside of CSR, 
it still unlikely to be able to explain the severity of the DNA-PKcsKD/KDp53-/-. The sum of these data point 
outside of G1/G0 cell cycle phase and into S/G2 and replication. Given our model of end protection at 
stalled forks, KD DNA-PKcs protein would be unable to auto-phosphorylate, and thus would be at the other 
end of the protection spectrum as the 5A DNA-PKcs protein, and not allow end access to resection 
machinery for stalled fork resolution.  
Given the potential importance of auto-phosphorylation at the S2056 cluster as discussed above, 
it is also worth further exploring the physiological role of phosphorylation at this cluster in regulating stalled 
fork resolution. Unfortunately, we were unable to detect the S2056 peptide through our mass spectrometry 
analyses. Despite that, it would be interesting to use our KD DNA-PKcs model to study the role of DNA-
PKcs phosphorylation and possible structural function at replication forks using DNA fiber techniques. If 
this relationship is true, it would be blocked in DNA-PKcsKD/KD cells, and could potentially explain the early 
lethality of the mouse model. 
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Altogether, my thesis expanded the understanding of the role of DNA-PKcs in end joining and 
outside of it. We have shown a novel phosphorylation dependent structural function of DNA-PKcs. We 
further characterized two types of DNA-PKcs phosphorylation (intermolecular, autophosphorylation and 
ATM-mediated trans-phosphorylation), which together regulate the end ligation and end processing phases 
of cNHEJ. We further showed that the A-EJ pathway is intact in the kinase dead DNA-PKcs background, 
but revealed an important role for DNA-PKcs in the Sγ1 region, where a lack of DNA-PKcs protein results 
in an increase of A-EJ. Finally, we explored the importance of the T2609 phosphorylation cluster of DNA-
PKcs, and explored the function of DNA-PKcs in hematopoiesis and nucleoli biogenesis stress. The DNA-
PKcs protein is no longer restricted to the end processing phase of cNHEJ. Cumulatively, DNA-PKcs can 
now be considered in three areas: end processing, end ligation, and end protection. The third realm of end 
protection is new territory for the DNA-PKcs protein, and leaves the door open for interesting future research 
to come.  
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DNA-PKcs-/-, Ku70+/-, Ku80+/-, XRCC4+/-, p53+/- and HLk/k mice and cells have been described before 
(Gao et al., 1998a; Gao et al., 1998b; Gu et al., 1997; Jacks et al., 1994; Nussenzweig et al., 1996; Pelanda 
et al., 1997; Sonoda et al., 1997). The DNA-PKcs KD mutation converts the conserved aspartic acid 3922 
within the putative catalytic loop to alanine (D3922A) (Fig. 2-1A). To generate the DNA-PKcs KD mutant 
allele, DNA sequences from the genomic DNA-PKcs (Prkdc) locus were generated via PCR from TC1 ES 
cell DNA (129 strain).  A targeting construct was designed to insert a NeoR gene cassette oriented in the 
same transcriptional orientation from the endogenous DNA-PKcs (Prkdc) promoter into intron 83 next to 
the D3922A mutation in exon 83. A 2.6 kb 5’ arm and 4.9 kb 3’arm were PCR generated separately, cloned 
into the pBK vector and sequenced. The 3’arm was directly subcloned into pLNTK in the desired orientation. 
The mutation was introduced into the 5’ arm using site-directed mutagenesis and confirmed by sequencing 
(Fig. 2-1B). The mutated 5’ arm (indicated by open box in (Fig. 2-1C) was then sub-cloned into pLNTK. The 
targeting construct was then electroporated into CSL3 ES cells (129 strain) and successful targeting was 
determined via Southern blot analyses using SpeI digested genomic DNA and a 5’ genomic probe as 
outlined in (Fig. 2-1C). The WT band is ~7.0kb and the targeting introduced an additional SpeI site and 
reduced the band to ~4.5kb (Fig. 2-1D). The correct clones were confirmed with a 3’ probe. A total of five 
independent targeted clones were sequenced for the DNA-PKcs KD mutation, 3 were verified with correct 
mutations. Two were injected for germ line transmission and yielded identical phenotypes (hereafter 
referred to as the DNA-PKcs KD allele). 
The DNA-PKcs 5A mutation converts all 5 Threonines in the T2609 cluster of exon 58 of DNA-
PKcs to Alanines. To generate the DNA-PKcs 5A mutant allele, DNA sequences (5’ and 3’ arms) from the 
genomic DNA-PKcs (Prkdc) locus were generated via PCR from TC1 ES cell DNA (129 strain) and cloned 
into pGEMT. The sequence confirmed 5’ arm (3kb) was then subcloned into the pEMCneo targeting vector. 
We synthesized a ~500bp fragment containing the mutations (Genewiz), inserted it into an extended 3’arm 
(4.4kb) in pGEMT, and confirmed by sequencing. The extended 3’arm containing the mutations was then 
inserted into the pEMCneo vector containing the 5’arm, and confirmed by sequencing. The 3’ and 5’ arms 
are separated by an Inverted Neo-Resistance (NeoR) gene flanked by a pair of FRT sites. The Sma1 
linearized plasmids were electroporated into murine ES cells (129Sv background) and NeoR+ clones were 
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isolated and screened by Southern blotting with SpeI digestion and a 5’ probe (Germline =14.7kb and 
targeted =5.8kb) (Fig.4-1B and C). 1 clone was correctly targeted (Fig.4-1C), was confirmed to have all 5 
TQ->AQ substitutions by sequencing (Fig.4-2), and was further verified by a NeoR probe for single target 
integration (Fig.4-1C) and injected for germline transmission. The resultant DNA-PKcs+/5AN mice (N for neo 
positive) were crossed with constitutively FLIpase expressing ROSA26AFLIP/FLIP mice (Jax stock number 
003946, also in 129Sv background) to remove the NeoR cassette and allow the expression of the DNA-
PKcs-5A allele.  
 
Generation of DNA-PKcs+/HA/Flag targeting construct 
To generate the DNA-PKcs HA/F tagged allele, DNA sequences from the genomic DNA-PKcs 
(Prkdc) locus were generated via PCR from TC1 ES cell DNA (Wild type 129 strain). A targeting construct 
was designed to insert a NeoR gene cassette oriented in the opposite transcriptional orientation from the 
endogenous DNA-PKcs (Prkdc) promoter into the intron between the first and second exons. A ~4.9kB 5’ 
arm and a ~3.2kb 3’arm were PCR generated separately and cloned into the pGEMT vector and 
sequenced. The 3’ arm was then subcloned into the pEMCneo vector and confirmed by sequencing. The 
HA/F tag was PCR amplified from the pWG-HA/F vector with overhanging restriction sites added to the 
primer ends. Corresponding sites in the 5’ arm (Sph and BsiWI) were used to subclone the HA/F tag into 
the pGEMT-5’arm, which was confirmed by sequencing. The tagged 5’arm was then subcloned into 
pEMCneo-3’arm and confirmed by sequencing. The targeting construct was then electroporated into CSL3 
and DNA-PKcsKD/KD ES cells (129 strain) and successful targeting was determined via Southern blot 
analyses using AflII digested genomic DNA and a 5’ genomic probe as outlined in (Fig. 2-11B). The 
untargeted band is ~8.5kb and the targeting destroyed an AflII site and increased the band to ~10.2kb (Fig. 
2-1B). The correct clones were confirmed with a 5’ probe, a neo probe and PCRs against both the 5’ and 
3’ arms, and 8 WT and 2 DNA-PKcs KD/KD clones were positive. 2 clones of each genotype were 
transfected with pGK-Flipase expressing vector to remove the NeoR cassette, subcloned, and then PCR 
screened for deletion confirmation. Finally, the clones were sequence confirmed and verified for protein 




Flag-DNA-PKcs purification and mass spectrometry analyses 
 Purified HA/F tagged DNA-PKcs+/+ (or 5A/5A) was treated with or without 30Gy IR and harvested 
immediately (~15 minutes) after. Cells were then lysed in a lysis buffer containing 50mM Tris.CL (pH 7.3), 
137mM NaCl, 10mM NaF, 1mM NaVO4, 10% glycerol, 1% Triton X-100, 0.2% Sarkosyl, Sigma protease 
inhibitor cocktail (Sigma P8340), 1mM PMSF, and 6.25U/ul Benzonase (EMD Millipore 71205). Cells were 
incubated in this lysis buffer for 1hr on ice, and then the same buffer with 5X EDTA (7.5mM, without 
benzonase) was added at 1/5th of the original lysate volume (for 1x, 0.5mM EDTA final). Cells were mixed 
and spun down at 4oC for 15 min at 13,000 rpm. Supernatants were transferred to a fresh tube and M2 
beads (washed in lysis buffer 2x first; Sigma A2220) were added. Sample was rotated overnight at 4oC. 
The following morning, beads were centrifuged at 4oC (5min, 400rpm), washed with lysis buffer, and 
transferred to a stoppered compact reaction column (Affymetrix 13928) with filters (Affymetrix 139121). 
Beads were then incubated with 3x flag peptide (Sigma F4799) while rotating at 4oC for 1 hour. Column 
stopper was removed, and the eluted Flag-DNA-PKcs was centrifuged at 4oC (30s, 200rpm) into a fresh 
tube. The purified protein was then concentrated with the ProteoExtract Protein Precipitation Kit (), 
according to the manufacturer’s instructions. After concentration, protein was run on a SDS-PAGE gel, 
stained with Super Blue Coomassie (Protea SB-G250). The band at 460kDa was excised and sent to the 
Taplin Mass Spectrometry Facility (Harvard) for trypsin and trypsin/chymotrypsin digestion followed by 
mass spectrometry for protein phosphorylation.  
 
V(D)J recombination assays. 
Chromosomal V(D)J recombination with an integrated substrate was carried out as described (Zha 
et al., 2011a).  Briefly, v-abl transformed pro-B-cell lines were isolated from various mouse lines that 
harbored an E-Bcl2 transgene. EµBcl2+ is included to prevent apoptosis associated with STI57I treatment 
(Zha et al., 2011b).  The pro-B lines were infected with the pMX-INV, or pMX-Del-SJ retroviral vector and 
assayed for V(D)J recombination as described. STI571 is used at 3µM and ATM inhibitor KU55933 is used 
at 15µM final concentration throughout the paper. The diagram of pMX-INV is shown in (Fig. 2-6A) and of 
pMX-SJ deletional substrates is shown in (Fig. 2-6E). For sequence analyses, the chromosomal SJs were 
amplified by PCR and cloned into the pGEMTeasy vector (Promega). Precise SJs reconstitute a restriction 
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site for ApaL1. Imprecise SJs were sequenced. Extra-chromosomal V(D)J recombination assays were 
performed in v-abl transformed cell lines as described before (Zha et al., 2011a).   
 
Lymphocyte development and Class Switch Recombination 
 Lymphocyte organs were evaluated for stage specific markers by flow cytometry as described 
previously (Rooney et al., 2002). CSR was performed on 6-10 week old mice as described previously(Liu 
et al., 2017). Breifly, splenic cells were sorted with CD43 magnetic beads (MACS, Miltenyi), cultured in 
RPMI medium at a density of 1x106 cells per ml in medium containing anti-CD40 (1ng/mL; BD Pharmingen) 
and IL-4 (20ng/ml; R&D). Cells were analyzed by flow cytometry at indicated days with the following 
antibodies: IgG1, BD Pharmingen and B220, eBioscience. In chapter 3, splenic B cells from young DNA-
PKcsKD/KD mice were stimulated for CSR at 3 weeks of age. To compensate for the young age and small 
stature of the mice (i.e. low B cell number), cells were not CD43 purified prior to stimulation.  
 
DNA-PKcs kinase activity 
 Specific DNA-PK kinase activity is measured in DNA-PKcs+/+, DNA-PKcs-/- and DNA-PKcsKD/KD 
MEFs using a DNA-PK kinase assay kit from Promega. The kit uses a scintillation counter to measure the 
release of p32 from ATP [-p32] as an indicator of kinase activity. A synthesized peptide is used as the 
substrate and calf thymus DNA is used to activate the DNA-dependent activity of DNA-PK. The assay was 
performed according to manufacture suggestions with following modifications to increase the specificity and 
sensitivity in murine cells:  ~5x107 highly confluent MEFs were used per assay (~50x) to enrich for G1/G0 
phase cells and to compensate the relative low expression of DNA-PK in murine cells in comparison to 
human cells, nuclear extract instead of the total cell lysates was used.  
 
Cas9 mediated deletion of Ku80 or Artemis 
 Guide RNA sequence targeting murine Ku80 (5’GTCCAGGACTCAGCTAGTTAAGG and 
5’GATCTCGGCATCCCTCATGCAGG) or Artemis (5’GTTCCCGGAAGTGGCGCCCAGG and 
5’GGTAAGACTAGACAGGGGTCTGG) were cloned into the pX330 Crispr plasmid (http://www.genome-
engineering.org/crispr/?page_id=23). PAMs are underlined.  A pair of gRNA containing plasmids were 
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electroporated into v-abl kinase transformed DNA-PKcsKD/KD cells using the 4D Nucleofector apparatus 
(Buffer SF, program N100, Lonza, Walkersville, MD). One day later, the cells were plated for single clones 
and PCR was used to screen each single clone for the deletion. When necessary, heterozygous targeted 
clones were subjected to a 2nd round of gRNA targeted deletion to remove the 2nd allele. Complete deletion 
was verified by Western blot for Ku80 or by sequencing the deletion junctions for Artemis. Reliable 
antibodies for murine Ku80 and Artemis are not available. However, Ku80 is required for the protein stability 
of Ku70, so we verified the functional loss of Ku80 by the absence of Ku70 protein in DNA-PKcsKD/KDKu80-
/- abelson lines. For Artemis deletion, we cloned and sequenced the deletional junction (Fig. 2-10A) and 
confirmed the loss of ATG and the first exon. The specificity of the deletion was further validated by 
reconstitution with wild type Ku80 (Fig. 2-6F) or Artemis (Fig. 2-10B). 
 In Chapter 4, the same gRNA sequences were used to delete Ku80 from DNA-PKcs+/+ and DNA-
PKcs5A/5A mice. P5 ES cells were transfected in suspension using lipofectamine onto a layer of irradiated 
MEF feeder cells, and medium was changed ~18hours later. After two days, cells were plated in a 1:10 
dilution series over 3x10cm dishes and grown out for 10 days for single clones. Single clones were then 
subjected to 2 PCR screens (Fig. 4-19E-F). The first screen verified targeting of the allele, while the second 
confirmed heterozygous versus homozygous deletion (Fig. 4-19E-F).  Two DNA-PKcs5A/5A ES cell lines 
had average targeting efficiencies of ~9% (24/257 clones) for homozygous deletion and ~4% (9/257 clones) 
for heterozygous deletion of Ku80. One DNA-Pkcs+/+ ES cell line had a targeting efficiency of ~2% (2/91 
clones) for homozygous deletion and ~10% (9/91 clones) for heterozygous deletion of Ku80. 
 
Laser induced recruitment of Artemis and Ligase 4.  
The open reading frames of Artemis or Lig 4 were cloned into the pEGFP-C1 vector (Clontech) in 
frame with GFP. Immortalized MEFs were transiently transfected with GFP-Artemis or GFP-Lig4 and 
seeded into special plates.  The recruitment of GFP-Artemis (Wei et al., 2013) or GFP-Lig4 (Li and Yu, 
2013) was performed as previously described. Briefly, Olympus FV1000 confocal microscopy 
(F10PRDMYR-1, Olympus) equipped with FV1000 SIM Scanner, the 405 nm laser diode (F10OSIM405, 
Olympus) and FV1000 software package was employed to induced DNA damage (output power at the 
lens5 mW/scan) and follow the recruitment of GFP-Artemis. The recruitment of GFP-Artemis to the laser 
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damaged area is quantified by calculating the ratio of the mean intensity between the sites of laser 
microirradiation/background area in the same nucleus. At least 10 cells were quantified at each time frame 
to obtain the average and standard deviation.  
 
IR sensitivity, proliferation, and colony size assays 
 DNA-PKcsKD/KD and DNA-PKcs5A/5A ES cells were derived from timed breeding of super-ovulated 
young female DNA-PKcs+/KD female mice and mature DNA-PKcs+/KD males as described before (Yamamoto 
et al., 2012). Colony survival assays and proliferation assay were performed as previously described 
(Rooney et al., 2003) in Chapter 2. In Chapter 4, sensitivity and proliferation assays performed in MEF 
(primary and immortalized) were done by seeding 2000 cells per well in gelatinized 96-well plates. 24 hours 
after plating, cells were treated with indicated doses of compounds for 4 days. The cell number was 
quantified using CyQuant (Molecular Probes), according to the manufacturer’s instructions. For ES cell 
sensitivity (in Chapter 4), ES cells were plated for clonogenic survival assays on an irradiated layer of MEF 
feeder cells. 24hours later, drug compounds at the indicated dose were added to the ES cells for 24 hours 
(except for MMC, which was 2 hours) and then released. 10 days later, cells were stained with Coomassie 
and manually counted. Quantification of colony size in untreated conditions and after Ku80 deletion (by 
Crispr) was done with the ColonyArea plugin in ImageJ (Guzman et al., 2014).  
 
Telomere-FISH and genomic instability 
ES cells, not grown on feeders (or P3 primary MEFs), were plated 24 hrs before the addition of 
colcemid (KaryoMAX Colcemid Solution, GIBCO) at 100 ng/ml for 2-3 hours.  Metaphases were prepared 
and hybridized with a Cy3-labled (CCCTAA)3 peptide nucleic acid probe (PNA, Biosynthesis Inc.) as 
described (Yamamoto et al., 2012; Zha et al., 2011a). Images were acquired using the Metasystem 
automatic Metaphase search and scan system equipped with the Plan Fluor Nikon Lens (63x/1.30 Oil, 
Japan). 
 
Murine rDNA FISH analyses 
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The murine rDNA repeat (BK000964) is approximately 42 kb in length with about 12 kb of which 
are transcribed to produce pre-rRNA and a 30 kb intergenic spacer (IGS). To visualize rDNA by FISH, we 
use a ~12 kb EcoR I restriction fragment that is positioned in the IGS immediately upstream of the gene 
promoter , similarly to what have been published for human rDNA FISH probe (REF 
https://www.ncbi.nlm.nih.gov/pubmed/27576706). Since there sequences are non-transcribed, so we can 
be certain that we are visualizing rDNA as opposed to rRNA. This rDNA FISH probe can readily identify 
individual nucleoli organization region (NOR) on metaphase spreads and reveal the variation in their rDNA 
content. The plasmid with the 12kb RI fragment was generously proved by Dr. Brian McStay at National 
University of Ireland Galway,Ireland. Standard nick translation labeling were used to label the IGS fragment 
with Biotin containing nucleotide and detected with Alexe488 conjungated anti-Biotin antibody (Molecular 
Probe). The slide is also counter stained with DAPI to visualize the DNA. The imagines were acquired using 
the Metasystem automatic Metaphase search and scan system equipped with the Plan Fluor Nikon Lens 




 The following antibodies were used for western blotting: HA (clone 3F10, 1:1000) from Roche, 
Vinculin (clone V284, 1:10,000) and Flag (F7425, 1:1000) from Sigma-Aldrich; phospho-Kap1 (Cat. #A300-
767A, 1:1000) from Bethyl laboratory; phospho-RPA pT21 (Cat. # ab109394, 1:5000) from Abcam; RPA 
(clone RPA30, 1:5000), γH2AX (Cat. #07-164, 1:1000) and H2AX (Cat. #07-627) from EMD Millipore; 
Kap1/TIF1β (clone C42G12, 1:1000) from Cell Signaling; and DNA-PKcs (clone 18-2 + 25-4 + 42-psc; 





Table 6-1: Primers used for HTGTS library creation. Nested primer (red colored sequence of the I5-
RED-Imu-Barcode primer previously published (Dong et al., 2015a).  
 
HTGTS 
 We performed HTGTS as previously described on sonicated (Diagenode Bioruptor) DNA recovered 
from CSR stimulated B cells on day 4 of stimulation (see above). Briefly, HTGTS uses a linear PCR from a 
specific bait site. In the case of CSR, the bait site is located at the telomeric end of Sµ (closer to JH4) (Fig. 
3-6), and we used the same primer designed in previous studies (Dong et al., 2015b; Hu et al., 2016b). 
After linear amplification, the resultant single-stranded DNA is streptavidin purified and ligated to an adapter 
followed by PCR amplification with a pair of barcoded primers specific for the adaptor and the original bait 
site (Table 6-1). A restriction enzyme specific to the bait site germline sequence (AflII) was used to eliminate 
germline sequences from the preliminary library. A final round of PCR was done to add the Illumina 
sequencing primers. After PAGE-gel mediated size selection, the library was paired-end sequenced in a 
pool on the Illumina MiSeq (2 x 300 bp) with about 1x106 reads per library. 
 To analyze these libraries, sequencing runs were demultiplexed and processed as described (Hu 
et al., 2016a). Since our HTGTS libraries were prepared from HL mice (prearranged Ig loci), which is an 
allele generated in the 129 background, we modified the mm9 genome for library alignment. To do so, we 
replaced the switch region from JH4 to the last Cα exon in mm9 (chr12 114494415-114666816) with the 
corresponding region in the AJ851868.3 129 IgH sequence (1415966-1592715) in the reverse 
complemented direction. The new genome assembly is called mm9sr. 
Name Primer Type Sequence (5'->3')
5’-Bio-Iµ LAM-PCR /5BiosG/CAGACCTGGGAATGTATGGT
I5-RED-Imu-BARCODE
Barcoded Nested Pimer, 
use with I7 Blue
TCTTTCCCTACACGACGCTCTTCCGATCTBARCODECACACAAAGACTCTGGACCTC
I7 Blue Universal Nested PCR; use with I5 RED-IMU CTCGGCATTCCTGCTGAACCGCTCTTCCGATCTGACTATAGGGCACGCGTGG
Bridge Adapter_Upper Bridge adapter GCGACTATAGGGCACGCGTGG(N1:25252525)(N1)(N1)(N1)(N1)(N1)/3AmMO/
Lower Bridge Adapter Bridge adapter /5Phos/CCACGCGTGCCCTATAGTCGC/3AmMO/
P5-I5
Universal Tag PCR, use 
with P7-I7 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT
P7-I7
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